<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29740280</article-id>
<article-id pub-id-type="pmc">5928253</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00132</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ali Rodriguez</surname>
<given-names>Rachel</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/518187/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Joya</surname>
<given-names>Christina</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/515618/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hines</surname>
<given-names>Rochelle M.</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/515143/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Neuroscience Emphasis, Department of Psychology, University of Nevada, Las Vegas</institution>, <addr-line>Las Vegas, NV</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Hansen Wang, University of Toronto, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Audrey Christine Brumback, University of Texas at Austin, United States; Arianna Maffei, Stony Brook University, United States</p>
</fn>
<corresp id="c001">*Correspondence: Rochelle M. Hines, <email>rochelle.hines@unlv.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>132</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>4</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Ali Rodriguez, Joya and Hines.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Ali Rodriguez, Joya and Hines</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The term neurodevelopmental disorder (NDD) is an umbrella term used to group together a heterogeneous class of disorders characterized by disruption in cognition, emotion, and behavior, early in the developmental timescale. These disorders are heterogeneous, yet they share common behavioral symptomatology as well as overlapping genetic contributors, including proteins involved in the formation, specialization, and function of synaptic connections. Advances may arise from bridging the current knowledge on synapse related factors indicated from both human studies in NDD populations, and in animal models. Mounting evidence has shown a link to inhibitory synapse formation, specialization, and function among Autism, Angelman, Rett and Dravet syndromes. Inhibitory signaling is diverse, with numerous subtypes of inhibitory interneurons, phasic and tonic modes of inhibition, and the molecular and subcellular diversity of GABA<sub>A</sub> receptors. We discuss common ribs of inhibitory synapse dysfunction in the umbrella of NDD, highlighting alterations in the developmental switch to inhibitory GABA, dysregulation of neuronal activity patterns by parvalbumin-positive interneurons, and impaired tonic inhibition. Increasing our basic understanding of inhibitory synapses, and their role in NDDs is likely to produce significant therapeutic advances in behavioral symptom alleviation for interrelated NDDs.</p>
</abstract>
<kwd-group>
<kwd>neurodevelopment</kwd>
<kwd>GABA A receptor</kwd>
<kwd>autism spectrum disorders</kwd>
<kwd>Rett Syndrome (RTT)</kwd>
<kwd>Angelman Syndrome</kwd>
<kwd>Dravet Syndrome</kwd>
<kwd>seizures</kwd>
<kwd>phasic and tonic inhibition</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="283"></ref-count>
<page-count count="23"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<p>
<bold>Highlights:</bold>
</p>
<list list-type="simple" prefix-word="simple">
<list-item>
<p>• Human studies and animal models need to be bridged in neurodevelopmental disorders</p>
</list-item>
<list-item>
<p>• Inhibitory signaling emerges as a common contributor to neurodevelopmental disorders</p>
</list-item>
<list-item>
<p>• Inhibitory signaling is diverse in mode, source, and target</p>
</list-item>
<list-item>
<p>• Systematic evaluation of inhibitory diversity is lacking in neurodevelopment</p>
</list-item>
<list-item>
<p>• Understanding of inhibitory signaling diversity will advance therapeutic strategies</p>
</list-item>
</list>
<sec>
<title>Introduction</title>
<p>Neurodevelopmental disorders (NDDs) are a broad class of disorders involving disruption in one or more domains including cognitive, emotional, motor, and/or behavioral function. NDDs affect up to 36.8% of children in low- and middle-income earning countries as evaluated in 2015 (<xref ref-type="bibr" rid="B25">Boivin et al., 2015</xref>; <xref ref-type="bibr" rid="B179">McCoy et al., 2016</xref>). Although NDDs have been the subject of extensive research, the common underlying mechanisms for behavioral and neurobiological symptomatology have yet to be systematically evaluated and compared among broad NDD subtypes. A basis for commonality among this complex and seemingly heterogeneous class of disorders lies in shared symptomatology (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>) and common genetic factors (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). Further, genetic studies are beginning to indicate converging biological and phenotypic traits in complex disorders such as NDDs (<xref ref-type="bibr" rid="B206">Parikshak et al., 2016</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Brief overview of symptom commonalities in NDDs.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Neurodevelopmental disorder</th>
<th align="left" colspan="1" rowspan="1" valign="top">Autism-like characteristics</th>
<th align="left" colspan="1" rowspan="1" valign="top">Intellectual disability</th>
<th align="left" colspan="1" rowspan="1" valign="top">Epilepsy</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">Characteristic</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Angelman</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rett</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prevalent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dravet</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rare</td>
<td align="left" colspan="1" rowspan="1" valign="top">Common</td>
<td align="left" colspan="1" rowspan="1" valign="top">Characteristic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Summary of genes and proteins linked to synaptic function that are implicated, either directly through mutation or indirectly as secondary effects, in neurodevelopmental and associated disorders.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene human mouse</th>
<th align="left" colspan="1" rowspan="1" valign="top">Encoded protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Localization and/or function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Human populations</th>
<th align="left" colspan="1" rowspan="1" valign="top">Mouse models</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA1 Gabra1</td>
<td align="left" colspan="1" rowspan="1" valign="top">α1 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enriched at synaptic sites on dendrites and soma, relatively rapid decay</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B56">Cossette et al., 2002</xref>) Dravet Syndrome (<xref ref-type="bibr" rid="B36">Carvill et al., 2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA2 Gabra2</td>
<td align="left" colspan="1" rowspan="1" valign="top">α2 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enriched at synaptic sites on AIS, and early in development, relatively slow decay</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dravet Syndrome (<xref ref-type="bibr" rid="B36">Carvill et al., 2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dravet Syndrome (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA3 Gabra3</td>
<td align="left" colspan="1" rowspan="1" valign="top">α3 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Found in phasic receptors predominantly on the dendrites, high sensitivity to GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B192">Niturad et al., 2017</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B192">Niturad et al., 2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA4 Gabra4</td>
<td align="left" colspan="1" rowspan="1" valign="top">α4 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extrasynaptic localization (tonic), diazepam insensitive, high sensitivity to GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B169">Ma et al., 2005</xref>; <xref ref-type="bibr" rid="B237">Sesarini et al., 2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA5 Gabra5</td>
<td align="left" colspan="1" rowspan="1" valign="top">α5 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extrasynaptic localization (tonic), diazepam insensitive, high sensitivity to GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angelman Syndrome (<xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>) ASD (Dup15q) (<xref ref-type="bibr" rid="B207">Park and Bolton, 2001</xref>; <xref ref-type="bibr" rid="B143">Kwasnicka-Crawford et al., 2007</xref>; <xref ref-type="bibr" rid="B66">Depienne et al., 2009</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B267">Vien et al., 2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRA6 Gabra6</td>
<td align="left" colspan="1" rowspan="1" valign="top">α6 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extrasynaptic localization (tonic), diazepam insensitive, high sensitivity to GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B107">Hernandez et al., 2011</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRB1 Gabra1</td>
<td align="left" colspan="1" rowspan="1" valign="top">β1 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histamine, benzodiazepine, and anesthetic sensitive</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B51">Collins et al., 2006</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRB2 Gabrb2</td>
<td align="left" colspan="1" rowspan="1" valign="top">β2 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histamine, benzodiazepine, and anesthetic sensitive</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B245">Srivastava et al., 2014</xref>) Schizophrenia (<xref ref-type="bibr" rid="B161">Lo et al., 2007</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRB3 Gabrb3</td>
<td align="left" colspan="1" rowspan="1" valign="top">β3 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (Dup15q) (<xref ref-type="bibr" rid="B207">Park and Bolton, 2001</xref>; <xref ref-type="bibr" rid="B143">Kwasnicka-Crawford et al., 2007</xref>; <xref ref-type="bibr" rid="B66">Depienne et al., 2009</xref>) Angelman Syndrome (<xref ref-type="bibr" rid="B253">Tanaka et al., 2012</xref>) Epilepsy (<xref ref-type="bibr" rid="B253">Tanaka et al., 2012</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angelman Syndrome (<xref ref-type="bibr" rid="B253">Tanaka et al., 2012</xref>) Epilepsy (<xref ref-type="bibr" rid="B253">Tanaka et al., 2012</xref>; <xref ref-type="bibr" rid="B267">Vien et al., 2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRG2 Gabrg2</td>
<td align="left" colspan="1" rowspan="1" valign="top">γ2 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Most common subunit in synaptic receptors, relatively large channel conductance</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B17">Baulac et al., 2001</xref>; <xref ref-type="bibr" rid="B271">Wallace et al., 2001</xref>) Dravet Syndrome (<xref ref-type="bibr" rid="B114">Huang et al., 2012</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRG3 Gabrg3</td>
<td align="left" colspan="1" rowspan="1" valign="top">γ3 subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (Dup15q) (<xref ref-type="bibr" rid="B207">Park and Bolton, 2001</xref>; <xref ref-type="bibr" rid="B143">Kwasnicka-Crawford et al., 2007</xref>; <xref ref-type="bibr" rid="B66">Depienne et al., 2009</xref>) Angelman Syndrome (<xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRD Gabrd</td>
<td align="left" colspan="1" rowspan="1" valign="top">δ subunit of the GABA<sub>A</sub> receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Extrasynaptic localization (tonic), diazepam insensitive, high sensitivity to GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B170">Macdonald et al., 2012</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy (<xref ref-type="bibr" rid="B170">Macdonald et al., 2012</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GPHN Gphn</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gephyrin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scaffolding protein of inhibitory synapses, protein–cytoskeleton interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B44">Chen et al., 2014</xref>)-rare</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARHGEF9 Arhgef9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rho guanine nucleotide exchange factor 9/collybistin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scaffolding protein of inhibitory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B44">Chen et al., 2014</xref>)-rare Hyperekplexia (<xref ref-type="bibr" rid="B257">Tijssen and Rees, 1993</xref>; <xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>; <xref ref-type="bibr" rid="B4">Alber et al., 2017</xref>) Intellectual disability (<xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>; <xref ref-type="bibr" rid="B163">Long et al., 2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperekplexia (<xref ref-type="bibr" rid="B257">Tijssen and Rees, 1993</xref>; <xref ref-type="bibr" rid="B101">Harvey et al., 2004</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NRXN1 Nrxn1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell surface proteins involved in cell–cell interactions, export of secretory granules and modulation of signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>; <xref ref-type="bibr" rid="B44">Chen et al., 2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>; <xref ref-type="bibr" rid="B94">Grayton et al., 2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NRXN2 Nrxn2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NRXN3 Nrxn3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CNTNAP2 Cntnap2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin associated protein-like 2 CSPR2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Role player in formation of domains for salutatory conduction of nervous impulses, part of neurexin family</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B121">Jacob, 2016</xref>; <xref ref-type="bibr" rid="B223">Rodenas-Cuadrado et al., 2016</xref>) Epilepsy (<xref ref-type="bibr" rid="B121">Jacob, 2016</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B209">Peñagarikano et al., 2011</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NLGN1 Nlgn1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell surface protein with role in synapse function via interaction with neurexin, localized at excitatory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>; <xref ref-type="bibr" rid="B44">Chen et al., 2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B60">Dahlhaus et al., 2010</xref>) Rett Syndrome (<xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>) Fragile-X (<xref ref-type="bibr" rid="B59">Dahlhaus and El-Husseini, 2010</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NLGN2 Nlgn2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scaffolding protein that interacts with neurexins to aid in cell–cell interaction, localized at inhibitory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B109">Hines et al., 2008</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NLGN3 Nlgn3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell surface protein with role in synapse function via interaction with neurexin, localized at excitatory and inhibitory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B250">Tabuchi et al., 2007</xref>; <xref ref-type="bibr" rid="B125">Jaramillo et al., 2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NLGN4 Nlgn4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell surface protein involved in cell–cell interactions, localized at inhibitory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B124">Jamain et al., 2008</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CNTN Cntn</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactins</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mediators of cell surface interactions during nervous system development</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B13">Bakkaloglu et al., 2008</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SHANK2 Shank2</td>
<td align="left" colspan="1" rowspan="1" valign="top">SH3 and multiple ankyrin repeat domains protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scaffolding protein of inhibitory synapses</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B235">Schmeisser et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SHANK3 Shank3</td>
<td align="left" colspan="1" rowspan="1" valign="top">SH3 and multiple ankyrin repeat domains protein 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B73">Durand et al., 2007</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD (<xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>; <xref ref-type="bibr" rid="B180">McGee et al., 2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MECP2 Mecp2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methyl-CpG-binding protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chromosomal protein that binds to DNA that has been methylated</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett Syndrome (<xref ref-type="bibr" rid="B140">Kozinetz et al., 1993</xref>; <xref ref-type="bibr" rid="B6">Amir et al., 1999</xref>; <xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>) ASD (<xref ref-type="bibr" rid="B253">Tanaka et al., 2012</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett Syndrome (<xref ref-type="bibr" rid="B41">Chao et al., 2007</xref>; <xref ref-type="bibr" rid="B181">Medrihan et al., 2008</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">UBE3A Ube3a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ubiquitin-protein ligase E3A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Accepts ubiquitin from E2 and transfers to substrate</td>
<td align="left" colspan="1" rowspan="1" valign="top">Angelman Syndrome (<xref ref-type="bibr" rid="B126">Jiang et al., 1998</xref>; <xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>) Epilepsy (<xref ref-type="bibr" rid="B126">Jiang et al., 1998</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Autism spectrum disorder (ASD) is a prototypical NDD, and acts as a reference point for this class of disorders, with others often being described as possessing “autistic-like features.” Features of ASD include any range of impairments in social interaction, language development, and cognition, along with stereotyped behavior, and restricted interests (<xref ref-type="bibr" rid="B219">Rapin and Katzman, 1998</xref>). In addition to these core features, ASD is also frequently associated with epilepsy, impaired sensory processing, hyperactivity, and disrupted brain activity patterns as characterized by electroencephalogram (EEG) recordings (<xref ref-type="bibr" rid="B225">Rubenstein and Merzenich, 2003</xref>). These associated symptoms, in particular, hint that impaired inhibitory signaling is a contributor to ASD.</p>
<p>Other NDDs with similar symptoms to ASD, including Rett Syndrome (RS) and Angelman Syndrome (AS), have a clear genetic cause (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). Specifically, RS is linked to the MECP2 gene (<xref ref-type="bibr" rid="B14">Banerjee et al., 2012</xref>), and AS linked to UBE3A and/or GABA<sub>A</sub>R subunit dysfunction through a loss of activity within the 15q11-13 locus (<xref ref-type="bibr" rid="B172">Malzac et al., 1998</xref>). The monogenetic nature of these disorders raises them as attractive targets to begin investigating NDDs. This is in contrast to ASD that is linked to an extremely heterogeneous and inconsistent genetic profile (<xref ref-type="bibr" rid="B113">Hu and Steinberg, 2009</xref>; <xref ref-type="bibr" rid="B112">Hu et al., 2009</xref>). Strikingly, RS and AS often share features of ASD, including the associated symptoms indicative of impaired inhibitory signaling. RS and AS also have a high incidence of epilepsy, with the vast majority of patients being affected by seizures (<xref ref-type="bibr" rid="B84">Fiumara et al., 2010</xref>; <xref ref-type="bibr" rid="B268">Vignoli et al., 2017</xref>). Comparing and contrasting the current knowledge on these disorders stands to provide information about the common neuropathological underpinnings of NDDs. In particular, examination of their association with epilepsy and other indications of impaired inhibitory control of principal cell firing, alongside an analysis of inhibitory synapse dysfunction could advance our understanding.</p>
<p>In typical development of the central nervous system, excitatory and inhibitory signals work in concert achieving regulated and orchestrated signaling patterns or oscillations. This tenet is the basis for a theory originally proposed by <xref ref-type="bibr" rid="B225">Rubenstein and Merzenich (2003)</xref>, which suggests that NDDs are the result of an atypical “balance” between excitation and inhibition. An “imbalance” is proposed to increase the signal-to-noise ratio and decrease the efficiency of processing in afflicted individuals, leaving the cortex susceptible to seizures and other dysfunctional symptoms linked to hyperexcitability (<xref ref-type="bibr" rid="B225">Rubenstein and Merzenich, 2003</xref>). Mounting evidence is demonstrating that a number of genetic mutations can disrupt this balance, and in the case of NDDs, can tip the balance toward excitation at the expense of inhibition, contributing to multiple symptoms including a lower seizure threshold and a high incidence of epilepsy. Although the concept of an excitatory-inhibitory balance has been useful in understanding pathological and non-pathological brain states, it is likely an oversimplification and may not be sufficient to explain the immense heterogeneity and complex etiology of NDDs.</p>
<p>To advance from the excitatory-inhibitory balance hypothesis we need to understand synapses more fundamentally in the brain, particularly during development. We need both more detailed understanding of the developmental regulation of specific synapse types and implications for network activity, as well as more global understanding of the functional intersection between molecular and ionic states, synapse types, and network signaling during development. The current state of knowledge on inhibitory synapse development and regulation is limited compared to that of excitatory glutamatergic synapses. Furthering research in the field of inhibitory synapse development is essential to gaining insight into how this system impacts typical and atypical neurodevelopment. This review will examine the commonalities between seemingly heterogeneous NDDs, highlighting common genetic links and evidence of inhibitory synaptic dysfunction, in pursuit of a common rib in the umbrella of NDD.</p>
</sec>
<sec>
<title>Inhibitory Signaling</title>
<p>Neuronal network signaling relies not only on excitation, but also heavily on inhibition to spatially and temporally pattern principal cell activity. Inhibition in the brain is governed by interneurons that synthesize and release the neurotransmitter γ-aminobutyric acid (GABA). A large body of work has documented and characterized 16 subtypes of interneurons in the hippocampus and/or cortex that possess unique morphologies, differential protein expression patterns, and specialized connectivity, physiological function, and functional impact within neuronal networks (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>; <xref ref-type="bibr" rid="B138">Klausberger and Somogyi, 2008</xref>; <xref ref-type="bibr" rid="B210">Petilla Interneuron Nomenclature Group et al., 2008</xref>). A number of these interneuron types are relevant to the investigation of inhibitory signaling in NDD, due to their enrichment in cortical circuitry, and implication in patterning network activity. The majority of hippocampal and cortical interneurons express either the calcium binding protein Parvalbumin (PV), or the neuropeptide cholecystokinin (CCK) (<xref ref-type="bibr" rid="B138">Klausberger and Somogyi, 2008</xref>; <xref ref-type="bibr" rid="B210">Petilla Interneuron Nomenclature Group et al., 2008</xref>). PV-positive axo-axonic chandelier cells innervate the axon initial segment (AIS) of principal cells at or near the site of action potential generation, and can coordinate the activity of the up to 1,200 cells that they innervate (<xref ref-type="bibr" rid="B155">Li et al., 1992</xref>; <xref ref-type="bibr" rid="B138">Klausberger and Somogyi, 2008</xref>; <xref ref-type="bibr" rid="B210">Petilla Interneuron Nomenclature Group et al., 2008</xref>). PV-positive and CCK-positive basket cells innervate the soma and proximal dendrites of principal cells, and again play a role in coordinating activity patterns due to proximity to the AIS (<xref ref-type="bibr" rid="B85">Freund and Katona, 2007</xref>; <xref ref-type="bibr" rid="B138">Klausberger and Somogyi, 2008</xref>; <xref ref-type="bibr" rid="B210">Petilla Interneuron Nomenclature Group et al., 2008</xref>). In the cortex, Martinotti cells express the neuropeptide somatostatin (SOM) and innervate the dendrites of principal cells, providing local effects on incoming excitatory input (<xref ref-type="bibr" rid="B227">Rudy et al., 2011</xref>). In addition, hippocampal and cortical networks also include interneurons that innervate interneurons, thereby acting in a disinhibitory manner (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). One example in the cortex is a type of bipolar cell that is positive for the neuropeptide vasoactive intestinal polypeptide (VIP), which have been shown to target the majority of PV-positive interneurons (<xref ref-type="bibr" rid="B61">Dávid et al., 2007</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Interneurons contact multiple domains of their postsynaptic targets producing different forms of phasic inhibition. Somatostatin (SOM) positive Martinotti cells contact the dendritic domain to provide local inhibitory influences on excitatory inputs. Basket cells positive for CCK contact the soma where GABA<sub>A</sub>Rs containing the α2/3 subunits are enriched, while basket cells positive for parvalbumin (PV) contact the cell body at sites enriched with α1 containing GABA<sub>A</sub>Rs. PV positive chandelier cells project to the axon initial segment where GABA<sub>A</sub>Rs containing the α2 subunit are enriched. Somatic and axonal inhibition plays a role in coordinating neural activity patterns due to the proximity of the incoming graded potentials to the site of action potential generation. Disinhibitory interneurons innervate other interneurons providing net excitation, as seen with vasoactive intestinal polypeptide (VIP) positive bipolar cells.</p>
</caption>
<graphic xlink:href="fnmol-11-00132-g001"></graphic>
</fig>
<p>Once released by interneurons, GABA acts on ionotropic GABA type <sub>A</sub> receptors (GABA<sub>A</sub>Rs; as well as metabotropic GABA type <italic><sub>B</sub></italic> receptors). GABA<sub>A</sub>Rs are heteropentamers gating a chloride channel, composed of combinations of subunits from seven families: α(1-6), β(1-3), γ(1-3), δ, ε, θ, π, and ρ(1-3) (<xref ref-type="bibr" rid="B226">Rudolph and Möhler, 2006</xref>). The genes and protein products for the most abundant CNS subunits are briefly described in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold> and depicted in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>. Subtypes of GABA<sub>A</sub>Rs composed of different subunit combinations have specific localization patterns and diverse functional impacts. In addition, GABA<sub>A</sub>Rs can be found at both synaptic and extrasynaptic sites mediating functionally distinct modes of inhibition (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). The most abundant subtypes of GABA<sub>A</sub>Rs are synaptic, sensitive to benzodiazepines, and composed of α1-3, β1-3, and γ2 subunits (<xref ref-type="bibr" rid="B168">Lüscher and Keller, 2004</xref>; <xref ref-type="bibr" rid="B226">Rudolph and Möhler, 2006</xref>; <xref ref-type="bibr" rid="B122">Jacob et al., 2008</xref>). In contrast, extrasynaptic, benzodiazepine insensitive receptors typically contain α4-6, β2/3, and δ subunits (<xref ref-type="bibr" rid="B106">Herd et al., 2013</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Molecular characterization of phasic and tonic modes of inhibition. Fast inhibitory synaptic transmission, also known as phasic inhibition, is governed by GABA<sub>A</sub>R’s with relatively low sensitivity to GABA densely clustered at sites opposing interneuron terminal boutons. Several general factors have been identified that play a role in establishing the contact between pre and post (neurexin-neuroligin2/3; neurexin-dystroglycan), and/or retaining receptors at these sites (gephyrin, collybistin). Phasic GABA<sub>A</sub>Rs are most commonly composed of 2-α1-3, 2-β, and a γ subunit and are sensitive to benzodiazepines. Tonic inhibition is governed by GABA<sub>A</sub>R’s that reside outside of synaptic sites, are highly sensitive to GABA, and are most commonly composed of 2-α4-6, 2-β, and a δ subunit. Much less is known about the mechanisms that localize extrasynaptic GABA<sub>A</sub>Rs, but radixin is implicated.</p>
</caption>
<graphic xlink:href="fnmol-11-00132-g002"></graphic>
</fig>
<p>In addition to modulation by benzodiazepines, synaptic GABA<sub>A</sub>Rs are also the site of action for non-benzodiazepine Z-drugs (<xref ref-type="bibr" rid="B69">Dixon et al., 2015</xref>), and barbiturates, while extrasynaptic GABA<sub>A</sub>Rs are thought to be the site of action of intravenous and inhaled anesthetics (<xref ref-type="bibr" rid="B46">Chiara et al., 2016</xref>), anesthetic steroids, neurosteroids and other exogenous modulators such as ethanol (<xref ref-type="bibr" rid="B30">Brickley and Mody, 2012</xref>; <xref ref-type="bibr" rid="B242">Sigel and Steinmann, 2012</xref>; <xref ref-type="bibr" rid="B200">Olsen, 2015</xref>). In addition to clinically relevant ligands, there are also a number of preclinical or experimental ligands such as muscimol (synaptic), and gaboxadol (extrasynaptic), and the channel blocker picrotoxin (<xref ref-type="bibr" rid="B242">Sigel and Steinmann, 2012</xref>; <xref ref-type="bibr" rid="B200">Olsen, 2015</xref>). The diversity of localization and function, paired with the clear clinical and behavioral impact of pharmacological manipulation, make GABA<sub>A</sub>Rs an important target of study.</p>
<sec>
<title>Synaptic GABA<sub>A</sub> Receptors – Phasic Inhibition</title>
<p>GABA<sub>A</sub>Rs located at synaptic contacts are activated in a transient or ‘phasic’ manner by a high concentration of GABA released from presynaptic vesicles (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, right). GABA released from the presynaptic neuron bind to GABA<sub>A</sub>Rs gating a channel permeable to chloride and bicarbonate ions at the postsynaptic membrane. Generally, this leads to a net inward flow of anions, and a hyperpolarizing postsynaptic response known as the inhibitory postsynaptic potential (IPSP). Defining features of this phasic mode of receptor activation are the rapid synchronous opening of a relatively small number of channels that are clustered at the synaptic junction and the short duration of the GABA transient to which the postsynaptic receptors are exposed. Phasic receptors enriched at synapses are most commonly characterized by two α(1-3), two β, and one γ subunit.</p>
<p>The clustering and accumulation of GABA<sub>A</sub>Rs at synaptic sites relies upon the interaction of multiple receptor-associated, adhesion, and scaffolding proteins diagramed in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, including gephyrin (<xref ref-type="bibr" rid="B259">Tretter et al., 2008</xref>, <xref ref-type="bibr" rid="B260">2011</xref>; <xref ref-type="bibr" rid="B188">Mukherjee et al., 2011</xref>), collybistin (<xref ref-type="bibr" rid="B228">Saiepour et al., 2010</xref>), neuroligin 2 (<xref ref-type="bibr" rid="B47">Chih et al., 2005</xref>; <xref ref-type="bibr" rid="B216">Poulopoulos et al., 2009</xref>), neurexin (<xref ref-type="bibr" rid="B280">Zhang et al., 2010</xref>), and the dystroglycan, dystrophin–glycoprotein complex (<xref ref-type="bibr" rid="B203">Panzanelli et al., 2011</xref>; <xref ref-type="bibr" rid="B87">Früh et al., 2016</xref>). Despite a common pool of interacting proteins, heterogeneity exists in the complex mechanisms governing clustering of receptors containing different subunits. Composition is likely dependent upon the combination of interacting proteins involved, and their relative interaction affinities.</p>
<p>Inhibitory synapses that generate phasic inhibitory signals can be found on multiple compartments of the cell including the dendrites, axon, and cell body (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). For example, receptors containing α1 subunits are enriched at inhibitory synapses on the dendrites, those containing α2 subunits are preferentially enriched at inhibitory synapses on the AIS, and both α1 and α2 subunits can be found clustered at somatic inhibitory synapses (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>; <xref ref-type="bibr" rid="B195">Nusser et al., 1996</xref>; <xref ref-type="bibr" rid="B85">Freund and Katona, 2007</xref>; <xref ref-type="bibr" rid="B89">Gao and Heldt, 2016</xref>). AIS synapses are unique to principal neurons in the hippocampus and cortex, and are thought to control principal cell activity patterns by influencing the site of action potential generation (<xref ref-type="bibr" rid="B142">Kuba et al., 2010</xref>; <xref ref-type="bibr" rid="B273">Wefelmeyer et al., 2015</xref>). As mentioned above, AIS synapses originate from chandelier cells, which are highly specialized, fast-spiking, PV-positive interneurons (<xref ref-type="bibr" rid="B155">Li et al., 1992</xref>; <xref ref-type="bibr" rid="B138">Klausberger and Somogyi, 2008</xref>; <xref ref-type="bibr" rid="B210">Petilla Interneuron Nomenclature Group et al., 2008</xref>). The cortex is also enriched with PV-positive, fast-spiking basket cells, and CCK positive basket cells. CCK positive basket cell terminals contact the soma of pyramidal cells where clusters of GABA<sub>A</sub>Rs containing the α2/3 subunits are enriched (<xref ref-type="bibr" rid="B197">Nyíri et al., 2001</xref>). The formation and maintenance of CCK terminals on the soma has recently been linked to dystroglycan, a protein responsible for many inherited forms of muscular dystrophy (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>; <xref ref-type="bibr" rid="B87">Früh et al., 2016</xref>). Outside of the role for dystroglycan in CCK-basket cell contacts on the soma, detailed information about the mechanisms of other specialized subtypes of inhibitory synapses, such as those localized to the AIS is lacking.</p>
<p>In addition to localization and related impacts on function, subunit contents have also been shown to influence the physiological properties of GABA<sub>A</sub>Rs including the decay time of GABA-activated currents within single cells. Presence of a β2 subunit results in a decreased period of time in which the receptor chloride channel is open—leading to faster desensitization. In contrast, the γ2 subunit results in channels with larger conductance (<xref ref-type="bibr" rid="B264">Verdoorn et al., 1990</xref>). In addition, α1 subunit containing receptors show faster decay times compared to α2 containing receptors (<xref ref-type="bibr" rid="B146">Lavoie et al., 1997</xref>; <xref ref-type="bibr" rid="B76">Eyre et al., 2012</xref>).</p>
</sec>
<sec>
<title>Extrasynaptic GABA<sub>A</sub> Receptors – Tonic Inhibition</title>
<p>GABA<sub>A</sub>R activation can also take place in a less spatially and temporally restricted manner to generate a ‘tonic’ conductance (<xref ref-type="bibr" rid="B196">Nusser et al., 1998</xref>; <xref ref-type="bibr" rid="B77">Farrant and Nusser, 2005</xref>; <xref ref-type="bibr" rid="B108">Hines et al., 2012</xref>; <xref ref-type="bibr" rid="B149">Lee and Maguire, 2014</xref>). Low GABA concentrations in the extracellular space escaping from the synaptic cleft can activate GABA<sub>A</sub>Rs distant from sites of neurotransmitter release (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, left; <xref ref-type="bibr" rid="B77">Farrant and Nusser, 2005</xref>; <xref ref-type="bibr" rid="B108">Hines et al., 2012</xref>). The tonic mode of receptor activation has one straightforward outcome: a persistent increase in the cell’s input conductance. This increase in conductance affects the magnitude and duration of the voltage response to an injected current, and increases the decrement of voltage with distance (<xref ref-type="bibr" rid="B77">Farrant and Nusser, 2005</xref>; <xref ref-type="bibr" rid="B32">Bright and Smart, 2013</xref>). Tonic GABA<sub>A</sub>Rs exhibit a high sensitivity to GABA and show little desensitization, allowing them to detect and respond to ambient levels of GABA at extrasynaptic sites (<xref ref-type="bibr" rid="B194">Nusser and Mody, 2002</xref>; <xref ref-type="bibr" rid="B77">Farrant and Nusser, 2005</xref>; <xref ref-type="bibr" rid="B108">Hines et al., 2012</xref>). Tonic receptors are most commonly characterized by two α(4-6), two β and one δ subunit (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, left). GABA<sub>A</sub>Rs containing δ subunits tend to be purely extrasynaptic (<xref ref-type="bibr" rid="B77">Farrant and Nusser, 2005</xref>; <xref ref-type="bibr" rid="B149">Lee and Maguire, 2014</xref>). The α4 and α6 subunits are diazepam-insensitive receptors, as their inclusion results in decreased sensitivity to complete desensitization to benzodiazepine binding on the receptor (<xref ref-type="bibr" rid="B274">Whiting et al., 1995</xref>). While the complex mechanisms governing localization of GABA<sub>A</sub>Rs at synaptic sites have been somewhat clarified, very little is known about the mechanisms that are involved in regulation of extrasynaptic GABA<sub>A</sub>Rs. One of the few proteins implicated in regulation of extrasynaptic GABA<sub>A</sub>Rs is radixin, which has been shown to influence clustering of α5 containing receptors (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, left; <xref ref-type="bibr" rid="B162">Loebrich et al., 2006</xref>). Further research is needed to understand how these receptors are localized and regulated, and also to understand further how their action may be harnessed to control excitation.</p>
</sec>
<sec>
<title>Chloride Ion Reversal and GABA Signaling</title>
<p>Another factor that can modulate the efficacy of GABAergic inhibition is the reversal potential for GABA<sub>A</sub> (EGABA) receptor-mediated current and voltage responses. EGABA is controlled by the equilibrium potential for chloride (ECl) which in turn is regulated by the expression and function of cation-chloride cotransporters (CCCs; <xref ref-type="bibr" rid="B222">Rivera et al., 2005</xref>; <xref ref-type="bibr" rid="B19">Ben-Ari et al., 2007</xref>; <xref ref-type="bibr" rid="B18">Ben-Ari, 2014</xref>; <xref ref-type="bibr" rid="B129">Kaila et al., 2014</xref>). Two key members of the CCC family for controlling neuronal ECl are the potassium chloride cotransporter (KCC2) and the sodium potassium chloride cotransporter (NKCC1) which provide outwardly and inwardly directed chloride fluxes in neuronal cells, respectively (<xref ref-type="bibr" rid="B19">Ben-Ari et al., 2007</xref>; <xref ref-type="bibr" rid="B100">Hartmann and Nothwang, 2014</xref>; <xref ref-type="bibr" rid="B70">Doyon et al., 2016</xref>). In mature neurons, chloride is extruded by high levels of expression and function of KCC2, using the potassium gradient in order to maintain a low intracellular chloride concentration (<xref ref-type="bibr" rid="B19">Ben-Ari et al., 2007</xref>; <xref ref-type="bibr" rid="B70">Doyon et al., 2016</xref>). A low intracellular concentration of chloride is important to maintaining the driving force of chloride, such that when GABA binds, chloride will enter the cell through the pore of the GABA<sub>A</sub>R and hyperpolarize the cell (<xref ref-type="bibr" rid="B18">Ben-Ari, 2014</xref>; <xref ref-type="bibr" rid="B129">Kaila et al., 2014</xref>). Early in development, KCC2 is low in expression and activity in neurons leading to a high intracellular chloride concentration (<xref ref-type="bibr" rid="B19">Ben-Ari et al., 2007</xref>; <xref ref-type="bibr" rid="B18">Ben-Ari, 2014</xref>). High levels of chloride inside the neuron cause depolarization in response to GABA<sub>A</sub>R activation, and under specific conditions, excitatory GABAergic transmission (<xref ref-type="bibr" rid="B222">Rivera et al., 2005</xref>; <xref ref-type="bibr" rid="B19">Ben-Ari et al., 2007</xref>; <xref ref-type="bibr" rid="B129">Kaila et al., 2014</xref>). Excitatory GABA is proposed to play a trophic role in early development, with important effects on the cell cycle, cell migration, and primitive oscillatory patterns thought to influence network wiring (<xref ref-type="bibr" rid="B221">Represa and Ben-Ari, 2005</xref>). During development there is a caudal to rostral gradient in the increase of KCC2 expression, with the cortex showing continued increases in KCC2 expression well after birth (<xref ref-type="bibr" rid="B129">Kaila et al., 2014</xref>). Beyond the developmental state of high intracellular chloride and depolarizing GABA, it is now established that pathological states including epilepsy and trauma are also characterized by reduced KCC2 expression and high intracellular chloride (<xref ref-type="bibr" rid="B129">Kaila et al., 2014</xref>). Further understanding is required about the conditions for inducing change in the expression of KCC2, and also for the implications, that this has on circuit level function.</p>
<p>Understanding the distinctive functional contributions of GABAergic synapses on specific subcellular compartments, phasic and tonic forms of GABAergic signaling, as well as the impact of alterations in ECl will lead to greater ability to fine tune inhibitory signaling. An understanding that is currently lacking is of the neurodevelopmental processes that establish and maintain the structurally and functionally distinctive types of GABAergic synapses, as well as the roles for tonic inhibition throughout development. Further, we are continuing to understand the roles of excitatory GABA early in development. We need to evaluate perturbations in each of these specializations of GABAergic signaling in NDDs with a subunit specific, cell-domain specific level of detail, deciphering precisely which subtypes of GABA<sub>A</sub>Rs are affected, and what role the transition from excitatory to inhibitory GABA may play. In the following sections, we will describe the features of specific NDDs and highlight existing studies that have assessed GABAergic signaling in either NDD populations or disease models.</p>
</sec>
</sec>
<sec>
<title>Autism Spectrum Disorders</title>
<p>Autism spectrum disorder affects boys more commonly than girls, with a ratio between 3:1 and 4:1, with a prevalence of 1 in 54 boys (<xref ref-type="bibr" rid="B57">Coury et al., 2014</xref>; <xref ref-type="bibr" rid="B164">Loomes et al., 2017</xref>). The disorder is characterized by core symptomatology that includes compulsive or repetitive behaviors and social communication deficits (American Psychiatric Association, Diagnostic and Statistical Manual 5th Edn). These core symptoms are often accompanied by intellectual disability, sensory sensitivity, and seizures. Seizures (and/or epilepsy) occur in ∼30–60% of individuals with ASD (<xref ref-type="bibr" rid="B225">Rubenstein and Merzenich, 2003</xref>; <xref ref-type="bibr" rid="B121">Jacob, 2016</xref>). Historically, the relationship between ASD and abnormal EEG recordings was the first reason it was considered a brain disorder (<xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>). This suggests that altered oscillatory activity is a prominent feature of ASD. The heritability of ASD has been studied in family and twin studies and shows a heritability rate of 70% (<xref ref-type="bibr" rid="B256">Tick et al., 2016</xref>). Accumulating genomic/genetic investigations indicate hundreds of genetic variants in the occurrence of ASD, including a range from common to rare variants (<xref ref-type="bibr" rid="B141">Krumm et al., 2014</xref>). Several of these identified genetic mutations producing autistic-like behaviors have been investigated in mouse models. Despite extensive research in human populations and mouse models, no unifying cause has been determined.</p>
<p>Multiple genetic contributors to ASD are synaptic proteins, and in particular can be classified as trans-synaptic adhesion molecules, or synaptic scaffolding proteins, or synaptic signaling proteins (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). Specific genes implicated within these categories are discussed in detail below: adhesion molecules from the neurexin, neuroligin, and contactin families; synaptic scaffolding proteins from the shank family; and GABA<sub>A</sub>R subunit genes within the 15q11–13 locus.</p>
<sec>
<title>Adhesion Molecules: Neuroligin, Neurexin and Contactin Families of Proteins</title>
<p>The neurexin (NRXN/Nrxn), neuroligin (NLGN/Nlgn), and contactin (CNTN) families are cell adhesion molecules (CAMs; <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). In broad terms, CAMs are membrane proteins that extend into the extracellular space and facilitate physical interaction with other cells or with the extracellular matrix. NRXNs are enriched in the presynaptic compartment whereas NLGNs are enriched postsynaptically (<xref ref-type="bibr" rid="B116">Ichtchenko et al., 1995</xref>). The two families of proteins interact to form a transsynaptic bridge, linking pre to post, and are thought to be early contributors to synapse formation (<xref ref-type="bibr" rid="B234">Scheiffele et al., 2000</xref>; <xref ref-type="bibr" rid="B154">Levinson and El-Husseini, 2005</xref>). Within their respective compartments, these proteins also interact with components of the active zone and postsynaptic density, including components linked to neurotransmitter vesicle release, and neurotransmitter receptors and scaffolding proteins (<xref ref-type="bibr" rid="B119">Irie et al., 1997</xref>; <xref ref-type="bibr" rid="B217">Prange et al., 2004</xref>). The NRXN family includes three genes (NRXN1-3) that can be expressed via one of two promoters, termed α and β. Transcription via the α promoter yields a longer protein with six laminin/neurexin/sex hormone (LNS) binding domains, whereas transcription via the β promoter yields a shorter protein with a single LNS binding domain (<xref ref-type="bibr" rid="B251">Tabuchi and Südhof, 2002</xref>). NRXN proteins also contain extracellular epidermal growth factor (EGF) repeats and a PSD-95-Discs Large-zona occludens-1 (PDZ) binding motif. The NRXN family also includes the contactin associated protein (CNTNAP) genes that encode CASPR proteins that are structurally similar with LNS binding domains, EGF repeats, and a PDZ binding motif (<xref ref-type="bibr" rid="B90">Gennarini et al., 2017</xref>). The NLGN family includes five genes in humans (NLGN1-3, 4X, 4Y; <xref ref-type="bibr" rid="B26">Bolliger et al., 2001</xref>) and four genes in mice (Nlgn1-4; <xref ref-type="bibr" rid="B27">Bolliger et al., 2008</xref>). NLGN proteins contain an intracellular PDZ binding motif and an extracellular acetylcholinesterase domain (<xref ref-type="bibr" rid="B154">Levinson and El-Husseini, 2005</xref>).</p>
<p>Members of the NLGN family show some synapse specificity, with NLGN1 enriched at excitatory synaptic contacts, and NLGN2 at inhibitory contacts (<xref ref-type="bibr" rid="B244">Song et al., 1999</xref>; <xref ref-type="bibr" rid="B263">Varoqueaux et al., 2004</xref>; <xref ref-type="bibr" rid="B48">Chubykin et al., 2007</xref>). NLGN3 can be localized at either type of contact (<xref ref-type="bibr" rid="B33">Budreck and Scheiffele, 2007</xref>), while NLGN4 is enriched at central and peripheral inhibitory contacts (<xref ref-type="bibr" rid="B111">Hoon et al., 2011</xref>). This preferential enrichment pattern points to a role in synapse specificity. Indeed, Nrxn and Nlgn protein families have been shown to influence the “balance” of excitation and inhibition <italic>in vitro</italic> (<xref ref-type="bibr" rid="B217">Prange et al., 2004</xref>; <xref ref-type="bibr" rid="B154">Levinson and El-Husseini, 2005</xref>), and in animal models (<xref ref-type="bibr" rid="B109">Hines et al., 2008</xref>; <xref ref-type="bibr" rid="B60">Dahlhaus et al., 2010</xref>; <xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>). Specific genes within NRXN and NLGN families of CAMs have been implicated in the etiology of ASD, including: NLGN1, NLGN2, NLGN3, NLGN4, NRXN1, NRXN2, CNTNAP2, and CNTNAP4 (<xref ref-type="bibr" rid="B123">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Baig et al., 2017</xref>). Alterations to NRXN and NLGN family members in ASD range from <italic>de novo</italic> mutations to common genetic variants, and include polymorphisms, variants, frameshift mutations, truncations, and deletions. Although validated in multiple independent studies these mutations are relatively rare (<xref ref-type="bibr" rid="B123">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B105">Hedges et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>). CNTNAP2 (<xref ref-type="bibr" rid="B10">Arking et al., 2008</xref>; <xref ref-type="bibr" rid="B8">Anney et al., 2012</xref>) and NRXN1 (<xref ref-type="bibr" rid="B232">Sanders et al., 2011</xref>) in particular have been validated through genome-wide association studies.</p>
<p>Several animal models have been developed to examine the contributions of Nrxn to excitatory signaling and the symptoms of ASD (<xref ref-type="bibr" rid="B37">Cattabeni et al., 1999</xref>; <xref ref-type="bibr" rid="B136">Kattenstroth et al., 2004</xref>; <xref ref-type="bibr" rid="B94">Grayton et al., 2013</xref>; <xref ref-type="bibr" rid="B58">Dachtler et al., 2014</xref>) but information about inhibitory signaling in these models is limited. Ablation of individual <italic>Nlgn</italic> genes in mouse models have somewhat subtle effects on development and behavior likely due to compensation, yet combined deletion of <italic>Nlgn</italic>1-<italic>3</italic> results brainstem inhibitory dysfunction leading to respiratory failure (<xref ref-type="bibr" rid="B262">Varoqueaux et al., 2006</xref>). Detailed examination of Nlgn1 KO mice revealed an impairment in <italic>N</italic>-methyl-<sc>D</sc>-aspartate (NMDA) signaling consistent with enrichment at excitatory synapses, along with repetitive behavior and impaired spatial memory (<xref ref-type="bibr" rid="B23">Blundell et al., 2010</xref>). Nlgn3 KO mice show a lack of social novelty preference and reduced vocalization, accompanied by an olfactory deficit (<xref ref-type="bibr" rid="B218">Radyushkin et al., 2009</xref>).</p>
<p>Expression of one of the Nlgn3 mutations identified in autism (R451C substitution) was shown to result in impaired social interactions paralleled by an increase in inhibitory synaptic transmission, leaving excitatory synapses unaffected (<xref ref-type="bibr" rid="B250">Tabuchi et al., 2007</xref>). However, a follow up study was not able to reproduce the deficits in social interaction in Nlgn3R451C mice (<xref ref-type="bibr" rid="B38">Chadman et al., 2008</xref>). In these studies Nlgn3R451C mice were shown to have impairments in ultrasonic vocalizations, and other subtle indications of impaired development (<xref ref-type="bibr" rid="B38">Chadman et al., 2008</xref>). In another follow up study the Nlgn3R451C mutation was backcrossed onto a different background strain (129S2/SvPasCrl), which reproduced deficits in social interaction (<xref ref-type="bibr" rid="B125">Jaramillo et al., 2014</xref>). The discrepancies among these studies may be attributed to subtle differences in methodology, particularly given that the social interaction tasks in mice are very sensitive to variations in protocol. Nlgn4 loss of function mutation results in deficits in reciprocal social interaction and vocalizations (<xref ref-type="bibr" rid="B124">Jamain et al., 2008</xref>).</p>
<p>Increased expression of NLGNs has also been shown to result in several abnormalities relevant to ASD, including behavioral deficits. Increased expression of Nlgns1-4 was shown to result from KO of the eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2; <xref ref-type="bibr" rid="B92">Gkogkas et al., 2013</xref>). 4E-BP2 is a repressor of eukaryotic translation initiation factor 4E (eIF4E), which is downstream in the signaling cascade of mammalian target of rapamycin (mTOR). 4E-BP2 KO mice exhibit an altered ratio of excitatory to inhibitory synapses, along with deficits in social interaction, ultrasonic vocalizations, and the occurrence of repetitive behaviors (<xref ref-type="bibr" rid="B92">Gkogkas et al., 2013</xref>). In other studies, transgenic mice with an overexpression of Nlgn1 and Nlgn2 were generated to determine the effect of specific single Nlgns on the excitatory to inhibitory ratio (<xref ref-type="bibr" rid="B109">Hines et al., 2008</xref>; <xref ref-type="bibr" rid="B60">Dahlhaus et al., 2010</xref>). Mice with enhanced expression of Nlgn1 show deficits in memory acquisition, along with enlarged excitatory synapse morphology and enhanced excitatory signaling (<xref ref-type="bibr" rid="B60">Dahlhaus et al., 2010</xref>). Mice with the enhanced expression of Nlgn2 were found to have behavioral symptoms of neurological disorders similar to those seen in RS (limb clasping), decreased social interaction, repetitive behaviors, as well as decreased viability. Immunohistochemical, electron microscopic and electrophysiological analysis of the Nlgn2 overexpressing mice revealed a shift in the excitatory to inhibitory ratio toward inhibition, with an increase in inhibitory synaptic contacts and overall enhancement of inhibitory responses (<xref ref-type="bibr" rid="B109">Hines et al., 2008</xref>). Nlgn2 has been shown to directly interact with gephyrin, which is known to aid in localizing and stabilizing GABA<sub>A</sub>Rs (<xref ref-type="bibr" rid="B213">Pizzarelli and Cherubini, 2011</xref>). Of particular interest, a recent study has shown that the NLGN2 R705C mutation identified in autism disrupts the interaction with gephyrin and thus has consequences for GABA<sub>A</sub>R function (<xref ref-type="bibr" rid="B193">Nguyen et al., 2016</xref>).</p>
<p>Although associated with contactins (discussed below), CNTNAP proteins are members of the NRXN family based on structural similarity, and are also associated with ASD (<xref ref-type="bibr" rid="B135">Katidou et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Burbach and van der Zwaag, 2009</xref>). CNTNAP genes code for CASPR proteins which act as CAMs. Similar to NRXNs, CASPR proteins contain LNS domains, and EGF-like repeats, but also contain discoidin homology domains, and an extracellular fibrinogen-like domain (<xref ref-type="bibr" rid="B135">Katidou et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Burbach and van der Zwaag, 2009</xref>). Within the CASPR cytoplasmic tail is a protein 4.1 biding site and class II PDZ binding motif (<xref ref-type="bibr" rid="B135">Katidou et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Burbach and van der Zwaag, 2009</xref>).</p>
<p>Genetic analysis of CNTNAP2 in ASD has revealed deletions producing a frameshift mutations leading to early introduction of a stop codon (<xref ref-type="bibr" rid="B247">Strauss et al., 2006</xref>; <xref ref-type="bibr" rid="B272">Watson et al., 2014</xref>). This causes a complete loss of function in the CASPR2 protein in homozygous individuals. Following this implication of CNTNAP2, several studies have shown a link between CNTNAP2 and ASD risk (<xref ref-type="bibr" rid="B3">Alarcón et al., 2008</xref>; <xref ref-type="bibr" rid="B10">Arking et al., 2008</xref>; <xref ref-type="bibr" rid="B13">Bakkaloglu et al., 2008</xref>; <xref ref-type="bibr" rid="B265">Vernes et al., 2008</xref>). In human populations, CNTNAP2 heterozygous mutations do not always produce symptoms of ASD, while homozygous individuals for the mutation display ASD symptoms, along with epilepsy, facial dysmorphisms, severe intellectual disability and impaired language (<xref ref-type="bibr" rid="B223">Rodenas-Cuadrado et al., 2016</xref>). CNTNAP2 has been shown to cluster voltage gated potassium channels at nodes of Ranvier (<xref ref-type="bibr" rid="B215">Poliak et al., 1999</xref>), and influence dendritic arborization, synapse strength, and plasticity (<xref ref-type="bibr" rid="B7">Anderson et al., 2012</xref>). In mice, homozygous KO of CNTNAP2 causes increased grooming and digging (repetitive behaviors), impaired ultrasonic vocalization, less time interacting, and epilepsy (<xref ref-type="bibr" rid="B209">Peñagarikano et al., 2011</xref>). The behavioral changes in CNTNAP2 KO mice are paralleled by a decrease in PV-positive interneurons, suggesting that CNTNAP2 plays role in GABAergic interneuron development (<xref ref-type="bibr" rid="B209">Peñagarikano et al., 2011</xref>).</p>
<p>Both <italic>de novo</italic> and maternally inherited deletions have been detected in ASD populations in a related family member, CNTNAP4 (<xref ref-type="bibr" rid="B201">O’Roak et al., 2012</xref>). CASPR4 protein is enriched in the presynaptic terminals of developing interneurons, and CNTNAP4 KO mice show a reduction in GABAergic signaling from PV-positive interneurons in the cortex (<xref ref-type="bibr" rid="B134">Karayannis et al., 2014</xref>). CNTNAP4 KO mice were also found to have enhanced midbrain dopamine release into the nucleus accumbens, paralleled by increased responsiveness to startle and enhanced sensory motor gating (linked to schizophrenia), along with excessive grooming behavior (<xref ref-type="bibr" rid="B134">Karayannis et al., 2014</xref>). Treatment of CNTNAP4 KO mice with an α1-selective positive allosteric modulator at GABA<sub>A</sub>Rs, indiplon, ameliorated the sensory-motor gating phenotype (<xref ref-type="bibr" rid="B134">Karayannis et al., 2014</xref>).</p>
<p>CASPR proteins interact with the contactin (CNTN) family of proteins. CNTN proteins perform diverse functions in the CNS including myelination, synapse formation, and plasticity. This group of proteins, like the NRXNs and NLGNs, is also adhered to the cell membrane (<xref ref-type="bibr" rid="B283">Zuko et al., 2013</xref>). Duplication or deletion mutations in CNTN4 near CNTN3 have been implicated in the development of ASD, with more rare mutations in CNTN5 and 6 also being implicated (<xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>). CNTN4 plays a role in the growth and development of axons and maintenance of mature networks. In contrast to CNTNAP mutations, loss of a single functional copy of CNTN4 can cause developmental delays (<xref ref-type="bibr" rid="B224">Roohi et al., 2009</xref>).</p>
</sec>
<sec>
<title>Scaffolding Proteins: SHANK Family of Proteins</title>
<p>Mutations in genes encoding scaffolding proteins, such as the SHANK family of proteins have also shown connection to the development of ASD (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>; <xref ref-type="bibr" rid="B147">Leblond et al., 2012</xref>; <xref ref-type="bibr" rid="B233">Sato et al., 2012</xref>; <xref ref-type="bibr" rid="B187">Monteiro and Feng, 2017</xref>). Scaffolding proteins function in clustering and anchoring synaptic proteins including neurotransmitter receptors, and serve to link post synaptic receptors with downstream signaling components. The SHANK family includes three genes (SHANK1-3), that can be alternatively spliced to generate multiple Shank protein variants (<xref ref-type="bibr" rid="B187">Monteiro and Feng, 2017</xref>). Full-length Shank proteins are composed of 5–6 N-terminal ankyrin repeat domains, a Src Homology 3 (SH3) domain, a PDZ domain, a proline-rich region and a C-terminal sterile alpha motif (SAM) domain (<xref ref-type="bibr" rid="B187">Monteiro and Feng, 2017</xref>). Based on the interactions of these domains, Shank can bind an estimated 30 synaptic partners, including other scaffold molecules, glutamatergic receptors, and cytoskeletal proteins (<xref ref-type="bibr" rid="B75">Ehlers, 1999</xref>; <xref ref-type="bibr" rid="B239">Sheng and Kim, 2000</xref>; <xref ref-type="bibr" rid="B16">Baron et al., 2006</xref>; <xref ref-type="bibr" rid="B96">Gundelfinger et al., 2006</xref>). Shank proteins are expressed in the postsynaptic compartment of glutamatergic synapses. As central regulators of receptors, signaling machinery, and the cytoskeleton at excitatory synapses, Shank proteins have been shown to be involved in spine morphogenesis, synapse formation, and glutamate receptor trafficking (<xref ref-type="bibr" rid="B189">Naisbitt et al., 1999</xref>; <xref ref-type="bibr" rid="B229">Sala et al., 2001</xref>, <xref ref-type="bibr" rid="B230">2005</xref>; <xref ref-type="bibr" rid="B91">Gerrow et al., 2006</xref>; <xref ref-type="bibr" rid="B266">Verpelli et al., 2011</xref>).</p>
<p>Mutations in all three SHANK family members have been connected with ASD and/or associated disorders (<xref ref-type="bibr" rid="B258">Ting et al., 2012</xref>; <xref ref-type="bibr" rid="B148">Leblond et al., 2014</xref>). SHANK1 deletions have been detected in ASD males (<xref ref-type="bibr" rid="B233">Sato et al., 2012</xref>), while multiple studies have detected <italic>de novo</italic> mutations and deletions in SHANK2 (<xref ref-type="bibr" rid="B20">Berkel et al., 2010</xref>; <xref ref-type="bibr" rid="B212">Pinto et al., 2010</xref>; <xref ref-type="bibr" rid="B147">Leblond et al., 2012</xref>). SHANK3 is even more strongly implicated in ASD and related disorders. SHANK3 haploinsufficiency is responsible for Phelan McDermid syndrome, which is characterized by intellectual disability, hypotonia, epilepsy, and ASD characteristics (<xref ref-type="bibr" rid="B211">Phelan and McDermid, 2012</xref>). In varied ASD populations, <italic>de novo</italic> mutations, truncations and terminal deletions have been detected in SHANK3 (<xref ref-type="bibr" rid="B73">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="B24">Boccuto et al., 2013</xref>; <xref ref-type="bibr" rid="B148">Leblond et al., 2014</xref>). SHANK3 has also been identified in genome wide association studies of ASD (<xref ref-type="bibr" rid="B53">Connolly et al., 2017</xref>).</p>
<p>Modeling of these mutations in mice has revealed that many of the mutant proteins do not achieve their synaptic localization, and are retained in the cell body or nucleus (<xref ref-type="bibr" rid="B93">Grabrucker et al., 2014</xref>), and that a variety of SHANK manipulations <italic>in vivo</italic> can produce ASD relevant phenotypes (<xref ref-type="bibr" rid="B231">Sala et al., 2015</xref>). SHANK2 mutations in mice result in upregulation of glutamate receptors and a decrease in synaptic transmission (<xref ref-type="bibr" rid="B235">Schmeisser et al., 2012</xref>). Behaviorally, SHANK2 mutant mice are hyperactive, exhibit repetitive grooming, and have impairments in social interactions and vocalizations (<xref ref-type="bibr" rid="B235">Schmeisser et al., 2012</xref>). SHANK3 KO leads to reduction in spine volume, a decrease in the thickness of the postsynaptic density, and a loss of dendritic spines (<xref ref-type="bibr" rid="B180">McGee et al., 2014</xref>). SHANK3 KO mice show abnormal social behaviors, and impairments in learning and memory (<xref ref-type="bibr" rid="B28">Bozdagi et al., 2010</xref>). SHANK3 mutations identified in patients with ASD show a modification in dendritic spine induction and morphology as well as actin accumulation in spines affecting growth cone motility which is nicely paralleled by the mouse model (<xref ref-type="bibr" rid="B73">Durand et al., 2007</xref>). SHANK3 duplication in mice leads to hyperactivity and spontaneous seizures much like human subjects who have small duplications in the SHANK3 locus (<xref ref-type="bibr" rid="B98">Han et al., 2013</xref>). KO mice for SHANK3 showed abnormal communication patterns, repetitive behaviors, and impaired learning (<xref ref-type="bibr" rid="B15">Banerjee et al., 2014</xref>; <xref ref-type="bibr" rid="B180">McGee et al., 2014</xref>). Again, these behaviors are consistent with the phenotype of ASD in humans.</p>
<p>SHANK3 interacts with NLGN genes as a binding partner to play role in synaptic plasticity (<xref ref-type="bibr" rid="B185">Meyer et al., 2004</xref>), and SHANK3 is also involved in synapse formation and this results in an increase of excitatory signals (<xref ref-type="bibr" rid="B11">Arons et al., 2012</xref>). Although the link of Shank proteins to excitatory synapse function is clear, studies have not thoroughly investigated the impact that SHANK mutations may have on interneuron or inhibitory synapse function, downstream of excitation. Further studies on the existing SHANK mouse models generated may be helpful in examining the relationship between excitatory synapse dysfunction and downstream impacts on inhibitory signaling.</p>
</sec>
<sec>
<title>15q11-q13 Locus Genes: GABA<sub>A</sub> Receptor Subunits</title>
<p>A known unstable genetic locus, termed 15q11-q13, is located on chromosome 15 and contains UBE3A (Ubiquitin-protein ligase E3A), and three GABA<sub>A</sub>R subunit genes (<italic>GABRB3</italic>, <italic>GABRA5</italic>, and <italic>GABRG3</italic>; <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>). The 15q11-q13 region is subject to imprinting and recombination, and is regarded as one of the most complex regions in the genome (<xref ref-type="bibr" rid="B177">Martin et al., 2000</xref>). The partial trisomy of chromosome 15 was first reported as a syndrome in 1975 (<xref ref-type="bibr" rid="B104">Hecht, 1975</xref>). The syndrome produced by duplication of 15q11-q13, termed Dup15q, includes global developmental delay, social communication deficits, intellectual disability, with a high incidence of epilepsy and/or infantile spasms (<xref ref-type="bibr" rid="B261">Urraca et al., 2013</xref>). Children with Dup15q generally meet the diagnostic criteria for ASD diagnosis (<xref ref-type="bibr" rid="B261">Urraca et al., 2013</xref>), and several studies have now shown that duplications in 15q11-q13 are one of the most common copy number variants linked with ASD, which have been replicated in genome wide association studies (<xref ref-type="bibr" rid="B54">Cook et al., 1997</xref>; <xref ref-type="bibr" rid="B207">Park and Bolton, 2001</xref>; <xref ref-type="bibr" rid="B143">Kwasnicka-Crawford et al., 2007</xref>; <xref ref-type="bibr" rid="B66">Depienne et al., 2009</xref>; <xref ref-type="bibr" rid="B232">Sanders et al., 2011</xref>). Duplications in this region can take one of two forms, two extra copies of the 15q11.2-q13.1 region of maternal origin on a supernumerary chromosome (isodicentric), or one or more extra copies on the q arm of chromosome 15 (<xref ref-type="bibr" rid="B68">DiStefano et al., 2016</xref>). 15q11-q13 loss of activity is discussed specifically below in the “Angelman Syndrome” section.</p>
<p>Duplication specifically of the region containing GABA<sub>A</sub>Rs leads to a prediction of excessive inhibitory neurotransmission due to gene dosage; however, an <italic>in vitro</italic> model of 15q duplication displayed reduced transcripts for GABRB3 (and other nearby genes) due to impaired homologous pairing (<xref ref-type="bibr" rid="B182">Meguro-Horike et al., 2011</xref>). The symptoms of individuals with Dup15q also are suggestive of altered GABAergic control of oscillatory activity. Multiple reports have demonstrated enhanced activity in β frequency bands (12–30 Hz) of the EEG, with spontaneous β oscillations visually evident (<xref ref-type="bibr" rid="B261">Urraca et al., 2013</xref>). A further study demonstrated that enhanced power in the upper β frequencies (20–30 Hz) was significantly related to epilepsy diagnosis in Dup15q (<xref ref-type="bibr" rid="B86">Frohlich et al., 2016</xref>). The enhanced power and spontaneous oscillations noted in Dup15q are similar to the effects seen following treatment with benzodiazepines and other allosteric modulators of GABA<sub>A</sub>Rs, although none of the patients were on such medication (<xref ref-type="bibr" rid="B261">Urraca et al., 2013</xref>; <xref ref-type="bibr" rid="B2">Al Ageeli et al., 2014</xref>; <xref ref-type="bibr" rid="B86">Frohlich et al., 2016</xref>). Further, since the EEG β phenotype is observed with both maternal and paternal duplication cases, it is likely that this phenotype results from altered GABA<sub>A</sub>R function and not the maternally expressed (non-imprinted) Ube3a gene (<xref ref-type="bibr" rid="B86">Frohlich et al., 2016</xref>).</p>
<p>Examination of the seizure phenotype in patients with Dup15q have indicated about 63% of those with isodicentric mutations have seizures, with the majority of these cases having multiple seizure types (81%), and with a relatively high rate of infantile spasms (42%; <xref ref-type="bibr" rid="B52">Conant et al., 2014</xref>). In contrast, only about 25% of interstitial mutation type Dup15q patients had seizures (<xref ref-type="bibr" rid="B52">Conant et al., 2014</xref>). This study also revealed that broad spectrum anti-epileptic drugs, and those that block voltage gated sodium channels (carbamazepine and oxcarbazepine) were typically effective, whereas typical benzodiazepines were relatively ineffective (<xref ref-type="bibr" rid="B52">Conant et al., 2014</xref>). Also indicative of abnormal GABAergic signaling, paradoxical increases in seizure severity have been reported in isodicentric Dup15q following treatment with pregabalin (<xref ref-type="bibr" rid="B67">Di Rocco et al., 2013</xref>), a drug that acts to increase extracellular GABA by increasing the density of GABA transporter proteins, increasing the rate of functional GABA transport, and increasing the enzyme responsible for making GABA (<sc>L</sc>-glutamic acid decarboxylase) as a result of high-affinity binding to the α2-δ subunit of voltage-gated calcium channels (<xref ref-type="bibr" rid="B249">Sze, 1979</xref>; <xref ref-type="bibr" rid="B175">Marks et al., 2009</xref>). Mouse models mimicking human 15q11-q13 duplication exhibit features of autism, such as poor social interaction, behavioral inflexibility, and abnormal ultrasonic vocalizations (<xref ref-type="bibr" rid="B190">Nakatani et al., 2009</xref>). Further, a mouse model with a point mutation altering the surface stability of the GABA<sub>A</sub>R β3 subunit (GABRB3 gene product) displays ASD-like features and enhanced susceptibility to seizure (<xref ref-type="bibr" rid="B267">Vien et al., 2015</xref>).</p>
<p>Indirectly reacted to the findings of loss of function of GABA<sub>A</sub>R in Dup15q, postmortem studies from subjects with ASD with non-specified genetic background have shown reduced levels of [<sup>3</sup>H]-muscimol binding compared to control (<xref ref-type="bibr" rid="B22">Blatt et al., 2001</xref>). Muscimol has a higher affinity for α4/δ-containing receptors than other GABA<sub>A</sub>R (<xref ref-type="bibr" rid="B115">Huh et al., 1996</xref>). Recently, expression and protein levels of subunits where found to be significantly reduced in different regions of brains from autistic subjects compared to age-matched controls. Protein expression of α1, α2, α3, α5, and β3 subunits were reduced in the parietal cortex whereas in the frontal cortex α1, α4, α5, and β1 subunits were reduced (<xref ref-type="bibr" rid="B81">Fatemi et al., 2009</xref>, <xref ref-type="bibr" rid="B79">2010</xref>, <xref ref-type="bibr" rid="B78">2013</xref>). These data would suggest a GABAergic hypofunction and in particular, a reduced tonic inhibition of patients with autism.</p>
<p>Other rare mutations implicated in ASD are directly or indirectly linked to GABAergic signaling, including, mutations in SLC12A5 impacting the C-terminal regulatory domain of KCC2 (<xref ref-type="bibr" rid="B184">Merner et al., 2015</xref>), <italic>RIM1A</italic> (<xref ref-type="bibr" rid="B118">Iossifov et al., 2014</xref>) which has been shown to modulate GABA release from interneurons (<xref ref-type="bibr" rid="B145">Lachamp et al., 2009</xref>), <italic>DLX</italic> homeobox transcription factors (<xref ref-type="bibr" rid="B117">International Molecular Genetic Study of Autism Consortium [IMGSAC], 2001</xref>; <xref ref-type="bibr" rid="B160">Liu et al., 2009</xref>) which play a role in interneuron differentiation and induction of GABA synthesis (<xref ref-type="bibr" rid="B214">Pleasure et al., 2000</xref>; <xref ref-type="bibr" rid="B49">Cobos et al., 2005</xref>; <xref ref-type="bibr" rid="B202">Paina et al., 2011</xref>), and <italic>ANK2</italic> (Ankyrin B; <xref ref-type="bibr" rid="B63">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="B118">Iossifov et al., 2014</xref>) which creates the AIS boundary, and is involved in modifying AIS length (<xref ref-type="bibr" rid="B88">Galiano et al., 2012</xref>). Collectively, these genetic and animal model studies suggest that dysfunction in the structure and or function of transmembrane adhesion, scaffolding, and receptor proteins critical for creating and stabilizing synapses are major contributors to ASD. In particular, evidence of altered inhibitory synapse adhesion molecules, scaffolding proteins, and GABA<sub>A</sub>R signaling is clearly implicated in ASD. Alterations in PV-positive neuron number and/or function, and alterations in tonic inhibition are common among multiple genetic causes of ASD, warranting further study. Below we will explore monogenetic NDDs with symptoms related to ASD, to examine the indications of inhibitory synapse dysfunction more broadly.</p>
</sec>
</sec>
<sec>
<title>Angelman Syndrome</title>
<p>Angelman syndrome (AS) is a NDD characterized by severe mental retardation, ataxic movements, speech impairment, and high incidence of seizures (<xref ref-type="bibr" rid="B34">Buiting et al., 2016</xref>). In contrast to other NDDs, people with AS display a sociable disposition and are prone to unprovoked bouts of laughter. AS is relatively rare, with an incidence of somewhere between 1:12,000 and 1:20,000, accounting for about 6% of all children with mental retardation and epilepsy (<xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>; <xref ref-type="bibr" rid="B34">Buiting et al., 2016</xref>). AS is caused by a loss of activity within the 15q11-13 locus, and about 70% of cases are due to a “<italic>de novo</italic>” interstitial deletion in the long arm region, arising on the maternally inherited chromosome (<xref ref-type="bibr" rid="B34">Buiting et al., 2016</xref>). The candidate gene in this region thought to be responsible for AS is UBE3A (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>; <xref ref-type="bibr" rid="B137">Kishino et al., 1997</xref>; <xref ref-type="bibr" rid="B178">Matsuura et al., 1997</xref>; <xref ref-type="bibr" rid="B248">Sutcliffe et al., 1997</xref>), although three GABA<sub>A</sub>R subunit genes are also located in this region as mentioned above. AS is a classic example of imprinting and is most commonly caused by deletion or inactivation of genes on the maternally inherited chromosome 15 while the paternal copy is imprinted or silenced in the brain producing the most severe cases, with seizures, mental and motor retardation, dysmorphic features and microcephaly phenotype (65–70% of probands; <xref ref-type="bibr" rid="B144">Kyllerman, 2013</xref>). The other two possible causes, uniparental disomy and imprinting center mutations (10%), and UBE3A point mutations (11%) result in more mild phenotypes (<xref ref-type="bibr" rid="B144">Kyllerman, 2013</xref>). The AS diagnosis is confirmed by methylation test or by mutation analysis of the UBE3A gene. Regardless of mutation type, seizures occur between ages 1 and 3 years in approximately 85% of patients and are most commonly characterized by atypical absence, erratic myoclonic, and rare tonic–clonic seizure types (<xref ref-type="bibr" rid="B84">Fiumara et al., 2010</xref>). Detailed EEG studies of AS patients have revealed high-amplitude δ frequency (2–3 Hz) activity, with spike and slow-wave discharges, and a circadian pattern to epileptiform discharges, showing sleep-activation (<xref ref-type="bibr" rid="B144">Kyllerman, 2013</xref>).</p>
<p>As discussed above, the GABA<sub>A</sub>R genes, GABRB3, GABRA5, and GABRG3 genes (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>), encoding β3, α5, and γ3 subunits, respectively, are also within the 15q11-13 locus. The presence of this GABA<sub>A</sub>R subunit gene cluster in 15q11-13 has led to the hypothesis that GABA neurotransmission may also be involved in AS (<xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>), as well as ASD. In particular, the GABRB3 gene is known to be associated with epilepsy in humans, and when a deficiency of UBE3A is also present, more severe symptoms result (<xref ref-type="bibr" rid="B208">Pelc et al., 2008</xref>).</p>
<p>The phenotype of maternal Ube3a-deficient mice resembles human AS with motor dysfunction, inducible seizures and a context-dependent learning deficit (<xref ref-type="bibr" rid="B126">Jiang et al., 1998</xref>). Using mouse models it has been demonstrated that Ube3a-deficiency results in reduced GABA-mediated tonic inhibition in the cerebellum, mechanistically caused by a GAT-1 dependent decrease of GABA concentration in the extracellular space (<xref ref-type="bibr" rid="B74">Egawa et al., 2012</xref>). A recent paper elegantly examined the contributions of Ube3a loss in specific populations of cells to the pathophysiology of AS (<xref ref-type="bibr" rid="B128">Judson et al., 2016</xref>). Using conditional deletion in mouse models it was shown that loss of Ube3a in GABAergic interneurons, but not glutamatergic principal cells, results in EEG abnormalities of enhanced δ, and seizures, similar to individuals with AS. Other studies have examined the combined Ube3a and GABRB3 effects using chromosomal deletion spanning Ube3a to GABRB3 (includes a deletion of the Atp10a gene; <xref ref-type="bibr" rid="B127">Jiang et al., 2010</xref>). Maternal (Ube3a<sup>m-/p++</sup>), but not paternal (Ube3a<sup>m+/p-</sup>), deletion mice had increased spontaneous seizure activity and abnormal EEG, along with impairments in motor function, learning and memory, ultrasonic vocalizations, and an anxiety-like phenotype demonstrating the impact of GABA<sub>A</sub>R function on the severity of phenotype (<xref ref-type="bibr" rid="B127">Jiang et al., 2010</xref>). The Ube3a<sup>m-/p+</sup> model has also been shown to have an inhibitory deficit resulting from impaired vesicle cycling in interneurons (<xref ref-type="bibr" rid="B270">Wallace et al., 2012</xref>). In addition to Ube3a, examination of GABA<sub>A</sub>R β3 subunit-deficient mouse models have also revealed a strong link between GABA<sub>A</sub>Rs and AS, β3 deficient mice show 90–95% neonatal mortality, with survivors displaying a phenotype resembling severe forms of human AS (<xref ref-type="bibr" rid="B110">Homanics et al., 1997</xref>; <xref ref-type="bibr" rid="B65">DeLorey et al., 1998</xref>).</p>
<p>The maternal deletion model of AS (Ube3a<sup>m-/p+</sup>) has also been shown to result in alterations to the intrinsic properties of neurons (<xref ref-type="bibr" rid="B133">Kaphzan et al., 2011</xref>). In these studies researchers demonstrated alterations in resting membrane potential, threshold potential, and action potential amplitude of principal cells. The changes in intrinsic properties were paralleled by significant increases in the expression of the voltage gated sodium channel NaV1.6, and the AIS anchoring protein ankyrin-G, as well as an increase in length of the AIS (<xref ref-type="bibr" rid="B133">Kaphzan et al., 2011</xref>). Previous studies have shown that the AIS can adapt to the inputs that a cell is receiving, with reduced synaptic input resulting in elongation of the AIS (<xref ref-type="bibr" rid="B142">Kuba et al., 2010</xref>), and increased excitability moving the AIS away from the cell body (<xref ref-type="bibr" rid="B95">Grubb and Burrone, 2010</xref>). The AIS is also of interest in considering GABAergic signaling, as it is the postsynaptic site of PV-positive chandelier cell contact, and changes in the properties of the AIS also likely effect GABAergic control at this important site.</p>
<p>As with ASD, AS is also clearly linked to dysfunction of inhibitory signaling, and in particular to dysfunction of GABA<sub>A</sub>R subunit expression and function. Again, dysfunction of PV-positive neurons emerges as a feature of AS. It is interesting that despite a common biological phenotype of reduced transcripts for GABA<sub>A</sub>R subunit genes in Dup15q ASD and AS, the EEG phenotype differs between these two syndromes, suggesting the need for regional, and more specific analysis of GABA<sub>A</sub>R subunit expression and function, as well as GABAergic synapse subtypes in these disorders.</p>
</sec>
<sec>
<title>Rett Syndrome</title>
<p>Rett syndrome (RS), is a genetic disorder that leads to severe impairments, affecting nearly every aspect of a child’s life. ASD-like features, especially stereotyped behaviors, loss of language skills, learning and memory deficits, loss of social skills, and seizures are common characteristics of RS (<xref ref-type="bibr" rid="B39">Chahrour and Zoghbi, 2007</xref>). RS may also include apraxia, ataxia, impaired coordination, tremor, respiratory dysrhythmias, and sometimes premature lethality (<xref ref-type="bibr" rid="B39">Chahrour and Zoghbi, 2007</xref>; <xref ref-type="bibr" rid="B41">Chao et al., 2007</xref>). Not all of the symptoms of RS are present during early postnatal development, but rather appear over stages, following a period of developmental stagnation that typically begins between 6 and 18 months of age (<xref ref-type="bibr" rid="B39">Chahrour and Zoghbi, 2007</xref>). The primary cause of RS is mutation of the gene encoding the transcriptional repressor methyl-CpG-binding protein 2 (MeCP2; <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>; <xref ref-type="bibr" rid="B140">Kozinetz et al., 1993</xref>). The MECP2 gene is located on the X-chromosome, and since males have only one X chromosome (instead of the two in genetic females), MECP2 mutation results in more severe symptoms, with the majority of RS males dying shortly after birth (<xref ref-type="bibr" rid="B183">Meloni et al., 2000</xref>). In females, RS represents one of the leading causes for mental retardation (<xref ref-type="bibr" rid="B191">Neul and Zoghbi, 2004</xref>). Within females, the severity of RS symptoms can vary widely depending upon the pattern of x-chromosome inactivation (<xref ref-type="bibr" rid="B71">Dragich et al., 2000</xref>). It is estimated that approximately 60–80% of females with RS have epilepsy (<xref ref-type="bibr" rid="B268">Vignoli et al., 2017</xref>), with severity of the syndrome positively correlated with the prevalence of epilepsy (<xref ref-type="bibr" rid="B255">Tarquinio et al., 2017</xref>). Longitudinal studies have indicated an even higher cumulative lifetime prevalence of epilepsy in RS, with approximately 90% incidence evaluated using a Kaplan–Meier method (<xref ref-type="bibr" rid="B255">Tarquinio et al., 2017</xref>). A fascinating link between ASD, AS, and RS was identified when researchers found that MECP2 (along with other factors) is required for the homologous pairing of 15q11-q13 during neuronal differentiation during the maturation process (<xref ref-type="bibr" rid="B182">Meguro-Horike et al., 2011</xref>).</p>
<p>Researchers have developed multiple animal models to study the underlying neuropathology associated with RS. Mecp2 deficient mice, created by deleting either exon 3, or exons 3 and 4, replicate all the features of the human disease (<xref ref-type="bibr" rid="B45">Chen et al., 2001</xref>). Truncation mutations (Mecp2<sup>308</sup>) produce a more moderate phenotype that shows the progressive pattern of symptom development (<xref ref-type="bibr" rid="B238">Shahbazian et al., 2002</xref>). It is also interesting to note that in mouse models (<xref ref-type="bibr" rid="B50">Collins et al., 2004</xref>), and in human NDDs (<xref ref-type="bibr" rid="B64">del Gaudio et al., 2006</xref>), increased expression of Mecp2 also produces a progressive neurological phenotype, indicating that precisely controlled levels of Mecp2 are essential for normal nervous system function.</p>
<p>Conditional, neuron specific deletion of Mecp2 in mice is sufficient to produce symptoms of RS (<xref ref-type="bibr" rid="B97">Guy et al., 2001</xref>), and the neurologic abnormalities can be reversed by activating the Mecp2 gene later in life (<xref ref-type="bibr" rid="B6">Amir et al., 1999</xref>; <xref ref-type="bibr" rid="B167">Luikenhuis et al., 2004</xref>). Surprisingly, despite the diversity of the features seen in RS, recent findings also indicate that deleting Mecp2 only from GABAergic inhibitory neurons in mice is sufficient to replicate most of the phenotypes of the human disease (<xref ref-type="bibr" rid="B181">Medrihan et al., 2008</xref>). In this elegantly performed study, researchers created a Mecp2 KO model by crossing Viaat-Cre to Mecp2<sup>flox/+</sup> mice. The result from this study was a loss of Mecp2 in male Viaat-Mecp2<sup>-/y</sup> mice from more than 90% GABAergic neurons (<xref ref-type="bibr" rid="B40">Chao et al., 2010</xref>). Mice with Mecp2 deficiency from GABA-releasing neurons recapitulate numerous RS and ASD features, including repetitive behaviors, ataxia, premature death, breathing abnormalities, and seizures. These mice initially exhibit normal behavior, then develop forepaw stereotyped movements, compulsive grooming, increased sociability, impaired motor coordination, learning/memory deficits, abnormal EEG hyperexcitability, severe respiratory dysrhythmias, and premature lethality (<xref ref-type="bibr" rid="B40">Chao et al., 2010</xref>). Specific interneuron subtypes have been shown to play distinctive roles in RS, determined by selectively deleting Mecp2 from either PV or SOM positive interneurons (<xref ref-type="bibr" rid="B120">Ito-Ishida et al., 2015</xref>). Deletion of MeCP2 in PV+ interneurons resulted in motor, sensory, cognitive, and social interaction deficits, whereas deletion of MeCP2 in SOM+ interneurons resulted in seizures and stereotypies (<xref ref-type="bibr" rid="B120">Ito-Ishida et al., 2015</xref>). Another recent study was able to genetically re-express Mecp2 solely in GABAergic neurons in a Mecp2 KO mouse, restoring inhibitory function. GABA concentrations in the striata of 8-week-old rescue mice were restored to wildtype levels. No behavioral seizures were seen in the rescue mice, while EEG recordings showed that five out of six rescue mice had normalized activity patterns (<xref ref-type="bibr" rid="B166">Lu et al., 2016</xref>). Another recent study demonstrated that KCC2 is a downstream target of Mecp2, and that human neurons derived from stem cells of RS patients have reduced KCC2 expression and a delayed switch in EGABA (<xref ref-type="bibr" rid="B254">Tang et al., 2016</xref>).</p>
<p>Studies examining the neuropathology of RS have identified strong depression of GABAergic neurotransmission in the ventrolateral medulla (<xref ref-type="bibr" rid="B181">Medrihan et al., 2008</xref>), and nucleus tractus solitarius (<xref ref-type="bibr" rid="B43">Chen et al., 2017</xref>) of Mecp2 null mice. Studies in the ventrolateral medulla indicated reduced GABA release paralleled by reduced levels of the vesicular inhibitory transmitter transporter and reduced levels of α2 (typically synaptic) and α4 (typically extrasynaptic) subunits of GABA<sub>A</sub>Rs (<xref ref-type="bibr" rid="B181">Medrihan et al., 2008</xref>). In the nucleus tractus solitarius, it has been shown that GABA<sub>A</sub>R δ subunit (typically extrasynaptic) expression is enhanced, paralleled by enhanced responsiveness to THIP, which selectively activates extrasynaptic GABA<sub>A</sub>R subtypes (<xref ref-type="bibr" rid="B43">Chen et al., 2017</xref>). Other studies have indicated reductions in the frequency of spontaneous inhibitory postsynaptic currents in hippocampal recordings from symptomatic Mecp2 null mice (<xref ref-type="bibr" rid="B281">Zhang et al., 2008</xref>). In addition, these studies found that Mecp2 null hippocampal circuitry was prone to hyperexcitability, as evidenced by induction of repetitive sharp wave-like discharges following a brief train of high-frequency stimulation (<xref ref-type="bibr" rid="B281">Zhang et al., 2008</xref>).</p>
<p>Similar to ASD and AS, several lines of evidence also link RS to dysfunction of inhibitory signaling. In particular, support for the role of PV-positive interneuron dysfunction in broad NDDs is apparent. In addition, indications of KCC2 dysfunction are present in both ASD and RS. Evidence is accumulating for dysfunction of specific GABA<sub>A</sub>R subunit expression and function, with regional specificity as well, this level of analysis is currently lacking in ASD and AS models. Studies in RS models have highlighted an interesting parameter for consideration in other NDD models, namely the ratio of synaptic to extrasynaptic GABAergic signaling (<xref ref-type="bibr" rid="B181">Medrihan et al., 2008</xref>; <xref ref-type="bibr" rid="B43">Chen et al., 2017</xref>). Changes in subunit expression and mode of inhibition (phasic versus tonic) as a direct result of mutation, or as a plastic or homeostatic adaptation could result in alterations in network function leading to some of the electrophysiological, EEG, and phenotypic manifestations of NDDs.</p>
</sec>
<sec>
<title>Dravet Syndrome</title>
<p>Developmental epilepsies are also considered in the umbrella of NDD, due to the high incidence of epilepsy in prototypical NDD, as well as the developmental factors known to contribute to epileptogenesis (<xref ref-type="bibr" rid="B29">Bozzi et al., 2012</xref>). Further, just as epilepsy has a high occurrence in NDD populations, NDD features are also commonly observed in epilepsy syndromes. In addition to the prototypical NDDs, consideration of the phenotypes of developmental epilepsy syndromes will provide insight into the cellular and circuit dysfunction in NDD. Dravet syndrome (DS), formerly known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures (<xref ref-type="bibr" rid="B99">Han et al., 2012</xref>). At early onset, DS is characterized by both febrile and non-febrile seizures, and progresses to myoclonic and/or partial seizures, psychomotor delay, and ataxia (<xref ref-type="bibr" rid="B236">Selmer et al., 2009</xref>). Patients with DS also have a high risk of sudden unexpected death in epilepsy (SUDEP; <xref ref-type="bibr" rid="B241">Shmuely et al., 2016</xref>). DS is also characterized by cognitive impairment, motor deficits, hyperactivity and/or impulsiveness, and in rare cases can include autistic-like behaviors (<xref ref-type="bibr" rid="B99">Han et al., 2012</xref>). The prevalence of DS is 1:15,700 individuals, with around 75% of patients bearing a mutation in their SCN1A gene, which encodes the α1 subunit of the voltage gated sodium channel (Na<sub>V</sub>1.1; <xref ref-type="bibr" rid="B277">Wu et al., 2015</xref>). The remaining 25% of DS cases have been linked to mutations in GABRG2, GABRA1 (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>), protocadherin 19 (PCDH 19), and Syntaxin Binding Protein-1 (STXBP1; <xref ref-type="bibr" rid="B36">Carvill et al., 2014</xref>). Mutations in SCN1A are also responsible for Genetic Epilepsy with Febrile Seizures Plus (GEFS+), which is an autosomal dominant form of epilepsy, typically less severe than DS (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>; <xref ref-type="bibr" rid="B132">Kang and Macdonald, 2016</xref>). These findings indicate additional factors beyond SCN1A mutation that contribute to the occurrence and severity of the phenotype (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>; <xref ref-type="bibr" rid="B132">Kang and Macdonald, 2016</xref>). A recent human study using single and paired pulse transcranial magnetic stimulation has found an absence of short interval intracortical inhibition in DS patients, suggestive of reduced cortical GABAergic neurotransmission (<xref ref-type="bibr" rid="B246">Stern et al., 2017</xref>).</p>
<p>Mouse models of DS (<italic>Scn1a</italic><sup>+/-</sup>) are characterized to have spontaneous seizures, including thermally evoked seizures (<xref ref-type="bibr" rid="B279">Yu et al., 2006</xref>; <xref ref-type="bibr" rid="B198">Oakley et al., 2009</xref>), and as well as behavioral phenotypes relevant to ASD (<xref ref-type="bibr" rid="B99">Han et al., 2012</xref>). Electrophysiological assessment of DS models has revealed a selective loss of sodium currents in GABAergic inhibitory neurons, resulting in reduced excitability of interneurons and thus reduced GABAergic neurotransmission (<xref ref-type="bibr" rid="B279">Yu et al., 2006</xref>; <xref ref-type="bibr" rid="B131">Kalume et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Cheah et al., 2012</xref>; <xref ref-type="bibr" rid="B99">Han et al., 2012</xref>). Field recordings in Scn1A<sup>+/-</sup> mice have demonstrated hyperexcitability of hippocampal circuits in both the pre-epileptic and epileptic periods (<xref ref-type="bibr" rid="B157">Liautard et al., 2013</xref>). Similar to the human variation in epilepsy severity, mouse models of SCN1A dysfunction, have been shown to have a strain dependent epilepsy phenotype, raising the possibility of additional factors contributing to pathogenesis (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>). Scn1a<sup>+/-</sup> mice on 129 background have no readily detectable phenotype and a normal lifespan, while Scn1a<sup>+/-</sup> F1 129/C57Bl6 hybrid mice experience spontaneous and hyperthermia-induced seizures and high rates of premature death. Genetic mapping comparing Scn1A<sup>+/-</sup> mutations on 129 versus F1 hybrid backgrounds identified multiple modifier loci, followed by RNA-Seq of a loci of interest on chromosome 5 (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>). RNA-Seq revealed three genes with significant differences in total gene expression between Scn1A deletion on the two backgrounds, including the α2 subunit of GABA<sub>A</sub>Rs, associating low <italic>Gabra2</italic> expression with the B6 allele and reduced survival of Scn1A mutants on this background (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>). These studies also showed that clobazam, which has preferential affinity for the GABA<sub>A</sub>R α2 subunit, normalized the temperature threshold for hyperthermia-induced seizures in <italic>Scn1a</italic><sup>+/-</sup> mice (<xref ref-type="bibr" rid="B103">Hawkins et al., 2016</xref>). Compared to wildtype mice, Scn1a<sup>+/-</sup> mice displayed behavioral/social deficits as shown by circling behavior and less time spent in open arms in an elevated plus maze. These stereotypical behaviors are marked as autistic traits, indicating that DS does have shared symptomatology (<xref ref-type="bibr" rid="B99">Han et al., 2012</xref>). PV-positive and SOM-positive fast-spiking interneurons have also been found to have reduced excitability in Scn1a<sup>+/-</sup> mice, leading to reduced GABAergic inhibition (<xref ref-type="bibr" rid="B252">Tai et al., 2014</xref>). Greater understanding of Scn1a localization and function may also reveal insights about pathogenesis in DS. The protein encoded by Scn1a, the α1 subunit of Na<sub>V</sub>1.1, has been localized to the AIS, particularly in GABAergic interneurons (<xref ref-type="bibr" rid="B72">Duflocq et al., 2008</xref>; <xref ref-type="bibr" rid="B165">Lorincz and Nusser, 2008</xref>). AIS dysfunction is a proposed mechanism of neuropathology in epilepsy (<xref ref-type="bibr" rid="B275">Wimmer et al., 2010</xref>; <xref ref-type="bibr" rid="B139">Kole and Stuart, 2012</xref>), and chandelier cell cartridges opposed to α2 containing GABA<sub>A</sub>Rs are known to mediate inhibitory control at this site (<xref ref-type="bibr" rid="B195">Nusser et al., 1996</xref>; <xref ref-type="bibr" rid="B85">Freund and Katona, 2007</xref>; <xref ref-type="bibr" rid="B89">Gao and Heldt, 2016</xref>), suggesting that GABAergic dysfunction at the AIS may be a key factor in epilepsy. Of particular interest, studies have also shown that the benzodiazepine clonazepam is effective at reducing the ASD-like features of the Scn1a<sup>+/-</sup> mice (<xref ref-type="bibr" rid="B99">Han et al., 2012</xref>).</p>
<p>Examination of developmental epilepsies, alongside NDDs with epilepsy as an associated symptom is useful in elucidating common mechanisms. <italic>De novo</italic> mutation of <italic>SCN2A</italic> was also recently identified using exome sequencing of ASD samples (<xref ref-type="bibr" rid="B63">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="B118">Iossifov et al., 2014</xref>), further suggesting that the AIS may be a key site to evaluate in NDDs. As we have seen with NDD, developmental epilepsy syndromes such as DS also highlight GABAergic dysfunction as a key pathogenic mechanism. Again a common indication of PV-positive interneuron dysfunction is revealed, drawing commonality with ASD, AS, and RS. Greater understanding of the specific roles of interneuron subtypes, subcellular domains of inhibition, and GABA<sub>A</sub>R subunits in these disorders may help to further advance our understanding, and improve therapeutic strategies in NDDs.</p>
</sec>
<sec>
<title>Very Rare Mutations and Associated Disorders</title>
<p>Insight into NDDs may also be gleaned by examining rare genetic causes and disorders. Of particular interest, mutations in the <italic>ARHGEF9</italic> gene (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>) have been reported to result in NDDs with varied behavioral symptoms (<xref ref-type="bibr" rid="B4">Alber et al., 2017</xref>). The <italic>ARHGEF9</italic> gene codes for the GDP/GTP exchange factor collybistin (also known as HPEM2 in humans), which is a neuron specific RhoGEF. All collybistin isoforms possess three major functional domains: an N-terminal SH3 domain, a GEF domain, and a PH domain. Through these domains, collybistin has been shown to interact with gephyrin, neuroligin-2, and the GABA<sub>A</sub>R α2 subunit, playing an important role in clustering of GABA<sub>A</sub>Rs at inhibitory synapses (<xref ref-type="bibr" rid="B228">Saiepour et al., 2010</xref>). To this point, 18 patients have been described to have either point mutations, chromosomal rearrangements and deletions involving <italic>ARHGEF9</italic>, with a range of manifestations including ASD (<xref ref-type="bibr" rid="B21">Bhat et al., 2016</xref>; <xref ref-type="bibr" rid="B171">Machado et al., 2016</xref>), behavior disorders (ADHD, anxiety, aggression; <xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>; <xref ref-type="bibr" rid="B153">Lesca et al., 2011</xref>), intellectual disability (<xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>; <xref ref-type="bibr" rid="B153">Lesca et al., 2011</xref>; <xref ref-type="bibr" rid="B174">Marco et al., 2011</xref>; <xref ref-type="bibr" rid="B240">Shimojima et al., 2011</xref>; <xref ref-type="bibr" rid="B62">de Ligt et al., 2012</xref>; <xref ref-type="bibr" rid="B150">Lemke et al., 2012</xref>), hyperekplexia (<xref ref-type="bibr" rid="B101">Harvey et al., 2004</xref>; <xref ref-type="bibr" rid="B173">Marco et al., 2008</xref>), and infantile epilepsy (<xref ref-type="bibr" rid="B101">Harvey et al., 2004</xref>; <xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>; <xref ref-type="bibr" rid="B153">Lesca et al., 2011</xref>; <xref ref-type="bibr" rid="B240">Shimojima et al., 2011</xref>). The majority of patients identified are male, and those that are female have been shown to have a near complete X-inactivation in favor of the affected gene (<xref ref-type="bibr" rid="B173">Marco et al., 2008</xref>; <xref ref-type="bibr" rid="B130">Kalscheuer et al., 2009</xref>). Collybistin KO mice recapitulate some aspects of the behavioral syndrome including anxiety-like behavior, learning deficits, and seizures (<xref ref-type="bibr" rid="B204">Papadopoulos et al., 2007</xref>; <xref ref-type="bibr" rid="B205">Papadopoulos and Soykan, 2011</xref>). Related to the collybistin mutations, rare mutations have also been identified in gephyrin associated with diverse NDD diagnoses (<bold>Table <xref ref-type="table" rid="T2">2</xref></bold>), including ASD, seizures, and schizophrenia (<xref ref-type="bibr" rid="B159">Lionel et al., 2013</xref>). Gephyrin KO mice die shortly after birth, and exhibit a phenotype of tactile-hyperresponsivity and difficulty breathing consistent with glycinergic signaling deficits (<xref ref-type="bibr" rid="B82">Feng et al., 1998</xref>). In general, further information is required to understand the detailed contribution of collybistin, gephyrin and other inhibitory synapse organizers in specialized subtypes of GABAergic synapses, and NDD. For both collybistin and gephyrin, studying the effects of the human mutations in mouse models may yield more clarity into the role of these proteins in NDD. Other rare mutations implicated in NDDs are indirectly linked to GABAergic scaffolding and signaling, including <italic>NONO</italic> (<xref ref-type="bibr" rid="B186">Mircsof et al., 2015</xref>; <xref ref-type="bibr" rid="B220">Reinstein et al., 2016</xref>) which impacts the expression of both gephyrin and the GABA<sub>A</sub>R α2 subunit (<xref ref-type="bibr" rid="B186">Mircsof et al., 2015</xref>). The data from rare NDD syndromes solidify direct and indirect links between NDDs and the proteins responsible for inhibitory GABA<sub>A</sub>R signaling.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Throughout this review we have identified commonalities in GABAergic signaling dysfunction in diverse NDDs. Specific perturbation in GABAergic signaling are emerging as ribs of commonality in these diverse disorders. One emerging rib centers on perturbations in the developmental excitatory to inhibitory shift in EGABA, caused by the onset of KCC2 expression. Studies have now directly indicated SLC12A5 gene (KCC2) mutation in ASD, with the C-terminus being impacted (<xref ref-type="bibr" rid="B184">Merner et al., 2015</xref>). Recent examination of the molecular structure of KCC2 reveals the C-terminus to be important for dimerization and function (<xref ref-type="bibr" rid="B1">Agez et al., 2017</xref>). Modeling of ASD and RS associated mutations has also revealed a delay in the chloride reversal associated with alterations in KCC2 expression and function, producing corresponding alterations in neuronal signaling (<xref ref-type="bibr" rid="B254">Tang et al., 2016</xref>; <xref ref-type="bibr" rid="B5">Amin et al., 2017</xref>). Environmental models of ASD, including maternal immune activation and valproic acid exposure have also indicated reductions in KCC2 expression and delays in the shift to inhibitory GABA (<xref ref-type="bibr" rid="B55">Corradini et al., 2017</xref>; <xref ref-type="bibr" rid="B156">Li et al., 2017</xref>). Clinical Trials of bumetanide, a high affinity inhibitor of NKCC1, have been successful in reducing the core symptoms of ASD (<xref ref-type="bibr" rid="B151">Lemonnier et al., 2012</xref>, <xref ref-type="bibr" rid="B152">2017</xref>). A second emerging rib is the control of excitation by PV-positive cells. PV positive cells contact sites at or near action potential generation in neurons, exerting powerful control over excitatory firing patterns (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). A number of studies have indicated perturbations in PV-positive cells in NDD populations and mouse models (<xref ref-type="bibr" rid="B209">Peñagarikano et al., 2011</xref>; <xref ref-type="bibr" rid="B134">Karayannis et al., 2014</xref>; <xref ref-type="bibr" rid="B102">Hashemi et al., 2017</xref>; <xref ref-type="bibr" rid="B243">Soghomonian et al., 2017</xref>; <xref ref-type="bibr" rid="B269">Vogt et al., 2017</xref>; <xref ref-type="bibr" rid="B9">Ariza et al., 2018</xref>). While several studies have indicated a loss of PV-positive cells, some evidence suggests that it may be a reduction in PV expression, bringing cells below the detection threshold (<xref ref-type="bibr" rid="B83">Filice et al., 2016</xref>). These studies are supported by the demonstration that knockout of PV in the mouse leads to behavioral phenotypes relevant to human ASD (<xref ref-type="bibr" rid="B276">Wöhr et al., 2015</xref>). A third emerging rib is the role of tonic inhibition (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, left), early in development and in NDDs. Studies have identified alterations in the expression of tonic GABA<sub>A</sub>R subunits in human populations (<xref ref-type="bibr" rid="B80">Fatemi et al., 2014</xref>), as well as deficits in tonic inhibition in mouse models of NDD (<xref ref-type="bibr" rid="B199">Olmos-Serrano et al., 2011</xref>; <xref ref-type="bibr" rid="B74">Egawa et al., 2012</xref>; <xref ref-type="bibr" rid="B176">Martin et al., 2014</xref>; <xref ref-type="bibr" rid="B267">Vien et al., 2015</xref>; <xref ref-type="bibr" rid="B282">Zhong et al., 2015</xref>; <xref ref-type="bibr" rid="B31">Bridi et al., 2017</xref>). Gaboxadol, a GABA<sub>A</sub>R agonist with preferential activity at δ-containing receptors, is being examined in clinical trials for patients with Fragile-x and AS (<xref ref-type="bibr" rid="B158">Ligsay et al., 2017</xref>).</p>
<p>Despite these emerging ribs, our understanding of the details of inhibitory signaling lags behind that which is known about excitatory signaling. In particular, further investigation of regional or subtype specific deficits in GABAergic signaling is warranted in in NDD populations and animal models. More specific information about GABA<sub>A</sub>R subunit alterations would provide insights about which modes of inhibition, and which subtypes of inhibitory synapses may be contributing to NDDs. Investigations comparing both phasic and tonic forms of inhibition across animal models of NDD would be illuminating, as tonic inhibition plays an important and powerful role in controlling brain activity but is understudied. In addition, subtypes of synaptic GABA<sub>A</sub>Rs, including somatic and AIS synapses, are known to have a powerful role in coordinating neuronal activity patterns, but we are just beginning to understand the roles of these synapses, how they are specified, how they develop, and their possible contributions to NDDs. In addition, there are many key adhesion, and scaffolding proteins required for the aforementioned processes at specific inhibitory synapse subtypes, including neuroligins, dystroglycan, dystrophin, gephyrin, and collybistin, among others. Increasing our understanding of these key proteins involved in the formation, maintenance, and function of specific inhibitory synapses will also advance our understanding of how subtypes impact neurodevelopment more globally.</p>
<p>Further, assessments of specific interneuron function also seem promising, with evidence pointing toward PV-positive interneuron dysfunction as a key factor mentioned above. In particular, it may be important to examine the mechanisms causing changes in PV expression, as well as understand the functional implications of such changes to neuronal circuit activity. In addition, analysis of markers for other subtypes of interneurons in NDD and mouse models have not been described. In particular, analysis of interneuron targeting interneurons that have disinhibiting effects on network signaling is lacking in NDD populations and models. This is of particular relevance as a recent study has shown that Nav1.2 (SCN2A), which bears an ASD related mutation (<xref ref-type="bibr" rid="B63">De Rubeis et al., 2014</xref>), is enriched in inhibitory cells that innervate other interneurons (<xref ref-type="bibr" rid="B278">Yamagata et al., 2017</xref>). Analysis of circuit level dysfunction in NDD populations and models is also currently focused on seizures and epilepsy, and more global assessment of patterned oscillatory activity may provide the next needed advance following specific inhibitory mode, interneuron, and synapse subtype assessments. In particular, systematic assessment of oscillatory activity across multiple mouse models of NDDs may provide illuminating insights into commonalities and distinctions. Also of importance is to evaluate and/or manipulate circuit activity during execution of specific behaviors relevant to NDD, allowing for further insight into the mechanisms producing symptoms, and promoting novel therapeutic approaches by modulating specific circuits to correct perturbations in oscillatory activity. Advances in our understanding of GABAergic signaling in normal development and in NDD models and populations will ultimately advance our therapeutic strategies, improving patient outcomes.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>RAR contributed to the writing. CJ contributed to the writing and tables. RH conceived of the topic, wrote the manuscript, and prepared the figures.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> University of Nevada, Las Vegas start-up funds supported this manuscript.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agez</surname><given-names>M.</given-names></name><name><surname>Schultz</surname><given-names>P.</given-names></name><name><surname>Medina</surname><given-names>I.</given-names></name><name><surname>Baker</surname><given-names>D. J.</given-names></name><name><surname>Burnham</surname><given-names>M. P.</given-names></name><name><surname>Cardarelli</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Molecular architecture of potassium chloride co-transporter KCC2.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>16452</issue>
<pub-id pub-id-type="doi">10.1038/s41598-017-15739-1</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Ageeli</surname><given-names>E.</given-names></name><name><surname>Drunat</surname><given-names>S.</given-names></name><name><surname>Delanoë</surname><given-names>C.</given-names></name><name><surname>Perrin</surname><given-names>L.</given-names></name><name><surname>Baumann</surname><given-names>C.</given-names></name><name><surname>Capri</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Duplication of the 15q11-q13 region: clinical and genetic study of 30 new cases.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>57</volume>
<fpage>5</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2013.10.008</pub-id><pub-id pub-id-type="pmid">24239951</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcón</surname><given-names>M.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Stone</surname><given-names>J. L.</given-names></name><name><surname>Duvall</surname><given-names>J. A.</given-names></name><name><surname>Perederiy</surname><given-names>J. V.</given-names></name><name><surname>Bomar</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>150</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.005</pub-id><pub-id pub-id-type="pmid">18179893</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alber</surname><given-names>M.</given-names></name><name><surname>Kalscheuer</surname><given-names>V. M.</given-names></name><name><surname>Marco</surname><given-names>E.</given-names></name><name><surname>Sherr</surname><given-names>E.</given-names></name><name><surname>Lesca</surname><given-names>G.</given-names></name><name><surname>Till</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ARHGEF9 disease: phenotype clarification and genotype-phenotype correlation.</article-title>
<source/><italic>Neurol. Genet.</italic>
<volume>3</volume>:<issue>e148</issue>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000148</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>H.</given-names></name><name><surname>Marinaro</surname><given-names>F.</given-names></name><name><surname>De Pietri Tonelli</surname><given-names>D.</given-names></name><name><surname>Berdondini</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>15752</issue>
<pub-id pub-id-type="doi">10.1038/s41598-017-15793-9</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2 encoding methyl-CpG-binding protein 2.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>23</volume>
<fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G. R.</given-names></name><name><surname>Galfin</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Aoto</surname><given-names>J.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>18120</fpage>–<lpage>18125</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1216398109</pub-id><pub-id pub-id-type="pmid">23074245</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Almeida</surname><given-names>J.</given-names></name><name><surname>Bacchelli</surname><given-names>E.</given-names></name><name><surname>Baird</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Individual common variants exert weak effects on the risk for autism spectrum disorders.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>4781</fpage>–<lpage>4792</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds301</pub-id><pub-id pub-id-type="pmid">22843504</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariza</surname><given-names>J.</given-names></name><name><surname>Rogers</surname><given-names>H.</given-names></name><name><surname>Hashemi</surname><given-names>E.</given-names></name><name><surname>Noctor</surname><given-names>S. C.</given-names></name><name><surname>Martínez-Cerdeño</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title>The number of chandelier and basket cells are differentially decreased in prefrontal cortex in autism.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>28</volume>
<fpage>411</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw349</pub-id><pub-id pub-id-type="pmid">28122807</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Cutler</surname><given-names>D. J.</given-names></name><name><surname>Brune</surname><given-names>C. W.</given-names></name><name><surname>Teslovich</surname><given-names>T. M.</given-names></name><name><surname>West</surname><given-names>K.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>160</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.015</pub-id><pub-id pub-id-type="pmid">18179894</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arons</surname><given-names>M. H.</given-names></name><name><surname>Thynne</surname><given-names>C. J.</given-names></name><name><surname>Grabrucker</surname><given-names>A. M.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Schoen</surname><given-names>M.</given-names></name><name><surname>Cheyne</surname><given-names>J. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>14966</fpage>–<lpage>14978</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2215-12.2012</pub-id><pub-id pub-id-type="pmid">23100419</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>D. N.</given-names></name><name><surname>Yanagawa</surname><given-names>T.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>129</volume>
<fpage>82</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2016.10.006</pub-id><pub-id pub-id-type="pmid">27743928</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkaloglu</surname><given-names>B.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Louvi</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>A. R.</given-names></name><name><surname>Abelson</surname><given-names>J. F.</given-names></name><name><surname>Morgan</surname><given-names>T. M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>165</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.017</pub-id><pub-id pub-id-type="pmid">18179895</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A.</given-names></name><name><surname>Castro</surname><given-names>J.</given-names></name><name><surname>Sur</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Rett syndrome: genes, synapses, circuits, and therapeutics.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>3</volume>:<issue>34</issue>
<pub-id pub-id-type="doi">10.3389/fpsyt.2012.00034</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Riordan</surname><given-names>M.</given-names></name><name><surname>Bhat</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetic aspects of autism spectrum disorders: insights from animal models.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>58</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00058</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>M. K.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Vaida</surname><given-names>B.</given-names></name><name><surname>Faham</surname><given-names>S.</given-names></name><name><surname>Gingery</surname><given-names>M.</given-names></name><name><surname>Sawaya</surname><given-names>M. R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>An architectural framework that may lie at the core of the postsynaptic density.</article-title>
<source/><italic>Science</italic>
<volume>311</volume>
<fpage>531</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1126/science.1118995</pub-id><pub-id pub-id-type="pmid">16439662</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baulac</surname><given-names>S.</given-names></name><name><surname>Huberfeld</surname><given-names>G.</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I.</given-names></name><name><surname>Mitropoulou</surname><given-names>G.</given-names></name><name><surname>Beranger</surname><given-names>A.</given-names></name><name><surname>Prud’homme</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>28</volume>
<fpage>46</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/88254</pub-id><pub-id pub-id-type="pmid">11326274</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>The GABA excitatory/inhibitory developmental sequence: a personal journey.</article-title>
<source/><italic>Neuroscience</italic>
<volume>279</volume>
<fpage>187</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.08.001</pub-id><pub-id pub-id-type="pmid">25168736</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name><name><surname>Gaiarsa</surname><given-names>J.-L.</given-names></name><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Khazipov</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>87</volume>
<fpage>1215</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00017.2006</pub-id><pub-id pub-id-type="pmid">17928584</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkel</surname><given-names>S.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Weiss</surname><given-names>B.</given-names></name><name><surname>Howe</surname><given-names>J.</given-names></name><name><surname>Roeth</surname><given-names>R.</given-names></name><name><surname>Moog</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>42</volume>
<fpage>489</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1038/ng.589</pub-id><pub-id pub-id-type="pmid">20473310</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>G.</given-names></name><name><surname>LaGrave</surname><given-names>D.</given-names></name><name><surname>Millson</surname><given-names>A.</given-names></name><name><surname>Herriges</surname><given-names>J.</given-names></name><name><surname>Lamb</surname><given-names>A. N.</given-names></name><name><surname>Matalon</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Xq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder.</article-title>
<source/><italic>Eur. J. Med. Genet.</italic>
<volume>59</volume>
<fpage>470</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2016.05.014</pub-id><pub-id pub-id-type="pmid">27238888</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blatt</surname><given-names>G. J.</given-names></name><name><surname>Fitzgerald</surname><given-names>C. M.</given-names></name><name><surname>Guptill</surname><given-names>J. T.</given-names></name><name><surname>Booker</surname><given-names>A. B.</given-names></name><name><surname>Kemper</surname><given-names>T. L.</given-names></name><name><surname>Bauman</surname><given-names>M. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>31</volume>
<fpage>537</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1023/A:1013238809666</pub-id><pub-id pub-id-type="pmid">11814263</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Blaiss</surname><given-names>C. A.</given-names></name><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>Espinosa</surname><given-names>F.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Walz</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>2115</fpage>–<lpage>2129</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4517-09.2010</pub-id><pub-id pub-id-type="pmid">20147539</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccuto</surname><given-names>L.</given-names></name><name><surname>Lauri</surname><given-names>M.</given-names></name><name><surname>Sarasua</surname><given-names>S. M.</given-names></name><name><surname>Skinner</surname><given-names>C. D.</given-names></name><name><surname>Buccella</surname><given-names>D.</given-names></name><name><surname>Dwivedi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>21</volume>
<fpage>310</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.175</pub-id><pub-id pub-id-type="pmid">22892527</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname><given-names>M. J.</given-names></name><name><surname>Kakooza</surname><given-names>A. M.</given-names></name><name><surname>Warf</surname><given-names>B. C.</given-names></name><name><surname>Davidson</surname><given-names>L. L.</given-names></name><name><surname>Grigorenko</surname><given-names>E. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Reducing neurodevelopmental disorders and disability through research and interventions.</article-title>
<source/><italic>Nature</italic>
<volume>527</volume>
<fpage>S155</fpage>–<lpage>S160</lpage>. <pub-id pub-id-type="doi">10.1038/nature16029</pub-id><pub-id pub-id-type="pmid">26580321</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolliger</surname><given-names>M. F.</given-names></name><name><surname>Frei</surname><given-names>K.</given-names></name><name><surname>Winterhalter</surname><given-names>K. H.</given-names></name><name><surname>Gloor</surname><given-names>S. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Identification of a novel neuroligin in humans which binds to PSD-95 and has a widespread expression.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>356</volume>
<fpage>581</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1042/bj3560581</pub-id><pub-id pub-id-type="pmid">11368788</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolliger</surname><given-names>M. F.</given-names></name><name><surname>Pei</surname><given-names>J.</given-names></name><name><surname>Maxeiner</surname><given-names>S.</given-names></name><name><surname>Boucard</surname><given-names>A. A.</given-names></name><name><surname>Grishin</surname><given-names>N. V.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Unusually rapid evolution of Neuroligin-4 in mice.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>6421</fpage>–<lpage>6426</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0801383105</pub-id><pub-id pub-id-type="pmid">18434543</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozdagi</surname><given-names>O.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Papapetrou</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Dickstein</surname><given-names>D. L.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>1</volume>:<issue>15</issue>
<pub-id pub-id-type="doi">10.1186/2040-2392-1-15</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzi</surname><given-names>Y.</given-names></name><name><surname>Casarosa</surname><given-names>S.</given-names></name><name><surname>Caleo</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Epilepsy as a neurodevelopmental disorder.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>3</volume>:<issue>19</issue>
<pub-id pub-id-type="doi">10.3389/fpsyt.2012.00019</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brickley</surname><given-names>S. G.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>Extrasynaptic GABAA receptors: their function in the CNS and implications for disease.</article-title>
<source/><italic>Neuron</italic>
<volume>73</volume>
<fpage>23</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.012</pub-id><pub-id pub-id-type="pmid">22243744</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridi</surname><given-names>M. S.</given-names></name><name><surname>Park</surname><given-names>S. M.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Developmental Disruption of GABAAR-Meditated Inhibition in Cntnap2 KO Mice.</article-title>
<source/><italic>eNeuro</italic>
<volume>4</volume>:<issue>ENEURO.0162-17.2017</issue>
<pub-id pub-id-type="doi">10.1523/ENEURO.0162-17.2017</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bright</surname><given-names>D. P.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Methods for recording and measuring tonic GABAA receptor-mediated inhibition.</article-title>
<source/><italic>Front. Neural Circuits</italic>
<volume>7</volume>:<issue>193</issue>
<pub-id pub-id-type="doi">10.3389/fncir.2013.00193</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budreck</surname><given-names>E. C.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>26</volume>
<fpage>1738</fpage>–<lpage>1748</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05842.x</pub-id><pub-id pub-id-type="pmid">17897391</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buiting</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><name><surname>Horsthemke</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Angelman syndrome - insights into a rare neurogenetic disorder.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>12</volume>
<fpage>584</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.133</pub-id><pub-id pub-id-type="pmid">27615419</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burbach</surname><given-names>J. P. H.</given-names></name><name><surname>van der Zwaag</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Contact in the genetics of autism and schizophrenia.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>32</volume>
<fpage>69</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.11.002</pub-id><pub-id pub-id-type="pmid">19135727</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname><given-names>G. L.</given-names></name><name><surname>Weckhuysen</surname><given-names>S.</given-names></name><name><surname>McMahon</surname><given-names>J. M.</given-names></name><name><surname>Hartmann</surname><given-names>C.</given-names></name><name><surname>Møller</surname><given-names>R. S.</given-names></name><name><surname>Hjalgrim</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.</article-title>
<source/><italic>Neurology</italic>
<volume>82</volume>
<fpage>1245</fpage>–<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000291</pub-id><pub-id pub-id-type="pmid">24623842</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattabeni</surname><given-names>F.</given-names></name><name><surname>Gardoni</surname><given-names>F.</given-names></name><name><surname>Di Luca</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Pathophysiological implications of the structural organization of the excitatory synapse.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>375</volume>
<fpage>339</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-2999(99)00299-X</pub-id><pub-id pub-id-type="pmid">10443587</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadman</surname><given-names>K. K.</given-names></name><name><surname>Gong</surname><given-names>S.</given-names></name><name><surname>Scattoni</surname><given-names>M. L.</given-names></name><name><surname>Boltuck</surname><given-names>S. E.</given-names></name><name><surname>Gandhy</surname><given-names>S. U.</given-names></name><name><surname>Heintz</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice.</article-title>
<source/><italic>Autism Res.</italic>
<volume>1</volume>
<fpage>147</fpage>–<lpage>158</lpage>.<pub-id pub-id-type="pmid">19360662</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2007</year>). <article-title>The story of Rett syndrome: from clinic to neurobiology.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>422</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.001</pub-id><pub-id pub-id-type="pmid">17988628</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H.-T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id><pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H.-T.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Rosenmund</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>58</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.08.018</pub-id><pub-id pub-id-type="pmid">17920015</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheah</surname><given-names>C. S.</given-names></name><name><surname>Yu</surname><given-names>F. H.</given-names></name><name><surname>Westenbroek</surname><given-names>R. E.</given-names></name><name><surname>Kalume</surname><given-names>F. K.</given-names></name><name><surname>Oakley</surname><given-names>J. C.</given-names></name><name><surname>Potter</surname><given-names>G. B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>14646</fpage>–<lpage>14651</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1211591109</pub-id><pub-id pub-id-type="pmid">22908258</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-Y.</given-names></name><name><surname>Di Lucente</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Y.-C.</given-names></name><name><surname>Lien</surname><given-names>C.-C.</given-names></name><name><surname>Rogawski</surname><given-names>M. A.</given-names></name><name><surname>Maezawa</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>109</volume>
<fpage>25</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2017.09.006</pub-id><pub-id pub-id-type="pmid">28927958</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>Synaptic proteins and receptors defects in autism spectrum disorders.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>276</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00276</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R. Z.</given-names></name><name><surname>Akbarian</surname><given-names>S.</given-names></name><name><surname>Tudor</surname><given-names>M.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>27</volume>
<fpage>327</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1038/85906</pub-id><pub-id pub-id-type="pmid">11242118</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiara</surname><given-names>D. C.</given-names></name><name><surname>Jounaidi</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Savechenkov</surname><given-names>P. Y.</given-names></name><name><surname>Bruzik</surname><given-names>K. S.</given-names></name><name><surname>Miller</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>General anesthetic binding sites in human α4β3δ γ-aminobutyric acid type a receptors (GABAARs).</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>26529</fpage>–<lpage>26539</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.753335</pub-id><pub-id pub-id-type="pmid">27821594</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chih</surname><given-names>B.</given-names></name><name><surname>Engelman</surname><given-names>H.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Control of excitatory and inhibitory synapse formation by neuroligins.</article-title>
<source/><italic>Science</italic>
<volume>307</volume>
<fpage>1324</fpage>–<lpage>1328</lpage>. <pub-id pub-id-type="doi">10.1126/science.1107470</pub-id><pub-id pub-id-type="pmid">15681343</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chubykin</surname><given-names>A. A.</given-names></name><name><surname>Atasoy</surname><given-names>D.</given-names></name><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name><name><surname>Kavalali</surname><given-names>E. T.</given-names></name><name><surname>Gibson</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.</article-title>
<source/><italic>Neuron</italic>
<volume>54</volume>
<fpage>919</fpage>–<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.05.029</pub-id><pub-id pub-id-type="pmid">17582332</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobos</surname><given-names>I.</given-names></name><name><surname>Calcagnotto</surname><given-names>M. E.</given-names></name><name><surname>Vilaythong</surname><given-names>A. J.</given-names></name><name><surname>Thwin</surname><given-names>M. T.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Baraban</surname><given-names>S. C.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>1059</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1038/nn1499</pub-id><pub-id pub-id-type="pmid">16007083</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A. L.</given-names></name><name><surname>Levenson</surname><given-names>J. M.</given-names></name><name><surname>Vilaythong</surname><given-names>A. P.</given-names></name><name><surname>Richman</surname><given-names>R.</given-names></name><name><surname>Armstrong</surname><given-names>D. L.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>13</volume>
<fpage>2679</fpage>–<lpage>2689</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh282</pub-id><pub-id pub-id-type="pmid">15351775</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A. L.</given-names></name><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Whitehead</surname><given-names>P. L.</given-names></name><name><surname>Martin</surname><given-names>E. R.</given-names></name><name><surname>Wright</surname><given-names>H. H.</given-names></name><name><surname>Abramson</surname><given-names>R. K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Investigation of autism and GABA receptor subunit genes in multiple ethnic groups.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>7</volume>
<fpage>167</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-006-0045-1</pub-id><pub-id pub-id-type="pmid">16770606</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conant</surname><given-names>K. D.</given-names></name><name><surname>Finucane</surname><given-names>B.</given-names></name><name><surname>Cleary</surname><given-names>N.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Muss</surname><given-names>C.</given-names></name><name><surname>Delany</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A survey of seizures and current treatments in 15q duplication syndrome.</article-title>
<source/><italic>Epilepsia</italic>
<volume>55</volume>
<fpage>396</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12530</pub-id><pub-id pub-id-type="pmid">24502430</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>S.</given-names></name><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Gallagher</surname><given-names>L.</given-names></name><name><surname>Heron</surname><given-names>E. A.</given-names></name></person-group> (<year>2017</year>). <article-title>A genome-wide investigation into parent-of-origin effects in autism spectrum disorder identifies previously associated genes including SHANK3.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>25</volume>
<fpage>234</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2016.153</pub-id><pub-id pub-id-type="pmid">27876814</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>E. H.</given-names></name><name><surname>Courchesne</surname><given-names>R.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Cox</surname><given-names>N. J.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Lincoln</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Evidence of linkage between the serotonin transporter and autistic disorder.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>2</volume>
<fpage>247</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000266</pub-id><pub-id pub-id-type="pmid">9152989</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Focchi</surname><given-names>E.</given-names></name><name><surname>Rasile</surname><given-names>M.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Desiato</surname><given-names>G.</given-names></name><name><surname>Tomasoni</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Maternal immune activation delays excitatory-to-inhibitory gamma-aminobutyric acid switch in offspring.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>83</volume>
<fpage>680</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.09.030</pub-id><pub-id pub-id-type="pmid">29146047</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossette</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Brisebois</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Lortie</surname><given-names>A.</given-names></name><name><surname>Vanasse</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mutation of <italic>GABRA1</italic> in an autosomal dominant form of juvenile myoclonic epilepsy.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>31</volume>
<fpage>184</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1038/ng885</pub-id><pub-id pub-id-type="pmid">11992121</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coury</surname><given-names>D. L.</given-names></name><name><surname>Swedo</surname><given-names>S. E.</given-names></name><name><surname>Thurm</surname><given-names>A. E.</given-names></name><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Veenstra-VanderWeele</surname><given-names>J. M.</given-names></name><name><surname>Carbone</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Treating the whole person with autism: the proceedings of the Autism Speaks National Autism Conference.</article-title>
<source/><italic>Curr. Probl. Pediatr. Adolesc. Health Care</italic>
<volume>44</volume>
<fpage>26</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.cppeds.2013.12.002</pub-id><pub-id pub-id-type="pmid">24491508</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dachtler</surname><given-names>J.</given-names></name><name><surname>Glasper</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>R. N.</given-names></name><name><surname>Ivorra</surname><given-names>J. L.</given-names></name><name><surname>Swiffen</surname><given-names>D. J.</given-names></name><name><surname>Jackson</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Deletion of α-neurexin II results in autism-related behaviors in mice.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>4</volume>:<issue>e484</issue>
<pub-id pub-id-type="doi">10.1038/tp.2014.123</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname><given-names>R.</given-names></name><name><surname>El-Husseini</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>208</volume>
<fpage>96</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2009.11.019</pub-id><pub-id pub-id-type="pmid">19932134</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname><given-names>R.</given-names></name><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Eadie</surname><given-names>B. D.</given-names></name><name><surname>Kannangara</surname><given-names>T. S.</given-names></name><name><surname>Hines</surname><given-names>D. J.</given-names></name><name><surname>Brown</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus.</article-title>
<source/><italic>Hippocampus</italic>
<volume>20</volume>
<fpage>305</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20630</pub-id><pub-id pub-id-type="pmid">19437420</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dávid</surname><given-names>C.</given-names></name><name><surname>Schleicher</surname><given-names>A.</given-names></name><name><surname>Zuschratter</surname><given-names>W.</given-names></name><name><surname>Staiger</surname><given-names>J. F.</given-names></name></person-group> (<year>2007</year>). <article-title>The innervation of parvalbumin-containing interneurons by VIP-immunopositive interneurons in the primary somatosensory cortex of the adult rat.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>25</volume>
<fpage>2329</fpage>–<lpage>2340</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05496.x</pub-id><pub-id pub-id-type="pmid">17445231</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ligt</surname><given-names>J.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><name><surname>van Bon</surname><given-names>B. W. M.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Yntema</surname><given-names>H. G.</given-names></name><name><surname>Kroes</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Diagnostic exome sequencing in persons with severe intellectual disability.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>367</volume>
<fpage>1921</fpage>–<lpage>1929</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id><pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id><pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Gaudio</surname><given-names>D.</given-names></name><name><surname>Fang</surname><given-names>P.</given-names></name><name><surname>Scaglia</surname><given-names>F.</given-names></name><name><surname>Ward</surname><given-names>P. A.</given-names></name><name><surname>Craigen</surname><given-names>W. J.</given-names></name><name><surname>Glaze</surname><given-names>D. G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>8</volume>
<fpage>784</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1097/01.gim.0000250502.28516.3c</pub-id><pub-id pub-id-type="pmid">17172942</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLorey</surname><given-names>T. M.</given-names></name><name><surname>Handforth</surname><given-names>A.</given-names></name><name><surname>Anagnostaras</surname><given-names>S. G.</given-names></name><name><surname>Homanics</surname><given-names>G. E.</given-names></name><name><surname>Minassian</surname><given-names>B. A.</given-names></name><name><surname>Asatourian</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>18</volume>
<fpage>8505</fpage>–<lpage>8514</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-20-08505.1998</pub-id><pub-id pub-id-type="pmid">9763493</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depienne</surname><given-names>C.</given-names></name><name><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><name><surname>Heron</surname><given-names>D.</given-names></name><name><surname>Bouteiller</surname><given-names>D.</given-names></name><name><surname>Gennetier</surname><given-names>A.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>66</volume>
<fpage>349</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.01.025</pub-id><pub-id pub-id-type="pmid">19278672</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Rocco</surname><given-names>A.</given-names></name><name><surname>Loggini</surname><given-names>A.</given-names></name><name><surname>Di Rocco</surname><given-names>M.</given-names></name><name><surname>Di Rocco</surname><given-names>P.</given-names></name><name><surname>Rossi</surname><given-names>R. P.</given-names></name><name><surname>Gimelli</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Paradoxical worsening of seizure activity with pregabalin in an adult with isodicentric 15 (IDIC-15) syndrome involving duplications of the GABRB3 GABRA5 and GABRG3 genes.</article-title>
<source/><italic>BMC Neurol.</italic>
<volume>13</volume>:<issue>43</issue>
<pub-id pub-id-type="doi">10.1186/1471-2377-13-43</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiStefano</surname><given-names>C.</given-names></name><name><surname>Gulsrud</surname><given-names>A.</given-names></name><name><surname>Huberty</surname><given-names>S.</given-names></name><name><surname>Kasari</surname><given-names>C.</given-names></name><name><surname>Cook</surname><given-names>E.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Identification of a distinct developmental and behavioral profile in children with Dup15q syndrome.</article-title>
<source/><italic>J. Neurodev. Disord.</italic>
<volume>8</volume>:<issue>19</issue>
<pub-id pub-id-type="doi">10.1186/s11689-016-9152-y</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>C. L.</given-names></name><name><surname>Harrison</surname><given-names>N. L.</given-names></name><name><surname>Lynch</surname><given-names>J. W.</given-names></name><name><surname>Keramidas</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>172</volume>
<fpage>3522</fpage>–<lpage>3536</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13142</pub-id><pub-id pub-id-type="pmid">25817320</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyon</surname><given-names>N.</given-names></name><name><surname>Vinay</surname><given-names>L.</given-names></name><name><surname>Prescott</surname><given-names>S. A.</given-names></name><name><surname>De Koninck</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Chloride regulation: a dynamic equilibrium crucial for synaptic inhibition.</article-title>
<source/><italic>Neuron</italic>
<volume>89</volume>
<fpage>1157</fpage>–<lpage>1172</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.030</pub-id><pub-id pub-id-type="pmid">26985723</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragich</surname><given-names>J.</given-names></name><name><surname>Houwink-Manville</surname><given-names>I.</given-names></name><name><surname>Schanen</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>Rett syndrome: a surprising result of mutation in MECP2.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>9</volume>
<fpage>2365</fpage>–<lpage>2375</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.16.2365</pub-id><pub-id pub-id-type="pmid">11005791</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duflocq</surname><given-names>A.</given-names></name><name><surname>Le Bras</surname><given-names>B.</given-names></name><name><surname>Bullier</surname><given-names>E.</given-names></name><name><surname>Couraud</surname><given-names>F.</given-names></name><name><surname>Davenne</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>39</volume>
<fpage>180</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2008.06.008</pub-id><pub-id pub-id-type="pmid">18621130</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>C. M.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>25</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/ng1933</pub-id><pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egawa</surname><given-names>K.</given-names></name><name><surname>Kitagawa</surname><given-names>K.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Takayama</surname><given-names>M.</given-names></name><name><surname>Takayama</surname><given-names>C.</given-names></name><name><surname>Saitoh</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>4</volume>:<issue>163ra157</issue>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3004655</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>M. D.</given-names></name></person-group> (<year>1999</year>). <article-title>Synapse structure: glutamate receptors connected by the shanks.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>9</volume>
<fpage>R848</fpage>–<lpage>R850</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-9822(00)80043-3</pub-id><pub-id pub-id-type="pmid">10574750</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyre</surname><given-names>M. D.</given-names></name><name><surname>Renzi</surname><given-names>M.</given-names></name><name><surname>Farrant</surname><given-names>M.</given-names></name><name><surname>Nusser</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>Setting the time course of inhibitory synaptic currents by mixing multiple GABA(A) receptor α subunit isoforms.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>5853</fpage>–<lpage>5867</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6495-11.2012</pub-id><pub-id pub-id-type="pmid">22539847</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrant</surname><given-names>M.</given-names></name><name><surname>Nusser</surname><given-names>Z.</given-names></name></person-group> (<year>2005</year>). <article-title>Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>6</volume>
<fpage>215</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1625</pub-id><pub-id pub-id-type="pmid">15738957</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Folsom</surname><given-names>T. D.</given-names></name><name><surname>Rooney</surname><given-names>R. J.</given-names></name><name><surname>Thuras</surname><given-names>P. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>3</volume>:<issue>e303</issue>
<pub-id pub-id-type="doi">10.1038/tp.2013.64</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Reutiman</surname><given-names>T. J.</given-names></name><name><surname>Folsom</surname><given-names>T. D.</given-names></name><name><surname>Rooney</surname><given-names>R. J.</given-names></name><name><surname>Patel</surname><given-names>D. H.</given-names></name><name><surname>Thuras</surname><given-names>P. D.</given-names></name></person-group> (<year>2010</year>). <article-title>mRNA and protein levels for GABAAalpha4 alpha5 beta1 and GABABR1 receptors are altered in brains from subjects with autism.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>40</volume>
<fpage>743</fpage>–<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-009-0924-z</pub-id><pub-id pub-id-type="pmid">20066485</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Reutiman</surname><given-names>T. J.</given-names></name><name><surname>Folsom</surname><given-names>T. D.</given-names></name><name><surname>Rustan</surname><given-names>O. G.</given-names></name><name><surname>Rooney</surname><given-names>R. J.</given-names></name><name><surname>Thuras</surname><given-names>P. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Downregulation of GABAA receptor protein subunits α6 β2 δ, ε, γ2 θ, and ρ2 in superior frontal cortex of subjects with autism.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>44</volume>
<fpage>1833</fpage>–<lpage>1845</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-014-2078-x</pub-id><pub-id pub-id-type="pmid">24668190</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Reutiman</surname><given-names>T. J.</given-names></name><name><surname>Folsom</surname><given-names>T. D.</given-names></name><name><surname>Thuras</surname><given-names>P. D.</given-names></name></person-group> (<year>2009</year>). <article-title>GABA(A) receptor downregulation in brains of subjects with autism.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>39</volume>
<fpage>223</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-008-0646-7</pub-id><pub-id pub-id-type="pmid">18821008</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Tintrup</surname><given-names>H.</given-names></name><name><surname>Kirsch</surname><given-names>J.</given-names></name><name><surname>Nichol</surname><given-names>M. C.</given-names></name><name><surname>Kuhse</surname><given-names>J.</given-names></name><name><surname>Betz</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity.</article-title>
<source/><italic>Science</italic>
<volume>282</volume>
<fpage>1321</fpage>–<lpage>1324</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5392.1321</pub-id><pub-id pub-id-type="pmid">9812897</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filice</surname><given-names>F.</given-names></name><name><surname>Vörckel</surname><given-names>K. J.</given-names></name><name><surname>Sungur</surname><given-names>A. Ö.</given-names></name><name><surname>Wöhr</surname><given-names>M.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism.</article-title>
<source/><italic>Mol. Brain</italic>
<volume>9</volume>:<issue>10</issue>
<pub-id pub-id-type="doi">10.1186/s13041-016-0192-8</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiumara</surname><given-names>A.</given-names></name><name><surname>Pittalà</surname><given-names>A.</given-names></name><name><surname>Cocuzza</surname><given-names>M.</given-names></name><name><surname>Sorge</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Epilepsy in patients with Angelman syndrome.</article-title>
<source/><italic>Ital. J. Pediatr.</italic>
<volume>36</volume>:<issue>31</issue>
<pub-id pub-id-type="doi">10.1186/1824-7288-36-31</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freund</surname><given-names>T. F.</given-names></name><name><surname>Katona</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Perisomatic inhibition.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>33</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.09.012</pub-id><pub-id pub-id-type="pmid">17920013</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frohlich</surname><given-names>J.</given-names></name><name><surname>Senturk</surname><given-names>D.</given-names></name><name><surname>Saravanapandian</surname><given-names>V.</given-names></name><name><surname>Golshani</surname><given-names>P.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Sankar</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A quantitative electrophysiological biomarker of duplication 15q11.2-q13.1 Syndrome.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0167179</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0167179</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Früh</surname><given-names>S.</given-names></name><name><surname>Romanos</surname><given-names>J.</given-names></name><name><surname>Panzanelli</surname><given-names>P.</given-names></name><name><surname>Bürgisser</surname><given-names>D.</given-names></name><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Campbell</surname><given-names>K. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Neuronal dystroglycan is necessary for formation and maintenance of functional CCK-positive basket cell terminals on pyramidal cells.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>10296</fpage>–<lpage>10313</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1823-16.2016</pub-id><pub-id pub-id-type="pmid">27707967</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galiano</surname><given-names>M. R.</given-names></name><name><surname>Jha</surname><given-names>S.</given-names></name><name><surname>Ho</surname><given-names>T. S.-Y.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Ogawa</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>K.-J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A distal axonal cytoskeleton forms an intra-axonal boundary that controls axon initial segment assembly.</article-title>
<source/><italic>Cell</italic>
<volume>149</volume>
<fpage>1125</fpage>–<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.03.039</pub-id><pub-id pub-id-type="pmid">22632975</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Heldt</surname><given-names>S. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Enrichment of GABAA receptor α-subunits on the axonal initial segment shows regional differences.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>10</volume>:<issue>39</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00039</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gennarini</surname><given-names>G.</given-names></name><name><surname>Bizzoca</surname><given-names>A.</given-names></name><name><surname>Picocci</surname><given-names>S.</given-names></name><name><surname>Puzzo</surname><given-names>D.</given-names></name><name><surname>Corsi</surname><given-names>P.</given-names></name><name><surname>Furley</surname><given-names>A. J. W.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>81</volume>
<fpage>49</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.11.006</pub-id><pub-id pub-id-type="pmid">27871938</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Romorini</surname><given-names>S.</given-names></name><name><surname>Nabi</surname><given-names>S. M.</given-names></name><name><surname>Colicos</surname><given-names>M. A.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>El-Husseini</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>A preformed complex of postsynaptic proteins is involved in excitatory synapse development.</article-title>
<source/><italic>Neuron</italic>
<volume>49</volume>
<fpage>547</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.015</pub-id><pub-id pub-id-type="pmid">16476664</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gkogkas</surname><given-names>C. G.</given-names></name><name><surname>Khoutorsky</surname><given-names>A.</given-names></name><name><surname>Ran</surname><given-names>I.</given-names></name><name><surname>Rampakakis</surname><given-names>E.</given-names></name><name><surname>Nevarko</surname><given-names>T.</given-names></name><name><surname>Weatherill</surname><given-names>D. B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Autism-related deficits via dysregulated eIF4E-dependent translational control.</article-title>
<source/><italic>Nature</italic>
<volume>493</volume>
<fpage>371</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1038/nature11628</pub-id><pub-id pub-id-type="pmid">23172145</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabrucker</surname><given-names>S.</given-names></name><name><surname>Proepper</surname><given-names>C.</given-names></name><name><surname>Mangus</surname><given-names>K.</given-names></name><name><surname>Eckert</surname><given-names>M.</given-names></name><name><surname>Chhabra</surname><given-names>R.</given-names></name><name><surname>Schmeisser</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>253</volume>
<fpage>126</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.12.015</pub-id><pub-id pub-id-type="pmid">24382453</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayton</surname><given-names>H. M.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><name><surname>Collier</surname><given-names>D. A.</given-names></name><name><surname>Fernandes</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e67114</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0067114</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grubb</surname><given-names>M. S.</given-names></name><name><surname>Burrone</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability.</article-title>
<source/><italic>Nature</italic>
<volume>465</volume>
<fpage>1070</fpage>–<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1038/nature09160</pub-id><pub-id pub-id-type="pmid">20543823</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundelfinger</surname><given-names>E. D.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Baron</surname><given-names>M. K.</given-names></name><name><surname>Bowie</surname><given-names>J. U.</given-names></name></person-group> (<year>2006</year>). <article-title>A role for zinc in postsynaptic density asSAMbly and plasticity?</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>31</volume>
<fpage>366</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2006.05.007</pub-id><pub-id pub-id-type="pmid">16793273</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Hendrich</surname><given-names>B.</given-names></name><name><surname>Holmes</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>J. E.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>27</volume>
<fpage>322</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/85899</pub-id><pub-id pub-id-type="pmid">11242117</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>K.</given-names></name><name><surname>Holder</surname><given-names>J. L.</given-names></name><name><surname>Schaaf</surname><given-names>C. P.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties.</article-title>
<source/><italic>Nature</italic>
<volume>503</volume>
<fpage>72</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1038/nature12630</pub-id><pub-id pub-id-type="pmid">24153177</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Tai</surname><given-names>C.</given-names></name><name><surname>Westenbroek</surname><given-names>R. E.</given-names></name><name><surname>Yu</surname><given-names>F. H.</given-names></name><name><surname>Cheah</surname><given-names>C. S.</given-names></name><name><surname>Potter</surname><given-names>G. B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.</article-title>
<source/><italic>Nature</italic>
<volume>489</volume>
<fpage>385</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1038/nature11356</pub-id><pub-id pub-id-type="pmid">22914087</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A.-M.</given-names></name><name><surname>Nothwang</surname><given-names>H. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular and evolutionary insights into the structural organization of cation chloride cotransporters.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>470</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00470</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>K.</given-names></name><name><surname>Duguid</surname><given-names>I. C.</given-names></name><name><surname>Alldred</surname><given-names>M. J.</given-names></name><name><surname>Beatty</surname><given-names>S. E.</given-names></name><name><surname>Ward</surname><given-names>H.</given-names></name><name><surname>Keep</surname><given-names>N. H.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>5816</fpage>–<lpage>5826</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1184-04.2004</pub-id><pub-id pub-id-type="pmid">15215304</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>E.</given-names></name><name><surname>Ariza</surname><given-names>J.</given-names></name><name><surname>Rogers</surname><given-names>H.</given-names></name><name><surname>Noctor</surname><given-names>S. C.</given-names></name><name><surname>Martínez-Cerdeño</surname><given-names>V.</given-names></name></person-group> (<year>2017</year>). <article-title>The number of parvalbumin-expressing interneurons is decreased in the medial prefrontal cortex in autism.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>27</volume>
<fpage>1931</fpage>–<lpage>1943</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw021</pub-id><pub-id pub-id-type="pmid">26922658</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>N. A.</given-names></name><name><surname>Zachwieja</surname><given-names>N. J.</given-names></name><name><surname>Miller</surname><given-names>A. R.</given-names></name><name><surname>Anderson</surname><given-names>L. L.</given-names></name><name><surname>Kearney</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Fine mapping of a dravet syndrome modifier locus on mouse chromosome 5 and candidate gene analysis by RNA-Seq.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>12</volume>:<issue>e1006398</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006398</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecht</surname><given-names>F.</given-names></name></person-group> (<year>1975</year>). <article-title>Letter: Partial trisomy 15 (dup15q) syndrome and the need for precision in clinical cytogenetics.</article-title>
<source/><italic>J. Pediatr.</italic>
<volume>87</volume>
<fpage>842</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3476(75)80340-4</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname><given-names>D. J.</given-names></name><name><surname>Hamilton-Nelson</surname><given-names>K. L.</given-names></name><name><surname>Sacharow</surname><given-names>S. J.</given-names></name><name><surname>Nations</surname><given-names>L.</given-names></name><name><surname>Beecham</surname><given-names>G. W.</given-names></name><name><surname>Kozhekbaeva</surname><given-names>Z. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>3</volume>:<issue>2</issue>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-2</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herd</surname><given-names>M. B.</given-names></name><name><surname>Brown</surname><given-names>A. R.</given-names></name><name><surname>Lambert</surname><given-names>J. J.</given-names></name><name><surname>Belelli</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Extrasynaptic GABAA receptors couple presynaptic activity to postsynaptic inhibition in the somatosensory thalamus.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>14850</fpage>–<lpage>14868</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1174-13.2013</pub-id><pub-id pub-id-type="pmid">24027285</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Gurba</surname><given-names>K. N.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2011</year>). <article-title>The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>589</volume>
<fpage>5857</fpage>–<lpage>5878</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.218883</pub-id><pub-id pub-id-type="pmid">21930603</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Davies</surname><given-names>P. A.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Maguire</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional regulation of GABAA receptors in nervous system pathologies.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>22</volume>
<fpage>552</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2011.10.007</pub-id><pub-id pub-id-type="pmid">22036769</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Hines</surname><given-names>D. J.</given-names></name><name><surname>Steenland</surname><given-names>H.</given-names></name><name><surname>Mansour</surname><given-names>S.</given-names></name><name><surname>Dahlhaus</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>6055</fpage>–<lpage>6067</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0032-08.2008</pub-id><pub-id pub-id-type="pmid">18550748</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homanics</surname><given-names>G. E.</given-names></name><name><surname>DeLorey</surname><given-names>T. M.</given-names></name><name><surname>Firestone</surname><given-names>L. L.</given-names></name><name><surname>Quinlan</surname><given-names>J. J.</given-names></name><name><surname>Handforth</surname><given-names>A.</given-names></name><name><surname>Harrison</surname><given-names>N. L.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>4143</fpage>–<lpage>4148</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.8.4143</pub-id><pub-id pub-id-type="pmid">9108119</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoon</surname><given-names>M.</given-names></name><name><surname>Soykan</surname><given-names>T.</given-names></name><name><surname>Falkenburger</surname><given-names>B.</given-names></name><name><surname>Hammer</surname><given-names>M.</given-names></name><name><surname>Patrizi</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>K.-F.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>108</volume>
<fpage>3053</fpage>–<lpage>3058</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1006946108</pub-id><pub-id pub-id-type="pmid">21282647</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>V. W.</given-names></name><name><surname>Sarachana</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>K. S.</given-names></name><name><surname>Nguyen</surname><given-names>A.</given-names></name><name><surname>Kulkarni</surname><given-names>S.</given-names></name><name><surname>Steinberg</surname><given-names>M. E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism.</article-title>
<source/><italic>Autism Res.</italic>
<volume>2</volume>
<fpage>78</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/aur.73</pub-id><pub-id pub-id-type="pmid">19418574</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>V. W.</given-names></name><name><surname>Steinberg</surname><given-names>M. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel clustering of items from the autism diagnostic interview-revised to define phenotypes within autism spectrum disorders.</article-title>
<source/><italic>Autism Res.</italic>
<volume>2</volume>
<fpage>67</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/aur.72</pub-id><pub-id pub-id-type="pmid">19455643</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>48</volume>
<fpage>115</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.06.013</pub-id><pub-id pub-id-type="pmid">22750526</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>K. H.</given-names></name><name><surname>Endo</surname><given-names>S.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>1996</year>). <article-title>Diazepam-insensitive GABAA receptors in rat cerebellum and thalamus.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>310</volume>
<fpage>225</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(96)00349-4</pub-id><pub-id pub-id-type="pmid">8884221</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichtchenko</surname><given-names>K.</given-names></name><name><surname>Hata</surname><given-names>Y.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Ullrich</surname><given-names>B.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><name><surname>Moomaw</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Neuroligin 1: a splice site-specific ligand for beta-neurexins.</article-title>
<source/><italic>Cell</italic>
<volume>81</volume>
<fpage>435</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90396-8</pub-id><pub-id pub-id-type="pmid">7736595</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><collab>International Molecular Genetic Study of Autism Consortium [IMGSAC]</collab> (<year>2001</year>). <article-title>A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>69</volume>
<fpage>570</fpage>–<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1086/323264</pub-id><pub-id pub-id-type="pmid">11481586</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The contribution of de novo coding mutations to autism spectrum disorder.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irie</surname><given-names>M.</given-names></name><name><surname>Hata</surname><given-names>Y.</given-names></name><name><surname>Takeuchi</surname><given-names>M.</given-names></name><name><surname>Ichtchenko</surname><given-names>K.</given-names></name><name><surname>Toyoda</surname><given-names>A.</given-names></name><name><surname>Hirao</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Binding of Neuroligins to PSD-95.</article-title>
<source/><italic>Science</italic>
<volume>277</volume>
<fpage>1511</fpage>–<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1126/science.277.5331.1511</pub-id><pub-id pub-id-type="pmid">9278515</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito-Ishida</surname><given-names>A.</given-names></name><name><surname>Ure</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Swann</surname><given-names>J. W.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Loss of MeCP2 in parvalbumin-and somatostatin-expressing neurons in mice leads to distinct rett syndrome-like phenotypes.</article-title>
<source/><italic>Neuron</italic>
<volume>88</volume>
<fpage>651</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.029</pub-id><pub-id pub-id-type="pmid">26590342</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders.</article-title>
<source/><italic>Epilepsia</italic>
<volume>57</volume>
<fpage>182</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13272</pub-id><pub-id pub-id-type="pmid">26682992</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Jurd</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>9</volume>
<fpage>331</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2370</pub-id><pub-id pub-id-type="pmid">18382465</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Quach</surname><given-names>H.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Råstam</surname><given-names>M.</given-names></name><name><surname>Colineaux</surname><given-names>C.</given-names></name><name><surname>Gillberg</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>34</volume>
<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ng1136</pub-id><pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Radyushkin</surname><given-names>K.</given-names></name><name><surname>Hammerschmidt</surname><given-names>K.</given-names></name><name><surname>Granon</surname><given-names>S.</given-names></name><name><surname>Boretius</surname><given-names>S.</given-names></name><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>1710</fpage>–<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0711555105</pub-id><pub-id pub-id-type="pmid">18227507</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname><given-names>T. C.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Pettersen</surname><given-names>A.</given-names></name><name><surname>Birnbaum</surname><given-names>S. G.</given-names></name><name><surname>Powell</surname><given-names>C. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism-related neuroligin-3 mutation alters social behavior and spatial learning.</article-title>
<source/><italic>Autism Res.</italic>
<volume>7</volume>
<fpage>264</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1362</pub-id><pub-id pub-id-type="pmid">24619977</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>U.</given-names></name><name><surname>Atkins</surname><given-names>C. M.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Eichele</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.</article-title>
<source/><italic>Neuron</italic>
<volume>21</volume>
<fpage>799</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80596-6</pub-id><pub-id pub-id-type="pmid">9808466</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.-H.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Landa</surname><given-names>L.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><name><surname>Spencer</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.</article-title>
<source/><italic>PLoS One</italic>
<volume>5</volume>:<issue>e12278</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0012278</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judson</surname><given-names>M. C.</given-names></name><name><surname>Wallace</surname><given-names>M. L.</given-names></name><name><surname>Sidorov</surname><given-names>M. S.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Gu</surname><given-names>B.</given-names></name><name><surname>van Woerden</surname><given-names>G. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>GABAergic neuron-specific loss of Ube3a causes angelman syndrome-Like EEG abnormalities and enhances seizure susceptibility.</article-title>
<source/><italic>Neuron</italic>
<volume>90</volume>
<fpage>56</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.040</pub-id><pub-id pub-id-type="pmid">27021170</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaila</surname><given-names>K.</given-names></name><name><surname>Price</surname><given-names>T. J.</given-names></name><name><surname>Payne</surname><given-names>J. A.</given-names></name><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Voipio</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cation-chloride cotransporters in neuronal development, plasticity and disease.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>15</volume>
<fpage>637</fpage>–<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3819</pub-id><pub-id pub-id-type="pmid">25234263</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalscheuer</surname><given-names>V. M.</given-names></name><name><surname>Musante</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>C.</given-names></name><name><surname>Hoffmann</surname><given-names>K.</given-names></name><name><surname>Fuchs</surname><given-names>C.</given-names></name><name><surname>Carta</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>30</volume>
<fpage>61</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20814</pub-id><pub-id pub-id-type="pmid">18615734</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalume</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>F. H.</given-names></name><name><surname>Westenbroek</surname><given-names>R. E.</given-names></name><name><surname>Scheuer</surname><given-names>T.</given-names></name><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>11065</fpage>–<lpage>11074</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2162-07.2007</pub-id><pub-id pub-id-type="pmid">17928448</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J.-Q.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to dravet syndrome.</article-title>
<source/><italic>JAMA Neurol.</italic>
<volume>73</volume>
<fpage>1009</fpage>–<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.0449</pub-id><pub-id pub-id-type="pmid">27367160</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaphzan</surname><given-names>H.</given-names></name><name><surname>Buffington</surname><given-names>S. A.</given-names></name><name><surname>Jung</surname><given-names>J. I.</given-names></name><name><surname>Rasband</surname><given-names>M. N.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of angelman syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>17637</fpage>–<lpage>17648</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4162-11.2011</pub-id><pub-id pub-id-type="pmid">22131424</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karayannis</surname><given-names>T.</given-names></name><name><surname>Au</surname><given-names>E.</given-names></name><name><surname>Patel</surname><given-names>J. C.</given-names></name><name><surname>Kruglikov</surname><given-names>I.</given-names></name><name><surname>Markx</surname><given-names>S.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.</article-title>
<source/><italic>Nature</italic>
<volume>511</volume>
<fpage>236</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nature13248</pub-id><pub-id pub-id-type="pmid">24870235</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katidou</surname><given-names>M.</given-names></name><name><surname>Vidaki</surname><given-names>M.</given-names></name><name><surname>Strigini</surname><given-names>M.</given-names></name><name><surname>Karagogeos</surname><given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>The immunoglobulin superfamily of neuronal cell adhesion molecules: lessons from animal models and correlation with human disease.</article-title>
<source/><italic>Biotechnol. J.</italic>
<volume>3</volume>
<fpage>1564</fpage>–<lpage>1580</lpage>. <pub-id pub-id-type="doi">10.1002/biot.200800281</pub-id><pub-id pub-id-type="pmid">19072911</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kattenstroth</surname><given-names>G.</given-names></name><name><surname>Tantalaki</surname><given-names>E.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name><name><surname>Gottmann</surname><given-names>K.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>2607</fpage>–<lpage>2612</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308626100</pub-id><pub-id pub-id-type="pmid">14983056</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishino</surname><given-names>T.</given-names></name><name><surname>Lalande</surname><given-names>M.</given-names></name><name><surname>Wagstaff</surname><given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>UBE3A/E6-AP mutations cause Angelman syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>15</volume>
<fpage>70</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/ng0197-70</pub-id><pub-id pub-id-type="pmid">8988171</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klausberger</surname><given-names>T.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.</article-title>
<source/><italic>Science</italic>
<volume>321</volume>
<fpage>53</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1126/science.1149381</pub-id><pub-id pub-id-type="pmid">18599766</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kole</surname><given-names>M. H. P.</given-names></name><name><surname>Stuart</surname><given-names>G. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Signal processing in the axon initial segment.</article-title>
<source/><italic>Neuron</italic>
<volume>73</volume>
<fpage>235</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.01.007</pub-id><pub-id pub-id-type="pmid">22284179</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozinetz</surname><given-names>C. A.</given-names></name><name><surname>Skender</surname><given-names>M. L.</given-names></name><name><surname>MacNaughton</surname><given-names>N.</given-names></name><name><surname>Almes</surname><given-names>M. J.</given-names></name><name><surname>Schultz</surname><given-names>R. J.</given-names></name><name><surname>Percy</surname><given-names>A. K.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Epidemiology of rett syndrome: a population-based registry.</article-title>
<source/><italic>Pediatrics</italic>
<volume>91</volume>
<fpage>445</fpage>–<lpage>450</lpage>.<pub-id pub-id-type="pmid">8424025</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Shendure</surname><given-names>J.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2014</year>). <article-title>A de novo convergence of autism genetics and molecular neuroscience.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>37</volume>
<fpage>95</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id><pub-id pub-id-type="pmid">24387789</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuba</surname><given-names>H.</given-names></name><name><surname>Oichi</surname><given-names>Y.</given-names></name><name><surname>Ohmori</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Presynaptic activity regulates Na(+) channel distribution at the axon initial segment.</article-title>
<source/><italic>Nature</italic>
<volume>465</volume>
<fpage>1075</fpage>–<lpage>1078</lpage>. <pub-id pub-id-type="doi">10.1038/nature09087</pub-id><pub-id pub-id-type="pmid">20543825</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwasnicka-Crawford</surname><given-names>D. A.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Characterization of an autism-associated segmental maternal heterodisomy of the chromosome 15q11-13 region.</article-title>
<source/><italic>J. Autism Dev. Disord.</italic>
<volume>37</volume>
<fpage>694</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-006-0225-8</pub-id><pub-id pub-id-type="pmid">17006779</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyllerman</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Angelman syndrome.</article-title>
<source/><italic>Handb. Clin. Neurol.</italic>
<volume>111</volume>
<fpage>287</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-52891-9.00032-4</pub-id><pub-id pub-id-type="pmid">23622177</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachamp</surname><given-names>P. M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>S. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Glutamatergic modulation of cerebellar interneuron activity is mediated by an enhancement of GABA release and requires protein kinase A/RIM1alpha signaling.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>381</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2354-08.2009</pub-id><pub-id pub-id-type="pmid">19144838</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavoie</surname><given-names>A. M.</given-names></name><name><surname>Tingey</surname><given-names>J. J.</given-names></name><name><surname>Harrison</surname><given-names>N. L.</given-names></name><name><surname>Pritchett</surname><given-names>D. B.</given-names></name><name><surname>Twyman</surname><given-names>R. E.</given-names></name></person-group> (<year>1997</year>). <article-title>Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform.</article-title>
<source/><italic>Biophys. J.</italic>
<volume>73</volume>
<fpage>2518</fpage>–<lpage>2526</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(97)78280-8</pub-id><pub-id pub-id-type="pmid">9370445</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Heinrich</surname><given-names>J.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><name><surname>Proepper</surname><given-names>C.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Huguet</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>8</volume>:<issue>e1002521</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002521</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Nava</surname><given-names>C.</given-names></name><name><surname>Polge</surname><given-names>A.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Huguet</surname><given-names>G.</given-names></name><name><surname>Lumbroso</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>10</volume>:<issue>e1004580</issue>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004580</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>V.</given-names></name><name><surname>Maguire</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type.</article-title>
<source/><italic>Front. Neural Circuits</italic>
<volume>8</volume>:<issue>3</issue>
<pub-id pub-id-type="doi">10.3389/fncir.2014.00003</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemke</surname><given-names>J. R.</given-names></name><name><surname>Riesch</surname><given-names>E.</given-names></name><name><surname>Scheurenbrand</surname><given-names>T.</given-names></name><name><surname>Schubach</surname><given-names>M.</given-names></name><name><surname>Wilhelm</surname><given-names>C.</given-names></name><name><surname>Steiner</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Targeted next generation sequencing as a diagnostic tool in epileptic disorders.</article-title>
<source/><italic>Epilepsia</italic>
<volume>53</volume>
<fpage>1387</fpage>–<lpage>1398</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03516.x</pub-id><pub-id pub-id-type="pmid">22612257</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemonnier</surname><given-names>E.</given-names></name><name><surname>Degrez</surname><given-names>C.</given-names></name><name><surname>Phelep</surname><given-names>M.</given-names></name><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Josse</surname><given-names>F.</given-names></name><name><surname>Grandgeorge</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A randomised controlled trial of bumetanide in the treatment of autism in children.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>2</volume>:<issue>e202</issue>
<pub-id pub-id-type="doi">10.1038/tp.2012.124</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemonnier</surname><given-names>E.</given-names></name><name><surname>Villeneuve</surname><given-names>N.</given-names></name><name><surname>Sonie</surname><given-names>S.</given-names></name><name><surname>Serret</surname><given-names>S.</given-names></name><name><surname>Rosier</surname><given-names>A.</given-names></name><name><surname>Roue</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>7</volume>:<issue>e1056</issue>
<pub-id pub-id-type="doi">10.1038/tp.2017.10</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesca</surname><given-names>G.</given-names></name><name><surname>Till</surname><given-names>M.</given-names></name><name><surname>Labalme</surname><given-names>A.</given-names></name><name><surname>Vallee</surname><given-names>D.</given-names></name><name><surname>Hugonenq</surname><given-names>C.</given-names></name><name><surname>Philip</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>De novo Xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features.</article-title>
<source/><italic>Am. J. Med. Genet. A.</italic>
<volume>155A</volume>, <fpage>1706</fpage>–<lpage>1711</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34004</pub-id><pub-id pub-id-type="pmid">21626670</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinson</surname><given-names>J. N.</given-names></name><name><surname>El-Husseini</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Building excitatory and inhibitory synapses: balancing neuroligin partnerships.</article-title>
<source/><italic>Neuron</italic>
<volume>48</volume>
<fpage>171</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.09.017</pub-id><pub-id pub-id-type="pmid">16242398</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X. G.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name><name><surname>Tepper</surname><given-names>J. M.</given-names></name><name><surname>Buzsáki</surname><given-names>G.</given-names></name></person-group> (<year>1992</year>). <article-title>Axonal and dendritic arborization of an intracellularly labeled chandelier cell in the CA1 region of rat hippocampus.</article-title>
<source/><italic>Exp. Brain Res.</italic>
<volume>90</volume>
<fpage>519</fpage>–<lpage>525</lpage>.<pub-id pub-id-type="pmid">1385200</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Reduced protein expressions of cytomembrane GABAARβ3 at different postnatal developmental stages of rats exposed prenatally to valproic acid.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1671</volume>
<fpage>33</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2017.06.018</pub-id><pub-id pub-id-type="pmid">28641949</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liautard</surname><given-names>C.</given-names></name><name><surname>Scalmani</surname><given-names>P.</given-names></name><name><surname>Carriero</surname><given-names>G.</given-names></name><name><surname>de Curtis</surname><given-names>M.</given-names></name><name><surname>Franceschetti</surname><given-names>S.</given-names></name><name><surname>Mantegazza</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome.</article-title>
<source/><italic>Epilepsia</italic>
<volume>54</volume>
<fpage>1251</fpage>–<lpage>1261</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12213</pub-id><pub-id pub-id-type="pmid">23663038</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligsay</surname><given-names>A.</given-names></name><name><surname>Van Dijck</surname><given-names>A.</given-names></name><name><surname>Nguyen</surname><given-names>D. V.</given-names></name><name><surname>Lozano</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Bickel</surname><given-names>E. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.</article-title>
<source/><italic>J. Neurodev. Disord.</italic>
<volume>9</volume>:<issue>26</issue>
<pub-id pub-id-type="doi">10.1186/s11689-017-9207-8</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Vaags</surname><given-names>A. K.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Gazzellone</surname><given-names>M. J.</given-names></name><name><surname>Mitchell</surname><given-names>E. B.</given-names></name><name><surname>Chen</surname><given-names>H. Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>2055</fpage>–<lpage>2066</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt056</pub-id><pub-id pub-id-type="pmid">23393157</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Novosedlik</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>A.</given-names></name><name><surname>Hudson</surname><given-names>M. L.</given-names></name><name><surname>Cohen</surname><given-names>I. L.</given-names></name><name><surname>Chudley</surname><given-names>A. E.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>The DLX1and DLX2 genes and susceptibility to autism spectrum disorders.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>17</volume>
<fpage>228</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2008.148</pub-id><pub-id pub-id-type="pmid">18728693</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>W.-S.</given-names></name><name><surname>Harano</surname><given-names>M.</given-names></name><name><surname>Gawlik</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Pun</surname><given-names>F. W.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title><italic>GABRB2</italic> association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>61</volume>
<fpage>653</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.05.003</pub-id><pub-id pub-id-type="pmid">16950232</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loebrich</surname><given-names>S.</given-names></name><name><surname>Bähring</surname><given-names>R.</given-names></name><name><surname>Katsuno</surname><given-names>T.</given-names></name><name><surname>Tsukita</surname><given-names>S.</given-names></name><name><surname>Kneussel</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Activated radixin is essential for GABAA receptor alpha5 subunit anchoring at the actin cytoskeleton.</article-title>
<source/><italic>EMBO J.</italic>
<volume>25</volume>
<fpage>987</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600995</pub-id><pub-id pub-id-type="pmid">16467845</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>P.</given-names></name><name><surname>May</surname><given-names>M. M.</given-names></name><name><surname>James</surname><given-names>V. M.</given-names></name><name><surname>Grannò</surname><given-names>S.</given-names></name><name><surname>Johnson</surname><given-names>J. P.</given-names></name><name><surname>Tarpey</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Missense mutation R338W in <italic>ARHGEF9</italic> in a family with X-linked intellectual disability with variable macrocephaly and macro-orchidism.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>8</volume>:<issue>83</issue>
<pub-id pub-id-type="doi">10.3389/fnmol.2015.00083</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loomes</surname><given-names>R.</given-names></name><name><surname>Hull</surname><given-names>L.</given-names></name><name><surname>Mandy</surname><given-names>W. P. L.</given-names></name></person-group> (<year>2017</year>). <article-title>What is the male-to-female ratio in autism spectrum disorder? a systematic review and meta-analysis.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>56</volume>
<fpage>466</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2017.03.013</pub-id><pub-id pub-id-type="pmid">28545751</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorincz</surname><given-names>A.</given-names></name><name><surname>Nusser</surname><given-names>Z.</given-names></name></person-group> (<year>2008</year>). <article-title>Cell-type-dependent molecular composition of the axon initial segment.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>14329</fpage>–<lpage>14340</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4833-08.2008</pub-id><pub-id pub-id-type="pmid">19118165</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.</given-names></name><name><surname>Ash</surname><given-names>R. T.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Kee</surname><given-names>S. E.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Loss and gain of MeCP2 cause similar hippocampal circuit dysfunction that is rescued by deep brain stimulation in a rett syndrome mouse model.</article-title>
<source/><italic>Neuron</italic>
<volume>91</volume>
<fpage>739</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.07.018</pub-id><pub-id pub-id-type="pmid">27499081</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luikenhuis</surname><given-names>S.</given-names></name><name><surname>Giacometti</surname><given-names>E.</given-names></name><name><surname>Beard</surname><given-names>C. F.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>6033</fpage>–<lpage>6038</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0401626101</pub-id><pub-id pub-id-type="pmid">15069197</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>B.</given-names></name><name><surname>Keller</surname><given-names>C. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Regulation of GABAA receptor trafficking, channel activity, and functional plasticity of inhibitory synapses.</article-title>
<source/><italic>Pharmacol. Ther.</italic>
<volume>102</volume>
<fpage>195</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.04.003</pub-id><pub-id pub-id-type="pmid">15246246</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>D. Q.</given-names></name><name><surname>Whitehead</surname><given-names>P. L.</given-names></name><name><surname>Menold</surname><given-names>M. M.</given-names></name><name><surname>Martin</surname><given-names>E. R.</given-names></name><name><surname>Ashley-Koch</surname><given-names>A. E.</given-names></name><name><surname>Mei</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>77</volume>
<fpage>377</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1086/433195</pub-id><pub-id pub-id-type="pmid">16080114</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>R. L.</given-names></name><name><surname>Kang</surname><given-names>J.-Q.</given-names></name><name><surname>Gallagher</surname><given-names>M. J.</given-names></name></person-group> (<year>2012</year>). “<article-title>GABA<sub>A</sub> receptor subunit mutations and genetic epilepsies</article-title>,” in <source/><italic>Jasper’s Basic Mechanisms of the Epilepsies</italic>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Avoli</surname><given-names>M.</given-names></name><name><surname>Rogawski</surname><given-names>M. A.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A. V.</given-names></name></person-group> (<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information</publisher-name>). Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK98205/">http://www.ncbi.nlm.nih.gov/books/NBK98205/</ext-link></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>F. P.</given-names></name><name><surname>Palladino</surname><given-names>R. R. R.</given-names></name><name><surname>Damasceno</surname><given-names>L. L.</given-names></name><name><surname>Cunha</surname><given-names>M. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Appropriateness of using autism spectrum disorders screening tools in a hearing evaluation service.</article-title>
<source/><italic>Folia Phoniatr. Logop.</italic>
<volume>68</volume>
<fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1159/000446984</pub-id><pub-id pub-id-type="pmid">27583711</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malzac</surname><given-names>P.</given-names></name><name><surname>Webber</surname><given-names>H.</given-names></name><name><surname>Moncla</surname><given-names>A.</given-names></name><name><surname>Graham</surname><given-names>J. M.</given-names></name><name><surname>Kukolich</surname><given-names>M.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Mutation analysis of UBE3A in angelman syndrome patients.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>62</volume>
<fpage>1353</fpage>–<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1086/301877</pub-id><pub-id pub-id-type="pmid">9585605</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marco</surname><given-names>E. J.</given-names></name><name><surname>Abidi</surname><given-names>F. E.</given-names></name><name><surname>Bristow</surname><given-names>J.</given-names></name><name><surname>Dean</surname><given-names>W. B.</given-names></name><name><surname>Cotter</surname><given-names>P.</given-names></name><name><surname>Jeremy</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>45</volume>
<fpage>100</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.052324</pub-id><pub-id pub-id-type="pmid">17893116</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marco</surname><given-names>E. J.</given-names></name><name><surname>Hinkley</surname><given-names>L. B. N.</given-names></name><name><surname>Hill</surname><given-names>S. S.</given-names></name><name><surname>Nagarajan</surname><given-names>S. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Sensory processing in autism: a review of neurophysiologic findings.</article-title>
<source/><italic>Pediatr. Res.</italic>
<volume>69</volume>
<fpage>48R</fpage>–<lpage>54R</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e3182130c54</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>D. M.</given-names></name><name><surname>Patkar</surname><given-names>A. A.</given-names></name><name><surname>Masand</surname><given-names>P. S.</given-names></name><name><surname>Pae</surname><given-names>C.-U.</given-names></name></person-group> (<year>2009</year>). <article-title>Does pregabalin have neuropsychotropic effects: a short perspective.</article-title>
<source/><italic>Psychiatry Investig.</italic>
<volume>6</volume>
<fpage>55</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.4306/pi.2009.6.2.55</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B. S.</given-names></name><name><surname>Corbin</surname><given-names>J. G.</given-names></name><name><surname>Huntsman</surname><given-names>M. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>112</volume>
<fpage>890</fpage>–<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00597.2013</pub-id><pub-id pub-id-type="pmid">24848467</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>E. R.</given-names></name><name><surname>Menold</surname><given-names>M. M.</given-names></name><name><surname>Wolpert</surname><given-names>C. M.</given-names></name><name><surname>Bass</surname><given-names>M. P.</given-names></name><name><surname>Donnelly</surname><given-names>S. L.</given-names></name><name><surname>Ravan</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>96</volume>
<fpage>43</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(20000207)96:1&lt;43::AID-AJMG9&gt;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">10686550</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuura</surname><given-names>T.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Fang</surname><given-names>P.</given-names></name><name><surname>Galjaard</surname><given-names>R. J.</given-names></name><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Benton</surname><given-names>C. S.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>15</volume>
<fpage>74</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1038/ng0197-74</pub-id><pub-id pub-id-type="pmid">8988172</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>D. C.</given-names></name><name><surname>Peet</surname><given-names>E. D.</given-names></name><name><surname>Ezzati</surname><given-names>M.</given-names></name><name><surname>Danaei</surname><given-names>G.</given-names></name><name><surname>Black</surname><given-names>M. M.</given-names></name><name><surname>Sudfeld</surname><given-names>C. R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Early childhood developmental status in low- and middle-income countries: national, regional, and global prevalence estimates using predictive modeling.</article-title>
<source/><italic>PLoS Med.</italic>
<volume>13</volume>:<issue>e1002034</issue>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1002034</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGee</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Convergent synaptic and circuit substrates underlying autism genetic risks.</article-title>
<source/><italic>Front. Biol.</italic>
<volume>9</volume>:<fpage>137</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1007/s11515-014-1298-y</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medrihan</surname><given-names>L.</given-names></name><name><surname>Tantalaki</surname><given-names>E.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Sargsyan</surname><given-names>V.</given-names></name><name><surname>Dudanova</surname><given-names>I.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>99</volume>
<fpage>112</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00826.2007</pub-id><pub-id pub-id-type="pmid">18032561</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meguro-Horike</surname><given-names>M.</given-names></name><name><surname>Yasui</surname><given-names>D. H.</given-names></name><name><surname>Powell</surname><given-names>W.</given-names></name><name><surname>Schroeder</surname><given-names>D. I.</given-names></name><name><surname>Oshimura</surname><given-names>M.</given-names></name><name><surname>Lasalle</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>3798</fpage>–<lpage>3810</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr298</pub-id><pub-id pub-id-type="pmid">21725066</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meloni</surname><given-names>I.</given-names></name><name><surname>Bruttini</surname><given-names>M.</given-names></name><name><surname>Longo</surname><given-names>I.</given-names></name><name><surname>Mari</surname><given-names>F.</given-names></name><name><surname>Rizzolio</surname><given-names>F.</given-names></name><name><surname>D’Adamo</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>A mutation in the rett syndrome gene, MECP2 causes X-linked mental retardation and progressive spasticity in males.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>67</volume>
<fpage>982</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1086/303078</pub-id><pub-id pub-id-type="pmid">10986043</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merner</surname><given-names>N. D.</given-names></name><name><surname>Chandler</surname><given-names>M. R.</given-names></name><name><surname>Bourassa</surname><given-names>C.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Khanna</surname><given-names>A. R.</given-names></name><name><surname>Dion</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Regulatory domain or CpG site variation in SLC12A5 encoding the chloride transporter KCC2 in human autism and schizophrenia.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>386</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00386</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>G.</given-names></name><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>Neeb</surname><given-names>A.</given-names></name><name><surname>Oschlies</surname><given-names>M.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>47</volume>
<fpage>724</fpage>–<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.06.023</pub-id><pub-id pub-id-type="pmid">15458844</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mircsof</surname><given-names>D.</given-names></name><name><surname>Langouët</surname><given-names>M.</given-names></name><name><surname>Rio</surname><given-names>M.</given-names></name><name><surname>Moutton</surname><given-names>S.</given-names></name><name><surname>Siquier-Pernet</surname><given-names>K.</given-names></name><name><surname>Bole-Feysot</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>
<fpage>1731</fpage>–<lpage>1736</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4169</pub-id><pub-id pub-id-type="pmid">26571461</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>P.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>SHANK proteins: roles at the synapse and in autism spectrum disorder.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>18</volume>
<fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.183</pub-id><pub-id pub-id-type="pmid">28179641</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Kretschmannova</surname><given-names>K.</given-names></name><name><surname>Gouzer</surname><given-names>G.</given-names></name><name><surname>Maric</surname><given-names>H.-M.</given-names></name><name><surname>Ramsden</surname><given-names>S.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The residence time of GABA(A)Rs at inhibitory synapses is determined by direct binding of the receptor α1 subunit to gephyrin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>14677</fpage>–<lpage>14687</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2001-11.2011</pub-id><pub-id pub-id-type="pmid">21994384</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naisbitt</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Tu</surname><given-names>J. C.</given-names></name><name><surname>Xiao</surname><given-names>B.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Valtschanoff</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin.</article-title>
<source/><italic>Neuron</italic>
<volume>23</volume>
<fpage>569</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80809-0</pub-id><pub-id pub-id-type="pmid">10433268</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>J.</given-names></name><name><surname>Tamada</surname><given-names>K.</given-names></name><name><surname>Hatanaka</surname><given-names>F.</given-names></name><name><surname>Ise</surname><given-names>S.</given-names></name><name><surname>Ohta</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism.</article-title>
<source/><italic>Cell</italic>
<volume>137</volume>
<fpage>1235</fpage>–<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.04.024</pub-id><pub-id pub-id-type="pmid">19563756</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neul</surname><given-names>J. L.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2004</year>). <article-title>Rett syndrome: a prototypical neurodevelopmental disorder.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>10</volume>
<fpage>118</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1177/1073858403260995</pub-id><pub-id pub-id-type="pmid">15070486</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niturad</surname><given-names>C. E.</given-names></name><name><surname>Lev</surname><given-names>D.</given-names></name><name><surname>Kalscheuer</surname><given-names>V. M.</given-names></name><name><surname>Charzewska</surname><given-names>A.</given-names></name><name><surname>Schubert</surname><given-names>J.</given-names></name><name><surname>Lerman-Sagie</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.</article-title>
<source/><italic>Brain J. Neurol.</italic>
<volume>140</volume>
<fpage>2879</fpage>–<lpage>2894</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awx236</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>Q.-A.</given-names></name><name><surname>Horn</surname><given-names>M. E.</given-names></name><name><surname>Nicoll</surname><given-names>R. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Distinct roles for extracellular and intracellular domains in neuroligin function at inhibitory synapses.</article-title>
<source/><italic>eLife</italic>
<volume>5</volume>:<issue>e19236</issue>
<pub-id pub-id-type="doi">10.7554/eLife.19236</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>2002</year>). <article-title>Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>87</volume>
<fpage>2624</fpage>–<lpage>2628</lpage>. <pub-id pub-id-type="doi">10.1152/jn.2002.87.5.2624</pub-id><pub-id pub-id-type="pmid">11976398</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>93</volume>
<fpage>11939</fpage>–<lpage>11944</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.21.11939</pub-id><pub-id pub-id-type="pmid">8876241</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>1998</year>). <article-title>Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>18</volume>
<fpage>1693</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-05-01693.1998</pub-id><pub-id pub-id-type="pmid">9464994</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyíri</surname><given-names>G.</given-names></name><name><surname>Freund</surname><given-names>T. F.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>13</volume>
<fpage>428</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2001.01407.x</pub-id><pub-id pub-id-type="pmid">11168550</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname><given-names>J. C.</given-names></name><name><surname>Kalume</surname><given-names>F.</given-names></name><name><surname>Yu</surname><given-names>F. H.</given-names></name><name><surname>Scheuer</surname><given-names>T.</given-names></name><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>3994</fpage>–<lpage>3999</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0813330106</pub-id><pub-id pub-id-type="pmid">19234123</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olmos-Serrano</surname><given-names>J. L.</given-names></name><name><surname>Corbin</surname><given-names>J. G.</given-names></name><name><surname>Burns</surname><given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.</article-title>
<source/><italic>Dev. Neurosci.</italic>
<volume>33</volume>
<fpage>395</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1159/000332884</pub-id><pub-id pub-id-type="pmid">22067669</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.</article-title>
<source/><italic>Adv. Pharmacol.</italic>
<volume>73</volume>
<fpage>167</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apha.2014.11.005</pub-id><pub-id pub-id-type="pmid">25637441</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id><pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paina</surname><given-names>S.</given-names></name><name><surname>Garzotto</surname><given-names>D.</given-names></name><name><surname>DeMarchis</surname><given-names>S.</given-names></name><name><surname>Marino</surname><given-names>M.</given-names></name><name><surname>Moiana</surname><given-names>A.</given-names></name><name><surname>Conti</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Wnt5a is a transcriptional target of Dlx homeogenes and promotes differentiation of interneuron progenitors in vitro and in vivo.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>2675</fpage>–<lpage>2687</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3110-10.2011</pub-id><pub-id pub-id-type="pmid">21325536</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panzanelli</surname><given-names>P.</given-names></name><name><surname>Gunn</surname><given-names>B. G.</given-names></name><name><surname>Schlatter</surname><given-names>M. C.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>589</volume>
<fpage>4959</fpage>–<lpage>4980</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.216028</pub-id><pub-id pub-id-type="pmid">21825022</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadopoulos</surname><given-names>T.</given-names></name><name><surname>Korte</surname><given-names>M.</given-names></name><name><surname>Eulenburg</surname><given-names>V.</given-names></name><name><surname>Kubota</surname><given-names>H.</given-names></name><name><surname>Retiounskaia</surname><given-names>M.</given-names></name><name><surname>Harvey</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice.</article-title>
<source/><italic>EMBO J.</italic>
<volume>26</volume>
<fpage>3888</fpage>–<lpage>3899</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601819</pub-id><pub-id pub-id-type="pmid">17690689</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadopoulos</surname><given-names>T.</given-names></name><name><surname>Soykan</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of collybistin in gephyrin clustering at inhibitory synapses: facts and open questions.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>5</volume>:<issue>11</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2011.00011</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Swarup</surname><given-names>V.</given-names></name><name><surname>Belgard</surname><given-names>T. G.</given-names></name><name><surname>Irimia</surname><given-names>M.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Gandal</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism.</article-title>
<source/><italic>Nature</italic>
<volume>540</volume>
<fpage>423</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1038/nature20612</pub-id><pub-id pub-id-type="pmid">27919067</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>R. J.</given-names></name><name><surname>Bolton</surname><given-names>P. F.</given-names></name></person-group> (<year>2001</year>). <article-title>Pervasive developmental disorder and obstetric complications in children and adolescents with tuberous sclerosis.</article-title>
<source/><italic>Autism Int. J. Res. Pract.</italic>
<volume>5</volume>
<fpage>237</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1177/1362361301005003002</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelc</surname><given-names>K.</given-names></name><name><surname>Boyd</surname><given-names>S. G.</given-names></name><name><surname>Cheron</surname><given-names>G.</given-names></name><name><surname>Dan</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Epilepsy in Angelman syndrome.</article-title>
<source/><italic>Seizure</italic>
<volume>17</volume>
<fpage>211</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.seizure.2007.08.004</pub-id><pub-id pub-id-type="pmid">17904873</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Herman</surname><given-names>E. I.</given-names></name><name><surname>Winden</surname><given-names>K. D.</given-names></name><name><surname>Gdalyahu</surname><given-names>A.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.</article-title>
<source/><italic>Cell</italic>
<volume>147</volume>
<fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id><pub-id pub-id-type="pmid">21962519</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><collab>Petilla Interneuron Nomenclature Group</collab>
<person-group person-group-type="author"><name><surname>Ascoli</surname><given-names>G. A.</given-names></name><name><surname>Alonso-Nanclares</surname><given-names>L.</given-names></name><name><surname>Anderson</surname><given-names>S. A.</given-names></name><name><surname>Barrionuevo</surname><given-names>G.</given-names></name><name><surname>Benavides-Piccione</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>9</volume>
<fpage>557</fpage>–<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2402</pub-id><pub-id pub-id-type="pmid">18568015</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>K.</given-names></name><name><surname>McDermid</surname><given-names>H. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).</article-title>
<source/><italic>Mol. Syndromol.</italic>
<volume>2</volume>
<fpage>186</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">22670140</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Pagnamenta</surname><given-names>A. T.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Anney</surname><given-names>R.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Regan</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Functional impact of global rare copy number variation in autism spectrum disorders.</article-title>
<source/><italic>Nature</italic>
<volume>466</volume>
<fpage>368</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nature09146</pub-id><pub-id pub-id-type="pmid">20531469</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzarelli</surname><given-names>R.</given-names></name><name><surname>Cherubini</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations of GABAergic signaling in autism spectrum disorders.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2011</volume>:<issue>297153</issue>
<pub-id pub-id-type="doi">10.1155/2011/297153</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pleasure</surname><given-names>S. J.</given-names></name><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Hevner</surname><given-names>R.</given-names></name><name><surname>Bagri</surname><given-names>A.</given-names></name><name><surname>Marin</surname><given-names>O.</given-names></name><name><surname>Lowenstein</surname><given-names>D. H.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons.</article-title>
<source/><italic>Neuron</italic>
<volume>28</volume>
<fpage>727</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00149-5</pub-id><pub-id pub-id-type="pmid">11163262</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poliak</surname><given-names>S.</given-names></name><name><surname>Gollan</surname><given-names>L.</given-names></name><name><surname>Martinez</surname><given-names>R.</given-names></name><name><surname>Custer</surname><given-names>A.</given-names></name><name><surname>Einheber</surname><given-names>S.</given-names></name><name><surname>Salzer</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Caspr2 a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.</article-title>
<source/><italic>Neuron</italic>
<volume>24</volume>
<fpage>1037</fpage>–<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)81049-1</pub-id><pub-id pub-id-type="pmid">10624965</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulopoulos</surname><given-names>A.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Meyer</surname><given-names>G.</given-names></name><name><surname>Soykan</surname><given-names>T.</given-names></name><name><surname>Hoon</surname><given-names>M.</given-names></name><name><surname>Papadopoulos</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin.</article-title>
<source/><italic>Neuron</italic>
<volume>63</volume>
<fpage>628</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.023</pub-id><pub-id pub-id-type="pmid">19755106</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prange</surname><given-names>O.</given-names></name><name><surname>Wong</surname><given-names>T. P.</given-names></name><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y. T.</given-names></name><name><surname>El-Husseini</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>13915</fpage>–<lpage>13920</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0405939101</pub-id><pub-id pub-id-type="pmid">15358863</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radyushkin</surname><given-names>K.</given-names></name><name><surname>Hammerschmidt</surname><given-names>K.</given-names></name><name><surname>Boretius</surname><given-names>S.</given-names></name><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>El-Kordi</surname><given-names>A.</given-names></name><name><surname>Ronnenberg</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<volume>8</volume>
<fpage>416</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2009.00487.x</pub-id><pub-id pub-id-type="pmid">19243448</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapin</surname><given-names>I.</given-names></name><name><surname>Katzman</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>Neurobiology of autism.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>43</volume>
<fpage>7</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410430106</pub-id><pub-id pub-id-type="pmid">9450763</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinstein</surname><given-names>E.</given-names></name><name><surname>Tzur</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>R.</given-names></name><name><surname>Bormans</surname><given-names>C.</given-names></name><name><surname>Behar</surname><given-names>D. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>24</volume>
<fpage>1635</fpage>–<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2016.72</pub-id><pub-id pub-id-type="pmid">27329731</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Represa</surname><given-names>A.</given-names></name><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Trophic actions of GABA on neuronal development.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>28</volume>
<fpage>278</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2005.03.010</pub-id><pub-id pub-id-type="pmid">15927682</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Voipio</surname><given-names>J.</given-names></name><name><surname>Kaila</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>562</volume>
<fpage>27</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.077495</pub-id><pub-id pub-id-type="pmid">15528236</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodenas-Cuadrado</surname><given-names>P.</given-names></name><name><surname>Pietrafusa</surname><given-names>N.</given-names></name><name><surname>Francavilla</surname><given-names>T.</given-names></name><name><surname>La Neve</surname><given-names>A.</given-names></name><name><surname>Striano</surname><given-names>P.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Characterisation of CASPR2 deficiency disorder–a syndrome involving autism, epilepsy and language impairment.</article-title>
<source/><italic>BMC Med. Genet.</italic>
<volume>17</volume>:<issue>8</issue>
<pub-id pub-id-type="doi">10.1186/s12881-016-0272-8</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roohi</surname><given-names>J.</given-names></name><name><surname>Montagna</surname><given-names>C.</given-names></name><name><surname>Tegay</surname><given-names>D. H.</given-names></name><name><surname>Palmer</surname><given-names>L. E.</given-names></name><name><surname>DeVincent</surname><given-names>C.</given-names></name><name><surname>Pomeroy</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Disruption of contactin 4 in three subjects with autism spectrum disorder.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>46</volume>
<fpage>176</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.057505</pub-id><pub-id pub-id-type="pmid">18349135</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>J. L. R.</given-names></name><name><surname>Merzenich</surname><given-names>M. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<volume>2</volume>
<fpage>255</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id><pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>U.</given-names></name><name><surname>Möhler</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>GABA-based therapeutic approaches: GABAA receptor subtype functions.</article-title>
<source/><italic>Curr. Opin. Pharmacol.</italic>
<volume>6</volume>
<fpage>18</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2005.10.003</pub-id><pub-id pub-id-type="pmid">16376150</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudy</surname><given-names>B.</given-names></name><name><surname>Fishell</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hjerling-Leffler</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>71</volume>
<fpage>45</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20853</pub-id><pub-id pub-id-type="pmid">21154909</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiepour</surname><given-names>L.</given-names></name><name><surname>Fuchs</surname><given-names>C.</given-names></name><name><surname>Patrizi</surname><given-names>A.</given-names></name><name><surname>Sassoè-Pognetto</surname><given-names>M.</given-names></name><name><surname>Harvey</surname><given-names>R. J.</given-names></name><name><surname>Harvey</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Complex role of collybistin and gephyrin in GABAA receptor clustering.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>285</volume>
<fpage>29623</fpage>–<lpage>29631</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.121368</pub-id><pub-id pub-id-type="pmid">20622020</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Piëch</surname><given-names>V.</given-names></name><name><surname>Wilson</surname><given-names>N. R.</given-names></name><name><surname>Passafaro</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of dendritic spine morphology and synaptic function by Shank and Homer.</article-title>
<source/><italic>Neuron</italic>
<volume>31</volume>
<fpage>115</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00339-7</pub-id><pub-id pub-id-type="pmid">11498055</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Roussignol</surname><given-names>G.</given-names></name><name><surname>Meldolesi</surname><given-names>J.</given-names></name><name><surname>Fagni</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Key role of the postsynaptic density scaffold proteins Shank and Homer in the functional architecture of Ca2+ homeostasis at dendritic spines in hippocampal neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>4587</fpage>–<lpage>4592</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4822-04.2005</pub-id><pub-id pub-id-type="pmid">15872106</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Vicidomini</surname><given-names>C.</given-names></name><name><surname>Bigi</surname><given-names>I.</given-names></name><name><surname>Mossa</surname><given-names>A.</given-names></name><name><surname>Verpelli</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>135</volume>
<fpage>849</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13232</pub-id><pub-id pub-id-type="pmid">26338675</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Hus</surname><given-names>V.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Murtha</surname><given-names>M. T.</given-names></name><name><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism.</article-title>
<source/><italic>Neuron</italic>
<volume>70</volume>
<fpage>863</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.002</pub-id><pub-id pub-id-type="pmid">21658581</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>SHANK1 deletions in males with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>879</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.017</pub-id><pub-id pub-id-type="pmid">22503632</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheiffele</surname><given-names>P.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Choih</surname><given-names>J.</given-names></name><name><surname>Fetter</surname><given-names>R.</given-names></name><name><surname>Serafini</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.</article-title>
<source/><italic>Cell</italic>
<volume>101</volume>
<fpage>657</fpage>–<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80877-6</pub-id><pub-id pub-id-type="pmid">10892652</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmeisser</surname><given-names>M. J.</given-names></name><name><surname>Ey</surname><given-names>E.</given-names></name><name><surname>Wegener</surname><given-names>S.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Stempel</surname><given-names>A. V.</given-names></name><name><surname>Kuebler</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2.</article-title>
<source/><italic>Nature</italic>
<volume>486</volume>
<fpage>256</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1038/nature11015</pub-id><pub-id pub-id-type="pmid">22699619</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selmer</surname><given-names>K. K.</given-names></name><name><surname>Lund</surname><given-names>C.</given-names></name><name><surname>Brandal</surname><given-names>K.</given-names></name><name><surname>Undlien</surname><given-names>D. E.</given-names></name><name><surname>Brodtkorb</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<volume>16</volume>
<fpage>555</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2009.08.021</pub-id><pub-id pub-id-type="pmid">19782004</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sesarini</surname><given-names>C. V.</given-names></name><name><surname>Costa</surname><given-names>L.</given-names></name><name><surname>Grañana</surname><given-names>N.</given-names></name><name><surname>Coto</surname><given-names>M. G.</given-names></name><name><surname>Pallia</surname><given-names>R. C.</given-names></name><name><surname>Argibay</surname><given-names>P. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Association between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD).</article-title>
<source/><italic>Psychiatry Res.</italic>
<volume>229</volume>
<fpage>580</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2015.07.077</pub-id><pub-id pub-id-type="pmid">26239769</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahbazian</surname><given-names>M.</given-names></name><name><surname>Young</surname><given-names>J.</given-names></name><name><surname>Yuva-Paylor</surname><given-names>L.</given-names></name><name><surname>Spencer</surname><given-names>C.</given-names></name><name><surname>Antalffy</surname><given-names>B.</given-names></name><name><surname>Noebels</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.</article-title>
<source/><italic>Neuron</italic>
<volume>35</volume>
<fpage>243</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00768-7</pub-id><pub-id pub-id-type="pmid">12160743</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>The Shank family of scaffold proteins.</article-title>
<source/><italic>J. Cell Sci.</italic>
<volume>113(Pt 11)</volume>, <fpage>1851</fpage>–<lpage>1856</lpage>.<pub-id pub-id-type="pmid">10806096</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimojima</surname><given-names>K.</given-names></name><name><surname>Sugawara</surname><given-names>M.</given-names></name><name><surname>Shichiji</surname><given-names>M.</given-names></name><name><surname>Mukaida</surname><given-names>S.</given-names></name><name><surname>Takayama</surname><given-names>R.</given-names></name><name><surname>Imai</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>56</volume>
<fpage>561</fpage>–<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2011.58</pub-id><pub-id pub-id-type="pmid">21633362</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shmuely</surname><given-names>S.</given-names></name><name><surname>Sisodiya</surname><given-names>S. M.</given-names></name><name><surname>Gunning</surname><given-names>W. B.</given-names></name><name><surname>Sander</surname><given-names>J. W.</given-names></name><name><surname>Thijs</surname><given-names>R. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Mortality in Dravet syndrome: a review.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<volume>64</volume>
<fpage>69</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.09.007</pub-id><pub-id pub-id-type="pmid">27732919</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigel</surname><given-names>E.</given-names></name><name><surname>Steinmann</surname><given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Structure, function, and modulation of GABAA receptors.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>40224</fpage>–<lpage>40231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R112.386664</pub-id><pub-id pub-id-type="pmid">23038269</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soghomonian</surname><given-names>J.-J.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Reprakash</surname><given-names>S.</given-names></name><name><surname>Blatt</surname><given-names>G. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Decreased parvalbumin mRNA levels in cerebellar Purkinje cells in autism.</article-title>
<source/><italic>Autism Res.</italic>
<volume>10</volume>
<fpage>1787</fpage>–<lpage>1796</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1835</pub-id><pub-id pub-id-type="pmid">28707805</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J. Y.</given-names></name><name><surname>Ichtchenko</surname><given-names>K.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>1999</year>). <article-title>Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>1100</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.3.1100</pub-id><pub-id pub-id-type="pmid">9927700</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Pevsner</surname><given-names>J.</given-names></name><name><surname>Aradhya</surname><given-names>S.</given-names></name><name><surname>McKnight</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A novel variant in <italic>GABRB2</italic> associated with intellectual disability and epilepsy.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>164</volume>
<fpage>2914</fpage>–<lpage>2921</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36714</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>W. M.</given-names></name><name><surname>Sander</surname><given-names>J. W.</given-names></name><name><surname>Rothwell</surname><given-names>J. C.</given-names></name><name><surname>Sisodiya</surname><given-names>S. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome.</article-title>
<source/><italic>Neurology</italic>
<volume>88</volume>
<fpage>1659</fpage>–<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000003868</pub-id><pub-id pub-id-type="pmid">28356460</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>K. A.</given-names></name><name><surname>Puffenberger</surname><given-names>E. G.</given-names></name><name><surname>Huentelman</surname><given-names>M. J.</given-names></name><name><surname>Gottlieb</surname><given-names>S.</given-names></name><name><surname>Dobrin</surname><given-names>S. E.</given-names></name><name><surname>Parod</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>354</volume>
<fpage>1370</fpage>–<lpage>1377</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa052773</pub-id><pub-id pub-id-type="pmid">16571880</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Galijaard</surname><given-names>R. J.</given-names></name><name><surname>Matsuura</surname><given-names>T.</given-names></name><name><surname>Fang</surname><given-names>P.</given-names></name><name><surname>Kubota</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.</article-title>
<source/><italic>Genome Res.</italic>
<volume>7</volume>
<fpage>368</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1101/gr.7.4.368</pub-id><pub-id pub-id-type="pmid">9110176</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname><given-names>P. Y.</given-names></name></person-group> (<year>1979</year>). <article-title>L-Glutamate decarboxylase.</article-title>
<source/><italic>Adv. Exp. Med. Biol.</italic>
<volume>123</volume>
<fpage>59</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4899-5199-1_4</pub-id><pub-id pub-id-type="pmid">390996</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>Hammer</surname><given-names>R. E.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Powell</surname><given-names>C. M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.</article-title>
<source/><italic>Science</italic>
<volume>318</volume>
<fpage>71</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1126/science.1146221</pub-id><pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Südhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing.</article-title>
<source/><italic>Genomics</italic>
<volume>79</volume>
<fpage>849</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1006/geno.2002.6780</pub-id><pub-id pub-id-type="pmid">12036300</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>C.</given-names></name><name><surname>Abe</surname><given-names>Y.</given-names></name><name><surname>Westenbroek</surname><given-names>R. E.</given-names></name><name><surname>Scheuer</surname><given-names>T.</given-names></name><name><surname>Catterall</surname><given-names>W. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>111</volume>
<fpage>E3139</fpage>–<lpage>E3148</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1411131111</pub-id><pub-id pub-id-type="pmid">25024183</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>DeLorey</surname><given-names>T. M.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2012</year>). “<article-title>GABRB3 epilepsy, and neurodevelopment</article-title>,” in <source/><italic>Jasper’s Basic Mechanisms of the Epilepsies</italic>, <role>eds</role>
<person-group person-group-type="editor"><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Avoli</surname><given-names>M.</given-names></name><name><surname>Rogawski</surname><given-names>M. A.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name><name><surname>Delgado-Escueta</surname><given-names>A. V.</given-names></name></person-group> (<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Center for Biotechnology Information</publisher-name>). Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK98178/">http://www.ncbi.nlm.nih.gov/books/NBK98178/</ext-link></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Wengert</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>751</fpage>–<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1524013113</pub-id><pub-id pub-id-type="pmid">26733678</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarquinio</surname><given-names>D. C.</given-names></name><name><surname>Hou</surname><given-names>W.</given-names></name><name><surname>Berg</surname><given-names>A.</given-names></name><name><surname>Kaufmann</surname><given-names>W. E.</given-names></name><name><surname>Lane</surname><given-names>J. B.</given-names></name><name><surname>Skinner</surname><given-names>S. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Longitudinal course of epilepsy in Rett syndrome and related disorders.</article-title>
<source/><italic>Brain</italic>
<volume>140</volume>
<fpage>306</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww302</pub-id><pub-id pub-id-type="pmid">28007990</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tick</surname><given-names>B.</given-names></name><name><surname>Bolton</surname><given-names>P.</given-names></name><name><surname>Happé</surname><given-names>F.</given-names></name><name><surname>Rutter</surname><given-names>M.</given-names></name><name><surname>Rijsdijk</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Heritability of autism spectrum disorders: a meta-analysis of twin studies.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>57</volume>
<fpage>585</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1111/jcpp.12499</pub-id><pub-id pub-id-type="pmid">26709141</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tijssen</surname><given-names>M. A.</given-names></name><name><surname>Rees</surname><given-names>M. I.</given-names></name></person-group> (<year>1993</year>). “<article-title>Hyperekplexia</article-title>,” in <source/><italic>GeneReviews</italic>(<italic><sup>®</sup></italic>), <role>eds</role>
<person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>R. A.</given-names></name><name><surname>Adam</surname><given-names>M. P.</given-names></name><name><surname>Ardinger</surname><given-names>H. H.</given-names></name><name><surname>Wallace</surname><given-names>S. E.</given-names></name><name><surname>Amemiya</surname><given-names>A.</given-names></name><name><surname>Bean</surname><given-names>L. J.</given-names></name><etal></etal></person-group> (<publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name>). Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1260/">http://www.ncbi.nlm.nih.gov/books/NBK1260/</ext-link></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>J. T.</given-names></name><name><surname>Peça</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>35</volume>
<fpage>49</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-062111-150442</pub-id><pub-id pub-id-type="pmid">22540979</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Fritschy</surname><given-names>J.-M.</given-names></name><name><surname>Pangalos</surname><given-names>M. N.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>1356</fpage>–<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5050-07.2008</pub-id><pub-id pub-id-type="pmid">18256255</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Kerschner</surname><given-names>B.</given-names></name><name><surname>Milenkovic</surname><given-names>I.</given-names></name><name><surname>Ramsden</surname><given-names>S. L.</given-names></name><name><surname>Ramerstorfer</surname><given-names>J.</given-names></name><name><surname>Saiepour</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Molecular basis of the γ-aminobutyric acid A receptor α3 subunit interaction with the clustering protein gephyrin.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>37702</fpage>–<lpage>37711</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.291336</pub-id><pub-id pub-id-type="pmid">21880742</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urraca</surname><given-names>N.</given-names></name><name><surname>Cleary</surname><given-names>J.</given-names></name><name><surname>Brewer</surname><given-names>V.</given-names></name><name><surname>Pivnick</surname><given-names>E. K.</given-names></name><name><surname>McVicar</surname><given-names>K.</given-names></name><name><surname>Thibert</surname><given-names>R. L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The interstitial duplication 15q11.2<italic>-q</italic>13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature.</article-title>
<source/><italic>Autism Res.</italic>
<volume>6</volume>
<fpage>268</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1284</pub-id><pub-id pub-id-type="pmid">23495136</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Rawson</surname><given-names>R. L.</given-names></name><name><surname>Mohrmann</surname><given-names>R.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><name><surname>Gottmann</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Neuroligins determine synapse maturation and function.</article-title>
<source/><italic>Neuron</italic>
<volume>51</volume>
<fpage>741</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.003</pub-id><pub-id pub-id-type="pmid">16982420</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroligin 2 is exclusively localized to inhibitory synapses.</article-title>
<source/><italic>Eur. J. Cell Biol.</italic>
<volume>83</volume>
<fpage>449</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1078/0171-9335-00410</pub-id><pub-id pub-id-type="pmid">15540461</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdoorn</surname><given-names>T. A.</given-names></name><name><surname>Draguhn</surname><given-names>A.</given-names></name><name><surname>Ymer</surname><given-names>S.</given-names></name><name><surname>Seeburg</surname><given-names>P. H.</given-names></name><name><surname>Sakmann</surname><given-names>B.</given-names></name></person-group> (<year>1990</year>). <article-title>Functional properties of recombinant rat GABAA receptors depend upon subunit composition.</article-title>
<source/><italic>Neuron</italic>
<volume>4</volume>
<fpage>919</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(90)90145-6</pub-id><pub-id pub-id-type="pmid">1694446</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Newbury</surname><given-names>D. F.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Winchester</surname><given-names>L.</given-names></name><name><surname>Nicod</surname><given-names>J.</given-names></name><name><surname>Groszer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>A functional genetic link between distinct developmental language disorders.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>359</volume>
<fpage>2337</fpage>–<lpage>2345</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0802828</pub-id><pub-id pub-id-type="pmid">18987363</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verpelli</surname><given-names>C.</given-names></name><name><surname>Dvoretskova</surname><given-names>E.</given-names></name><name><surname>Vicidomini</surname><given-names>C.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name><name><surname>Chiappalone</surname><given-names>M.</given-names></name><name><surname>Schoen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>34839</fpage>–<lpage>34850</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.258384</pub-id><pub-id pub-id-type="pmid">21795692</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vien</surname><given-names>T. N.</given-names></name><name><surname>Modgil</surname><given-names>A.</given-names></name><name><surname>Abramian</surname><given-names>A. M.</given-names></name><name><surname>Jurd</surname><given-names>R.</given-names></name><name><surname>Walker</surname><given-names>J.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Compromising the phosphodependent regulation of the GABAAR β3 subunit reproduces the core phenotypes of autism spectrum disorders.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>14805</fpage>–<lpage>14810</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1514657112</pub-id><pub-id pub-id-type="pmid">26627235</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignoli</surname><given-names>A.</given-names></name><name><surname>Savini</surname><given-names>M. N.</given-names></name><name><surname>Nowbut</surname><given-names>M. S.</given-names></name><name><surname>Peron</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>K.</given-names></name><name><surname>La Briola</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<volume>66</volume>
<fpage>27</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.10.006</pub-id><pub-id pub-id-type="pmid">27988477</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>D.</given-names></name><name><surname>Cho</surname><given-names>K. K. A.</given-names></name><name><surname>Shelton</surname><given-names>S. M.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>Z. J.</given-names></name><name><surname>Sohal</surname><given-names>V. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Mouse Cntnap2 and human CNTNAP2 ASD alleles cell autonomously regulate PV+ cortical interneurons.</article-title>
<source/><italic>Cereb. Cortex</italic>
<pub-id pub-id-type="doi">10.1093/cercor/bhx248</pub-id>
<comment>[Epub ahead of print]</comment>.</mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>M. L.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Weinberg</surname><given-names>R. J.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects.</article-title>
<source/><italic>Neuron</italic>
<volume>74</volume>
<fpage>793</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.036</pub-id><pub-id pub-id-type="pmid">22681684</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>R. H.</given-names></name><name><surname>Marini</surname><given-names>C.</given-names></name><name><surname>Petrou</surname><given-names>S.</given-names></name><name><surname>Harkin</surname><given-names>L. A.</given-names></name><name><surname>Bowser</surname><given-names>D. N.</given-names></name><name><surname>Panchal</surname><given-names>R. G.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Mutant GABA<sub>A</sub> receptor γ2-subunit in childhood absence epilepsy and febrile seizures.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>28</volume>
<fpage>49</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/ng0501-49</pub-id><pub-id pub-id-type="pmid">11326275</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>C. M.</given-names></name><name><surname>Crinnion</surname><given-names>L. A.</given-names></name><name><surname>Tzika</surname><given-names>A.</given-names></name><name><surname>Mills</surname><given-names>A.</given-names></name><name><surname>Coates</surname><given-names>A.</given-names></name><name><surname>Pendlebury</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Diagnostic whole genome sequencing and split-read mapping for nucleotide resolution breakpoint identification in CNTNAP2 deficiency syndrome.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>164A</volume>, <fpage>2649</fpage>–<lpage>2655</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36679</pub-id><pub-id pub-id-type="pmid">25045150</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wefelmeyer</surname><given-names>W.</given-names></name><name><surname>Cattaert</surname><given-names>D.</given-names></name><name><surname>Burrone</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Activity-dependent mismatch between axo-axonic synapses and the axon initial segment controls neuronal output.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>9757</fpage>–<lpage>9762</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1502902112</pub-id><pub-id pub-id-type="pmid">26195803</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiting</surname><given-names>P. J.</given-names></name><name><surname>McKernan</surname><given-names>R. M.</given-names></name><name><surname>Wafford</surname><given-names>K. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Structure and pharmacology of vertebrate GABAA receptor subtypes.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>38</volume>
<fpage>95</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(08)60525-5</pub-id><pub-id pub-id-type="pmid">8537206</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wimmer</surname><given-names>V. C.</given-names></name><name><surname>Reid</surname><given-names>C. A.</given-names></name><name><surname>So</surname><given-names>E. Y.-W.</given-names></name><name><surname>Berkovic</surname><given-names>S. F.</given-names></name><name><surname>Petrou</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Axon initial segment dysfunction in epilepsy.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>588</volume>
<fpage>1829</fpage>–<lpage>1840</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2010.188417</pub-id><pub-id pub-id-type="pmid">20375142</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wöhr</surname><given-names>M.</given-names></name><name><surname>Orduz</surname><given-names>D.</given-names></name><name><surname>Gregory</surname><given-names>P.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>U.</given-names></name><name><surname>Vörckel</surname><given-names>K. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>5</volume>:<issue>e525</issue>
<pub-id pub-id-type="doi">10.1038/tp.2015.19</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y. W.</given-names></name><name><surname>Sullivan</surname><given-names>J.</given-names></name><name><surname>McDaniel</surname><given-names>S. S.</given-names></name><name><surname>Meisler</surname><given-names>M. H.</given-names></name><name><surname>Walsh</surname><given-names>E. M.</given-names></name><name><surname>Li</surname><given-names>S. X.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Incidence of dravet syndrome in a US population.</article-title>
<source/><italic>Pediatrics</italic>
<volume>136</volume>
<fpage>e1310</fpage>–<lpage>e1315</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2015-1807</pub-id><pub-id pub-id-type="pmid">26438699</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagata</surname><given-names>T.</given-names></name><name><surname>Ogiwara</surname><given-names>I.</given-names></name><name><surname>Mazaki</surname><given-names>E.</given-names></name><name><surname>Yanagawa</surname><given-names>Y.</given-names></name><name><surname>Yamakawa</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Nav1.2 is expressed in caudal ganglionic eminence-derived disinhibitory interneurons: Mutually exclusive distributions of Nav1.1 and Nav1.2.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>491</volume>
<fpage>1070</fpage>–<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.08.013</pub-id><pub-id pub-id-type="pmid">28784306</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>F. H.</given-names></name><name><surname>Mantegazza</surname><given-names>M.</given-names></name><name><surname>Westenbroek</surname><given-names>R. E.</given-names></name><name><surname>Robbins</surname><given-names>C. A.</given-names></name><name><surname>Kalume</surname><given-names>F.</given-names></name><name><surname>Burton</surname><given-names>K. A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>9</volume>
<fpage>1142</fpage>–<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.1038/nn1754</pub-id><pub-id pub-id-type="pmid">16921370</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Atasoy</surname><given-names>D.</given-names></name><name><surname>Araç</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Fucillo</surname><given-names>M. V.</given-names></name><name><surname>Robison</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neurexins physically and functionally interact with GABA(A) receptors.</article-title>
<source/><italic>Neuron</italic>
<volume>66</volume>
<fpage>403</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.04.008</pub-id><pub-id pub-id-type="pmid">20471353</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Jugloff</surname><given-names>D. G. M.</given-names></name><name><surname>Eubanks</surname><given-names>J. H.</given-names></name></person-group> (<year>2008</year>). <article-title>The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability.</article-title>
<source/><italic>Hippocampus</italic>
<volume>18</volume>
<fpage>294</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20389</pub-id><pub-id pub-id-type="pmid">18058824</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Cui</surname><given-names>N.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Oginsky</surname><given-names>M. F.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Methyl CpG binding protein 2 gene disruption augments tonic currents of γ-aminobutyric acid receptors in locus coeruleus neurons: impact on neuronal excitability and breathing.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>290</volume>
<fpage>18400</fpage>–<lpage>18411</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.650465</pub-id><pub-id pub-id-type="pmid">25979331</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuko</surname><given-names>A.</given-names></name><name><surname>Kleijer</surname><given-names>K. T. E.</given-names></name><name><surname>Oguro-Ando</surname><given-names>A.</given-names></name><name><surname>Kas</surname><given-names>M. J. H.</given-names></name><name><surname>van Daalen</surname><given-names>E.</given-names></name><name><surname>van der Zwaag</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Contactins in the neurobiology of autism.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>719</volume>
<fpage>63</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2013.07.016</pub-id><pub-id pub-id-type="pmid">23872404</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>